
<html lang="en"     class="pb-page"  data-request-id="9794b94c-9578-46e6-8092-301615c2df08"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm9017465;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2010.53.issue-5;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Smoking Cessation" /></meta><meta name="dc.Creator" content="F. Ivy  Carroll" /></meta><meta name="dc.Creator" content="Bruce E.  Blough" /></meta><meta name="dc.Creator" content="S. Wayne  Mascarella" /></meta><meta name="dc.Creator" content="Hernán A.  Navarro" /></meta><meta name="dc.Creator" content="J. Brek  Eaton" /></meta><meta name="dc.Creator" content="Ronald J.  Lukas" /></meta><meta name="dc.Creator" content="M. Imad  Damaj" /></meta><meta name="dc.Description" content="Bupropion (2a) analogues were synthesized and tested for their ability to inhibit monoamine uptake and to antagonize the effects of human α3β4*, α4β2, α4β4, and α1* nAChRs. The analogues were evalu..." /></meta><meta name="Description" content="Bupropion (2a) analogues were synthesized and tested for their ability to inhibit monoamine uptake and to antagonize the effects of human α3β4*, α4β2, α4β4, and α1* nAChRs. The analogues were evalu..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 16, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm9017465" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm9017465" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm9017465" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm9017465" /></link>
        
    
    

<title>Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Smoking Cessation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm9017465" /></meta><meta property="og:title" content="Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Smoking Cessation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0003.jpeg" /></meta><meta property="og:description" content="Bupropion (2a) analogues were synthesized and tested for their ability to inhibit monoamine uptake and to antagonize the effects of human α3β4*, α4β2, α4β4, and α1* nAChRs. The analogues were evaluated for their ability to block nicotine-induced effects in four tests in mice. Nine analogues showed increased monoamine uptake inhibition. Similar to 2a, all but one analogue show inhibition of nAChR function selective for human α3β4*-nAChR. Nine analogues have higher affinity at α3β4*-nAChRs than 2a. Four analogues also had higher affinity for α4β2 nAChR. Analogues 2r, 2m, and 2n with AD50 values of 0.014, 0.015, and 0.028 mg/kg were 87, 81, and 43 times more potent than 2a in blocking nicotine-induced antinociception in the tail-flick test. Analogue 2x with IC50 values of 31 and 180 nM for DA and NE, respectively, and with IC50 of 0.62 and 9.8 μm for antagonism of α3β4 and α4β2 nAChRs had the best overall in vitro profile relative to 2a." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm9017465"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm9017465">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm9017465&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm9017465&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm9017465&amp;href=/doi/10.1021/jm9017465" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2204-2214</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901905j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901755g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Smoking Cessation</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F.+Ivy++Carroll">F. Ivy Carroll</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+E.++Blough">Bruce E. Blough</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S.+Wayne++Mascarella">S. Wayne Mascarella</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hern%C3%A1n+A.++Navarro">Hernán A. Navarro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J.+Brek++Eaton">J. Brek Eaton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald+J.++Lukas">Ronald J. Lukas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=M.+Imad++Damaj">M. Imad Damaj</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Center for Organic and Medicinal Chemistry, Research Triangle Institute, Research Triangle Park, North Carolina 27709-2194</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmacology and Toxicology, Medical Campus, Virginia Commonwealth University, Richmond, Virginia 23219</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Telephone: 919-541-6679. Fax: 919-541-8868. E-mail: <a href="/cdn-cgi/l/email-protection#f2949b91b280869bdc9d8095"><span class="__cf_email__" data-cfemail="30565953704244591e5f4257">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm9017465&amp;href=/doi/10.1021%2Fjm9017465" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2204–2214</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 16, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 November 2009</li><li><span class="item_label"><b>Published</b> online</span>16 February 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 March 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm9017465" title="DOI URL">https://doi.org/10.1021/jm9017465</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2204%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DF.%2BIvy%2BCarroll%252C%2BBruce%2BE.%2BBlough%252C%2BS.%2BWayne%2BMascarella%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D5%26contentID%3Djm9017465%26title%3DSynthesis%2Band%2BBiological%2BEvaluation%2Bof%2BBupropion%2BAnalogues%2Bas%2BPotential%2BPharmacotherapies%2Bfor%2BSmoking%2BCessation%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2214%26publicationDate%3DMarch%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm9017465"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2681</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">34</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm9017465" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Smoking Cessation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;Ivy Carroll&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;E. Blough&quot;},{&quot;first_name&quot;:&quot;S.&quot;,&quot;last_name&quot;:&quot;Wayne Mascarella&quot;},{&quot;first_name&quot;:&quot;Hernán&quot;,&quot;last_name&quot;:&quot;A. Navarro&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Brek Eaton&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;J. Lukas&quot;},{&quot;first_name&quot;:&quot;M.&quot;,&quot;last_name&quot;:&quot;Imad Damaj&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;2204-2214&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm9017465&quot;},&quot;abstract&quot;:&quot;Bupropion (2a) analogues were synthesized and tested for their ability to inhibit monoamine uptake and to antagonize the effects of human α3β4*, α4β2, α4β4, and α1* nAChRs. The analogues were evaluated for their ability to block nicotine-induced effects in four tests in mice. Nine analogues showed increased monoamine uptake inhibition. Similar to 2a, all but one analogue show inhibition of nAChR function selective for human α3β4*-nAChR. Nine analogues have higher affinity at α3β4*-nAChRs than 2a. Four analogues also had higher affinity for α4β2 nAChR. Analogues 2r, 2m, and 2n with AD50 values of 0.014, 0.015, and 0.028 mg/kg were 87, 81, and 43 times more potent than 2a in blocking nicotine-induced antinociception in the tail-flick test. Analogue 2x with IC50 values of 31 and 180 nM for DA and NE, respectively, and with IC50 of 0.62 and 9.8 μm for antagonism of α3β4 and α4β2 nAChRs had the best overall in vitro profile relative to 2a.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9017465&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9017465" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9017465&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9017465" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9017465&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9017465" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm9017465&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9017465&amp;href=/doi/10.1021/jm9017465" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm9017465" /></input><a href="/doi/pdf/10.1021/jm9017465" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (941 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm9017465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm9017465%26sid%3Dliteratum%253Aachs%26pmid%3D20158204%26genre%3Darticle%26aulast%3DCarroll%26date%3D2010%26atitle%3DSynthesis%2Band%2BBiological%2BEvaluation%2Bof%2BBupropion%2BAnalogues%2Bas%2BPotential%2BPharmacotherapies%2Bfor%2BSmoking%2BCessation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D5%26spage%3D2204%26epage%3D2214%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291184" title="Nicotine">Nicotine</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/medium/jm-2009-017465_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9017465&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Bupropion (<b>2a</b>) analogues were synthesized and tested for their ability to inhibit monoamine uptake and to antagonize the effects of human α3β4*, α4β2, α4β4, and α1* nAChRs. The analogues were evaluated for their ability to block nicotine-induced effects in four tests in mice. Nine analogues showed increased monoamine uptake inhibition. Similar to <b>2a</b>, all but one analogue show inhibition of nAChR function selective for human α3β4*-nAChR. Nine analogues have higher affinity at α3β4*-nAChRs than <b>2a</b>. Four analogues also had higher affinity for α4β2 nAChR. Analogues <b>2r</b>, <b>2m</b>, and <b>2n</b> with AD<sub>50</sub> values of 0.014, 0.015, and 0.028 mg/kg were 87, 81, and 43 times more potent than <b>2a</b> in blocking nicotine-induced antinociception in the tail-flick test. Analogue <b>2x</b> with IC<sub>50</sub> values of 31 and 180 nM for DA and NE, respectively, and with IC<sub>50</sub> of 0.62 and 9.8 μm for antagonism of α3β4 and α4β2 nAChRs had the best overall in vitro profile relative to <b>2a</b>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tobacco-related diseases remain as the predominant cause of premature mortality. An estimated one billion individuals worldwide are smokers.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Despite recent declines, it is estimated that 21% of the adult population in the U.S. are active smokers.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Since less than 10% of smokers are capable of quitting unaided, improvements in the clinical management of smoking are needed.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Nicotine (<b>1</b>, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) is the main active ingredient in tobacco smoke that causes and maintains tobacco addiction. Nicotine produces a myriad of profound behavioral and physiological effects and is able to initiate and support drug-seeking behavior in humans and in laboratory animals.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The pharmacological and behavioral effects result from the activation of different nicotinic acetylcholine receptor (nAChR<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: DA, dopamine; 5HT, serotonin; NE, norepinephrine; SR, sustained release; HEK, human embryonic kidney; DAT, dopamine transporter; SERT, serotonin transporter; NET, norepinephrine transporter; nAChR, nicotinic acetylcholine receptor; VTA, ventral tegmental area; NRT, nicotine replacement therapy; CTDP, Cocaine Treatment Discovery Program; NIDA, National Institute on Drug Abuse; MPE, maximum possible effect.</p></div> subtypes, which are members of an ionotropic neurotransmitter receptor superfamily.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> nAChRs containing α4 and β2 or α7 subunits (α4β2- and α7-nAChR, respectively) are the two major subtypes found in the brain, although appreciable amounts of α3β4*- and α6β2*-nAChRs also are present in brain regions implicated in reward and drug dependence such as the substantia nigra, the ventral tegmental area (VTA), and the medial habenula system.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10">(6-10)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/medium/jm-2009-017465_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0005.jpeg" id="_i2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9017465&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although nAChRs are the initial sites of action of nicotine in the brain, downstream events involving dopaminergic reward pathways may be critical in reinforcing smoking behavior. Nicotine, similar to other abused substances, is thought to be reinforcing because of the stimulation of mesolimbic dopamine reinforcement pathways.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Cigarette smoking acutely increases dopamine (DA) concentration in the ventral striatum/nucleus accumbens, key brain regions in the reward pathway.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">The first line medications on the market today to treat nicotine addiction are various nicotine replacement (NRT) formulations (nicotine gum, transdermal nicotine patches, vapor inhaler, nicotab, nasal spray, lozenges), presumed to mimic effects of tobacco-derived nicotine, the antidepressant bupropion (<b>2a</b>), and varenicline (<b>3</b>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Both varenicline and bupropion SR (a sustained-release formulation) reduce symptoms of withdrawal, cigarette craving, and smoking reinforcement and produce smoking cessation with efficacy equal to or better than nicotine replacement.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, none of these therapies has proven to be ideal, as smoking relapse still occurs at alarmingly high rates even after successful short-term therapies.</div><div class="NLM_p">The use of <b>2a</b> for treating nicotine addiction resulted from serendipitous observations that patients taking <b>2a</b> as an antidepressant were more successful in smoking cessation attempts. It was known that <b>2a</b> inhibited DA and norepinephrine (NE) uptake activity, but the discovery that it also preferentially antagonized α3β4*-nAChR<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> suggested that more than one of these targets might be involved in its smoking cessation efficacy. It is possible that bupropion SR is achieving its effects by increasing dopamine levels through DA uptake inhibition and shielding against nicotine induction of nAChR-mediated dopamine elevation. Although it is not clear what part if any is played by the ability of <b>2a</b> to inhibit NE uptake in its smoking cessation activity, it is likely to contribute to nicotine withdrawal amelioration. Surprisingly, very little effort has been devoted toward the development of <b>2a</b> analogues with improved smoking cessation properties.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a></div><div class="NLM_p">Compound <b>2a</b> inhibits DA reuptake, increasing the synaptic levels of DA. Compound <b>2a</b> also inhibits nicotine-induced DA and NE overflow from superfused striatial and hippocampal slices, respectively.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Thus, <b>2a</b> might be functioning as an indirect DA agonist by reward modulation of this downstream action of nicotine. The ability of <b>2a</b> to alleviate withdrawal symptoms is consistent with an indirect dopamine agonist mechanism.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Compound <b>2a</b> noncompetitively inhibits carbamylcholine-induced <sup>86</sup>Rb<sup>+</sup> efflux from human neuroblastoma cells expressing α3β4*-nAChR<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and function of α3β2-, α4β2-, and α7-nAChR heterologously expressed in Xenopus oocytes.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Other studies suggest that α3β4*-nAChR plays a major role in nicotine-evoked NE release from hippocampus.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a></div><div class="NLM_p last">We recently reported the synthesis of a number of <b>2a</b> analogues that were evaluated for their abilities to inhibit neurotransmitter uptake by the dopamine, norepinephrine, or serotonin (5HT) transporters, DAT, NET, or SERT, respectively, under the National Institute on Drug Abuse (NIDA) Cocaine Treatment Discovery Program (CTDP).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Those studies sought to identify entities with better potency and selectivity toward DAT than <b>2a</b> and whose activity as an indirect dopamine agonist might reveal a novel pharmacotherapy for treating cocaine addiction. In the current study, we designed and developed <b>2a</b> analogues as smoking cessation aids, seeking entities that possess increased inhibitory activity for DA and NE uptake inhibition and/or nAChR antagonism while retaining the druglike properties of the lead compound. In this study we report the synthesis and biological evaluation of <b>2a</b> analogues <b>2b</b>−<b>ff</b>, <b>4</b>, and <b>5</b>. Some of the analogues have higher inhibitory potencies than <b>2a</b> at DAT and NET as well as at α3β4*-nAChR. In addition, some of the compounds antagonize the antinociceptive, hyperlocomotor, and hypothermic effects of acutely administered nicotine in mice with potencies greater than that of <b>2a</b>. 2-(<i>N</i>-<i>tert</i>-Butylamino)-3′,4-dichloropentanophenone (<b>2x</b>), which was 41- and 7.5-fold more potent in inhibition of DA and NE uptake and 3-fold more potent as an α3β4*-nAChR antagonist than <b>2a</b>, is one of the more interesting compounds. Compound <b>2x</b> is also 9 times more potent than <b>2a</b> as an antagonist of nicotine-induced antinociception in the mouse tail-flick test.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43444" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43444" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The <b>2a</b> analogues <b>2b</b>−<b>d</b>, <b>2g</b>−<b>p</b>, <b>2r</b>, <b>2w</b>−<b>z</b>, <b>2ff</b>, <b>4</b>, and <b>5</b> were synthesized as previously reported.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The new <b>2a</b> analogues <b>2e</b>, <b>2f</b>, <b>2q</b>, <b>2s</b>−<b>v</b>, and <b>2aa−ee</b> were prepared using procedures exactly analogous to those used to synthesize the reported analogues. Thus, bromination of the ketones <b>6a</b>−<b>e</b> with bromine in acetic acid afforded the bromoketones <b>7a</b>−<b>e</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Treatment of <b>7a</b>−<b>e</b> with <i>tert</i>-butylamine, cyclopentylamine, and piperidine yielded the desired <b>2a</b> analogues <b>2e</b>, <b>2f</b>, <b>2q</b>, <b>2s</b>−<b>v</b>, <b>2aa</b>−<b>ee</b>, <b>4</b>, and <b>5</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/medium/jm-2009-017465_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <i><sup>a</sup></i></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9017465&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> In Vitro Assays</h3><div class="NLM_p">The <b>2a</b> analogues <b>2b</b>−<b>ff</b>, <b>4</b>, and <b>5</b> were evaluated for their ability to block reuptake of [<sup>3</sup>H]dopamine ([<sup>3</sup>H]DA), [<sup>3</sup>H]serotonin ([<sup>3</sup>H]5HT), and [<sup>3</sup>H]norepinephrine ([<sup>3</sup>H]NE) using (h)DAT, (h)SERT, and h(NET) stably expressed in HEK293 cells using conditions similar to those previously reported.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> The results are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. [<sup>3</sup>H]DA, [<sup>3</sup>H]5HT, and [<sup>3</sup>H]NE uptake values for <b>2a</b> and analogues <b>2b</b>−<b>d</b>, <b>2g</b>−<b>p</b>, <b>2r</b>, and <b>2n</b>−<b>z</b> were obtained as a part of the NIDA CTDP and previously reported.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> For the most part, the relative potency in both evaluations was the same. However, in general, the efficacy in this study tended to be higher (lower IC<sub>50</sub> values) for all analogues than the efficacies obtained in the CTDP program.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> There were some exceptions. For example, in the case of <b>2o</b>, we obtained IC<sub>50</sub> values of 209, 607, and 16 000 nM for the inhibition of [<sup>3</sup>H]DA, [<sup>3</sup>H]SERT, and [<sup>3</sup>H]NE uptake compared to 31 and 969 nM and inactive in the CTDP program.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Analogue Inhibition of Monoamine Uptake and Nicotinic Acetylcholine Receptor (nAChR) Function</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/medium/jm-2009-017465_0004.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th><th colspan="3" align="center">monoamine uptake inhibition<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><br /></br>IC<sub>50</sub> (nM)</th><th colspan="4" align="center">nAChR inhibition<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><br /></br>IC<sub>50</sub> (μM)</th></tr><tr valign="top"><th align="center">compd</th><th align="center">R</th><th align="center">R<sub>1</sub></th><th align="center">R<sub>2</sub></th><th align="center">X</th><th align="center">Y</th><th align="center">Z</th><th align="center">[<sup>3</sup>H]DA</th><th align="center">[<sup>3</sup>H]NE</th><th align="center">[<sup>3</sup>H]SERT</th><th align="center">α3β4*-</th><th align="center">α4β2-</th><th align="center">α4β4-</th><th align="center">α1*-</th></tr></thead><tbody><tr valign="top"><td align="char"><b>2a</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">658 ± 178</td><td align="left">1850 ± 300</td><td align="left">IA</td><td align="left">1.8 (1.15)</td><td align="left">12 (1.15)</td><td align="left">15 (1.07)</td><td align="left">7.9 (1.12)</td></tr><tr valign="top"><td align="char"><b>2b</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">F</td><td align="left">H</td><td align="left">H</td><td align="left">2320 ± 860</td><td align="left">6500 ± 270</td><td align="left">IA</td><td align="left">4.4 (1.07)</td><td align="left">21 (1.12)</td><td align="left">52 (1.07)</td><td align="left">32 (1.07)</td></tr><tr valign="top"><td align="char"><b>2c</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">Br</td><td align="left">H</td><td align="left">H</td><td align="left">511 ± 33</td><td align="left">5600 ± 1300</td><td align="left">IA</td><td align="left">1.3 (1.07)</td><td align="left">15 (1.12)</td><td align="left">13 (1.15)</td><td align="left">10 (1.07)</td></tr><tr valign="top"><td align="char"><b>2d</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">1470 ± 170</td><td align="left">6200 ± 3500</td><td align="left">IA</td><td align="left">1.5 (1.07)</td><td align="left">19 (1.07)</td><td align="left">17 (1.15)</td><td align="left">11 (1.07)</td></tr><tr valign="top"><td align="char"><b>2e</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">CH<sub>3</sub>O</td><td align="left">H</td><td align="left">H</td><td align="left">3620 ± 460</td><td align="left">IA</td><td align="left">IA</td><td align="left">2.0 (1.05)</td><td align="left">37 (1.07)</td><td align="left">23 (1.10)</td><td align="left">16 (1.15)</td></tr><tr valign="top"><td align="char"><b>2f</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">NO<sub>2</sub></td><td align="left">H</td><td align="left">H</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">11 (1.07)</td><td align="left">36 (1.10)</td><td align="left">74 (1.07)</td><td align="left">41 (1.12)</td></tr><tr valign="top"><td align="char"><b>2g</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">H</td><td align="left">Cl</td><td align="left">H</td><td align="left">1090 ± 150</td><td align="left">2070 ± 660</td><td align="left">9800 ± 4700</td><td align="left">2.4 (1.10)</td><td align="left">33 (1.12)</td><td align="left">18 (1.15)</td><td align="left">14 (1.07)</td></tr><tr valign="top"><td align="char"><b>2h</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">H</td><td align="left">Br</td><td align="left">H</td><td align="left">689 ± 229</td><td align="left">2540 ± 740</td><td align="left">4508 ± 1722</td><td align="left">1.4 (1.07)</td><td align="left">23 (1.10)</td><td align="left">13 (1.15)</td><td align="left">7.6 (1.07)</td></tr><tr valign="top"><td align="char"><b>2i</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">H</td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">1950 ± 390</td><td align="left">2350 ± 560</td><td align="left">IA</td><td align="left">2.4 (1.10)</td><td align="left">17 (1.07)</td><td align="left">16 (1.29)</td><td align="left">12 (1.15)</td></tr><tr valign="top"><td align="char"><b>2j</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">F</td><td align="left">F</td><td align="left">H</td><td align="left">7978 ± 4437</td><td align="left">6480 ± 2100</td><td align="left">IA</td><td align="left">2.6 (1.10)</td><td align="left">45 (1.12)</td><td align="left">40 (1.35)</td><td align="left">24 (1.07)</td></tr><tr valign="top"><td align="char"><b>2k</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">Cl</td><td align="left">Cl</td><td align="left">H</td><td align="left">463 ± 104</td><td align="left">1670 ± 250</td><td align="left">8800 ± 1030</td><td align="left">6.8 (1.07)</td><td align="left">29 (1.10)</td><td align="left">12 (1.15)</td><td align="left">9.8 (1.10)</td></tr><tr valign="top"><td align="char"><b>2l</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">Cl</td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">410 ± 75</td><td align="left">2040 ± 280</td><td align="left">IA</td><td align="left">0.65 (1.10)</td><td align="left">9.2 (1.07)</td><td align="left">4.8 (1.15)</td><td align="left">5.7 (1.07)</td></tr><tr valign="top"><td align="char"><b>2m</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">CH<sub>3</sub></td><td align="left">Br</td><td align="left">H</td><td align="left">2810 ± 590</td><td align="left">7250 ± 2370</td><td align="left">IA</td><td align="left">2.9 (1.07)</td><td align="left">32 (1.10)</td><td align="left">18 (1.20)</td><td align="left">12 (1.07)</td></tr><tr valign="top"><td align="char"><b>2n</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">Cl</td><td align="left">H</td><td align="left">Cl</td><td align="left">IA</td><td align="left">14000 ± 4700</td><td align="left">IA</td><td align="left">3.1 (1.12)</td><td align="left">19 (1.10)</td><td align="left">22 (1.35)</td><td align="left">17 (1.10)</td></tr><tr valign="top"><td align="char"><b>2o</b></td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">209 ± 28</td><td align="left">607 ± 190</td><td align="left">16000 ± 6700</td><td align="left">0.58 (1.23)</td><td align="left">8.6 (1.05)</td><td align="left">6.2 (1.26)</td><td align="left">3.9 (1.07)</td></tr><tr valign="top"><td align="char"><b>2p</b></td><td align="left">C<sub>3</sub>H<sub>7</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">56 ± 18</td><td align="left">370 ± 80</td><td align="left">IA</td><td align="left">0.70 (1.17)</td><td align="left">7.7 (1.07)</td><td align="left">4.9 (1.20)</td><td align="left">2.0 (1.07)</td></tr><tr valign="top"><td align="char"><b>2q</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">CH(CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)</td><td align="left">F</td><td align="left">H</td><td align="left">H</td><td align="left">693 ± 270</td><td align="left">2850 ± 520</td><td align="left">IA</td><td align="left">11 (1.07)</td><td align="left">81 (1.15)</td><td align="left">IA</td><td align="left">26 (1.07)</td></tr><tr valign="top"><td align="char"><b>2r</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">CH(CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)</td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">26 (1.10)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2s</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">CH(CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)</td><td align="left">Br</td><td align="left">H</td><td align="left">H</td><td align="left">845 ± 120</td><td align="left">2530 ± 930</td><td align="left">IA</td><td align="left">3.9 (1.07)</td><td align="left">42 (1.15)</td><td align="left">27 (1.07)</td><td align="left">6.5 (1.07)</td></tr><tr valign="top"><td align="char"><b>2t</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">CH(CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)</td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">842 ± 190</td><td align="left">8700 ± 3200</td><td align="left">IA</td><td align="left">3.7 (1.10)</td><td align="left">25 (1.05)</td><td align="left">23 (1.10)</td><td align="left">5.8 (1.10)</td></tr><tr valign="top"><td align="char"><b>2u</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">CH(CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)</td><td align="left">CH<sub>3</sub>O</td><td align="left">H</td><td align="left">H</td><td align="left">2270 ± 330</td><td align="left">8200 ± 2370</td><td align="left">6900 ± </td><td align="left">4.7 (1.07)</td><td align="left">31 (1.10)</td><td align="left">46 (1.07)</td><td align="left">9.2 (1.07)</td></tr><tr valign="top"><td align="char"><b>2v</b></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">CH(CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>)</td><td align="left">NO<sub>2</sub></td><td align="left">H</td><td align="left">H</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">15 (1.05)</td><td align="left">IA</td><td align="left">60 (1.07)</td><td align="left">19 (1.10)</td></tr><tr valign="top"><td align="char"><b>2w</b></td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">Cl</td><td align="left">Cl</td><td align="left">H</td><td align="left">118 ± 40</td><td align="left">389 ± 83</td><td align="left">1090 ± 480</td><td align="left">0.51 (1.20)</td><td align="left">10 (1.07)</td><td align="left">3.3 (1.17)</td><td align="left">2.7 (1.07)</td></tr><tr valign="top"><td align="char"><b>2x</b></td><td align="left">C<sub>3</sub>H<sub>7</sub></td><td align="left">H</td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">Cl</td><td align="left">Cl</td><td align="left">H</td><td align="left">31 ± 9.4</td><td align="left">180 ± 69</td><td align="left">2300 ± 370</td><td align="left">0.62 (1.29)</td><td align="left">9.8 (1.07)</td><td align="left">4.2 (1.20)</td><td align="left">1.5 (1.12)</td></tr><tr valign="top"><td align="char"><b>2y</b></td><td align="left">CH<sub>3</sub></td><td align="left">CH<sub>3</sub></td><td align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">6000 ± 316</td><td align="left">1570 ± 80</td><td align="left">IA</td><td align="left">1.2 (1.20)</td><td align="left">IA</td><td align="left">16 (1.23)</td><td align="left">16 (1.10)</td></tr><tr valign="top"><td align="char"><b>2z</b></td><td align="left">CH<sub>3</sub></td><td align="left">CH<sub>3</sub></td><td align="left">CH<sub>3</sub></td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">1750 ± 370</td><td align="left">1520 ± 250</td><td align="left">IA</td><td align="left">37 (1.12)</td><td align="left">IA</td><td align="left">33 (1.23)</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2aa</b></td><td align="left">CH<sub>3</sub></td><td colspan="2" align="left">CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub></td><td align="left">F</td><td align="left">H</td><td align="left">H</td><td align="left">156 ± 46</td><td align="left">135 ± 36</td><td align="left">IA</td><td align="left">35 (1.07)</td><td align="left">71 (1.66)</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2bb</b></td><td align="left">CH<sub>3</sub></td><td colspan="2" align="left">CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub></td><td align="left">Br</td><td align="left">H</td><td align="left">H</td><td align="left">750 ± 173</td><td align="left">1180 ± 270</td><td align="left">IA</td><td align="left">11 (1.07)</td><td align="left">74 (1.15)</td><td align="left">64 (1.05)</td><td align="left">19 (1.07)</td></tr><tr valign="top"><td align="char"><b>2cc</b></td><td align="left">CH<sub>3</sub></td><td colspan="2" align="left">CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub></td><td align="left">CH<sub>3</sub></td><td align="left">H</td><td align="left">H</td><td align="left">414 ± 89</td><td align="left">577 ± 61</td><td align="left">IA</td><td align="left">11 (1.10)</td><td align="left">56 (1.10)</td><td align="left">IA</td><td align="left">53 (1.10)</td></tr><tr valign="top"><td align="char"><b>2dd</b></td><td align="left">CH<sub>3</sub></td><td colspan="2" align="left">CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub></td><td align="left">CH<sub>3</sub>O</td><td align="left">H</td><td align="left">H</td><td align="left">452 ± 82</td><td align="left">718 ± 130</td><td align="left">IA</td><td align="left">16 (1.10)</td><td align="left">57 (1.10)</td><td align="left">IA</td><td align="left">87 (1.10)</td></tr><tr valign="top"><td align="char"><b>2ee</b></td><td align="left">CH<sub>3</sub></td><td colspan="2" align="left">CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub></td><td align="left">NO<sub>2</sub></td><td align="left">H</td><td align="left">H</td><td align="left">10000 ± 1900</td><td align="left">4100 ± 540</td><td align="left">IA</td><td align="left">53 (1.10)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2ff</b></td><td align="left">CH<sub>3</sub></td><td colspan="2" align="left">CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub></td><td align="left">Cl</td><td align="left">H</td><td align="left">H</td><td align="left">852 ± 220</td><td align="left">2520 ± 900</td><td align="left">IA</td><td align="left">7.7 (1.12)</td><td align="left">30 (1.12)</td><td align="left">83 (1.23)</td><td align="left">28 (1.07)</td></tr><tr valign="top"><td align="char"><b>4</b></td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">10 (1.12)</td><td align="left">32 (1.10)</td><td align="left">IA</td><td align="left">69 (1.07)</td></tr><tr valign="top"><td align="char"><b>5</b></td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">3.3 (1.17)</td><td align="left">35 (1.05)</td><td align="left">36 (1.23)</td><td align="left">16 (1.05)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values for mean ± standard error of three independent experiments, each conducted with triplicate determination.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Mean micromolar IC<sub>50</sub> values (to 2 significant digits) for <b>2a</b> and the indicated analogues from three independent experiments for inhibition of functional responses to an EC<sub>80</sub>−EC<sub>90</sub> concentration of carbamylcholine mediated by nAChR subtypes composed of the indicated subunits (where the asterisk (∗) indicates that additional subunits are or may be additional assembly partners with the subunits specified; see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). Numbers in parentheses indicate SEM as a multiplication/division factor of the mean micromolar IC<sub>50</sub> values shown [i.e., the value 1.8 (1.15) reflects a mean IC<sub>50</sub> value of 1.8 μM with an SEM range of 1.8 × 1.15 μM to 1.8/1.15 μM or 1.6−2.1 μM. IA: IC<sub>50</sub> > 100 μM.</p></div></div></div><div class="NLM_p">Compound <b>2a</b> analogues <b>2b</b>−<b>ff</b>, <b>4</b>, and <b>5</b> were also evaluated for their ability to antagonize functional responses of α3β4*-, α4β2-, α4β4-, and α1*-nAChR using previously reported methods<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> modified as described in <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. Results are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and in Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/medium/jm-2009-017465_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Specific <sup>86</sup>Rb<sup>+</sup> efflux (ordinate, percentage of control) was determined for functional, human muscle-type α1β1γδ-nAChR (△), ganglionic α3β4*-nAChR (▼), α4β2-nAChR (○), or α4β4-nAChR (▲) naturally or heterologously expressed in human cell lines in the presence of a receptor subtype-specific, EC<sub>80</sub>−EC<sub>90</sub> concentration of the full agonist, carbamylcholine, either alone or in the presence of the indicated concentrations (abscissa, log molar) of <b>2a</b> or its analogues having phenyl substitutions (compounds <b>2c</b>, <b>2l</b>, and <b>2h</b>) as indicated. Mean micromolar IC<sub>50</sub> values and SEM as a multiplication/division factor of the mean micromolar IC<sub>50</sub> value are provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9017465&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/medium/jm-2009-017465_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Specific <sup>86</sup>Rb<sup>+</sup> efflux (ordinate, percentage of control) was determined for functional, human muscle-type α1β1γδ-nAChR (Δ), ganglionic α3β4*-nAChR (▼), α4β2-nAChR (○), or α4β4-nAChR (▲) naturally or heterologously expressed in human cell lines in the presence of a receptor subtype-specific, EC<sub>80</sub>−EC<sub>90</sub> concentration of the full agonist, carbamylcholine, either alone or in the presence of the indicated concentrations (abscissa, log molar) of <b>2a</b> analogues having alkyl or phenyl plus alkyl substitutions (compounds <b>2y</b>, <b>2o</b>, <b>2w</b>, and <b>2x</b>) as indicated. Mean micromolar IC<sub>50</sub> values and SEM as a multiplication/division factor of the mean micromolar IC<sub>50</sub> value are provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9017465&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> In Vivo Assays</h3><div class="NLM_p">Compound <b>2a</b> and analogues <b>2b</b>−<b>ff</b>, <b>4</b>, and <b>5</b> were also evaluated for their ability to antagonize behavioral responses to acute nicotine administration as previously described.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Results are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacological Evaluation of <b>2a</b> Analogues as Noncompetitive Nicotinic Antagonists<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th colspan="4" align="center">AD<sub>50</sub> (mg/kg)</th></tr><tr valign="top"><th align="center">compd</th><th align="center">tail-flick</th><th align="center">hot-plate</th><th align="center">locomotion</th><th align="center">hypothermia</th></tr></thead><tbody><tr valign="top"><td align="char"><b>2a</b></td><td align="left">1.2 (1−1.8)</td><td align="left">15 (6−19)</td><td align="left">4.9 (0.9−46)</td><td align="left">9.2 (4−23)</td></tr><tr valign="top"><td align="char"><b>2b</b></td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2c</b></td><td align="left">0.12 (0.03−0.5)</td><td align="left">14.9 (6.5−34)</td><td align="left">27.1 (2.9−46)</td><td align="left">11.5 (8.2−16.1)</td></tr><tr valign="top"><td align="char"><b>2d</b></td><td align="left">0.05 (0.03−0.2)</td><td align="left">6.8 (4.2−11.1)</td><td align="left">4.3 (0.7−28)</td><td align="left">7.8 (7.4−8.2)</td></tr><tr valign="top"><td align="char"><b>2e</b></td><td align="left">1.6 (0.4−5.4)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2f</b></td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2g</b></td><td align="left">0.43 (0.08−2.3)</td><td align="left">IA</td><td align="left">31 (12.8−74.2)</td><td align="left">32 (10.1−100.1)</td></tr><tr valign="top"><td align="char"><b>2h</b></td><td align="left">0.15 (0.04−0.6)</td><td align="left">23.5 (12.3−44.6)</td><td align="left">IA</td><td align="left">29 (11.8−69.1)</td></tr><tr valign="top"><td align="char"><b>2i</b></td><td align="left">0.09 (0.03−0.9)</td><td align="left">7.75 (2.8−21)</td><td align="left">11.8 (5.8−23)</td><td align="left">8.8 (2−38.2)</td></tr><tr valign="top"><td align="char"><b>2j</b></td><td align="left">0.05 (0.02−0.11)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2k</b></td><td align="left">0.28 (0.08−0.9)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2l</b></td><td align="left">0.2 (0.13−1.3)</td><td align="left">7.2 (0.13−13)</td><td align="left">11 (1.5−83)</td><td align="left">10 (5.1−18.2)</td></tr><tr valign="top"><td align="char"><b>2m</b></td><td align="left">0.015 (0.005−0.04)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2n</b></td><td align="left">0.028 (0.01−0.07)</td><td align="left">4.3 (0.2−13.5)</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2o</b></td><td align="left">0.5 (0.1−2.1)</td><td align="left">IA</td><td align="left">11.7</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2p</b></td><td align="left">10 (3.7−26)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2q</b></td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2r</b></td><td align="left">0.014 (0.001−0.08)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2s</b></td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2t</b></td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2u</b></td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2v</b></td><td align="left">na</td><td align="left">na</td><td align="left">na</td><td align="left">na</td></tr><tr valign="top"><td align="char"><b>2w</b></td><td align="left">0.05 (0.03−0.8)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2x</b></td><td align="left">0.13 (0.06−0.3)</td><td align="left">15 (0.9−25)</td><td align="left">IA</td><td align="left">17.5 (13−24)</td></tr><tr valign="top"><td align="char"><b>2y</b></td><td align="left">0.46 (0.44−0.48)</td><td align="left">8.7 (2−37)</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2z</b></td><td align="left">5.2 (1.5−17.2)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2aa</b></td><td align="left">3.84 (3.3−4.4)</td><td align="left">IA</td><td align="left">IA</td><td align="left">7.5 (2.4−24)</td></tr><tr valign="top"><td align="char"><b>2bb</b></td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2cc</b></td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2dd</b></td><td align="left">4.5 (1.4−14.3)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2ee</b></td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>2ff</b></td><td align="left">0.05 (0.005−0.5)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>4</b></td><td align="left">0.077 (0.015−0.4)</td><td align="left">IA</td><td align="left">IA</td><td align="left">IA</td></tr><tr valign="top"><td align="char"><b>5</b></td><td align="left">10.5 (9.5−11.5)</td><td align="left">IA</td><td align="left">IA</td><td align="left">16 (9.3−26)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Results are expressed as AD<sub>50</sub> (mg/kg) ± confidence limits (CL) or % effect at the highest dose tested. Dose−response curves were determined using a minimum of four different doses of test compound, and at least eight mice were used per dose group. IA: IC<sub>50</sub> > 100 μM. na: not assayed.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31800" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31800" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>2a</b> and its analogues were evaluated for their ability to inhibit DA, NE, and 5-HT uptake inhibition using human DAT, NET, and SERT homologously expressed by HEK293 cells. Compound <b>2a</b> has IC<sub>50</sub> values of 658 and 1850 nM for inhibition of DA and NE uptake, respectively, and is inactive at SERT (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Very few <b>2a</b> analogues had appreciably better IC<sub>50</sub> values for DA uptake inhibition than <b>2a</b>. Compounds <b>2o</b> and <b>2p</b>, where the α-methyl group in <b>2a</b> was replaced by ethyl and propyl groups, respectively, have IC<sub>50</sub> values for inhibition of DA uptake of 209 and 56 nM, respectively, indicating that replacement of the α-methyl group with larger alkyl chains produced ligands with better efficacy, a finding that also is borne out by the improvement in inhibitory potency at DAT for <b>2w</b> (IC<sub>50</sub> = 118 nM) and <b>2x</b> (IC<sub>50</sub> = 31 nM) relative to <b>2k</b> (IC<sub>50</sub> = 463 nM) in the 3,4-dichlorophenyl analogue group. In each case, the 3,4-dichlorophenyl analogue has higher inhibitory potency for DA uptake inhibition than the otherwise equivalent monochlorophenyl analogue. Each 3,4-dichlorophenyl compound (<b>2k</b>, <b>2w</b>, <b>2x</b>) also has slightly better inhibitory potency for NE uptake (1670, 389, and 180 nM IC<sub>50</sub> values, respectively) greater than the equivalent monochlorophenyl compounds (<b>2a</b>, <b>2o</b>, <b>2p</b>; 1850, 607, 370 nM IC<sub>50</sub> values, respectively). The propyl <b>2a</b> analogue (<b>2p</b>) and 3,4-dichlorophenyl propyl analogue <b>2x</b> have 7- and 6-fold selectivity for DA over NE uptake inhibition.</div><div class="NLM_p">Compound <b>2aa</b> has 4- and 14-fold elevated inhibitory potency relative to <b>2a</b> for DA uptake inhibition (IC<sub>50</sub> = 156 nM) and NE uptake inhibition (IC<sub>50</sub> = 135 nM). Compound <b>2y</b> is the only compound tested that has higher selectivity (∼4-fold) for NE uptake inhibition relative to DA inhibition, but it is only marginally more potent as an NE uptake inhibitor than <b>2a</b> (IC<sub>50</sub> of 1570 and 1850 nM, respectively). None of these analogues has IC<sub>50</sub> values for inhibition of SERT less than 1 μM, although the dichlorophenyl analogues are more potent at this target than their monochlorophenyl equivalents.</div><div class="NLM_p">Thus, <b>2w</b>, <b>2x</b>, and <b>2p</b> are the most potent for DA uptake inhibition, with <b>2aa</b> and <b>2o</b> also being more potent for DA uptake inhibition than <b>2a</b>. Compounds <b>2w</b> and <b>2x</b> also are more selective for DA uptake inhibition relative to inhibitions of 5-HT and NE uptake. Compounds <b>2aa</b>, <b>2x</b>, and <b>2p</b> are the most potent analogues for NE uptake inhibition, and analogues <b>2w</b>, <b>2o</b>, and <b>2dd</b> are also more potent than <b>2a</b> for NE uptake inhibition. With the exception of <b>2y</b>, which is about 4-fold selective for NE over DA uptake inhibition uptake inhibition (although being about equipotent with <b>2a</b> at NET), none of the analogues is selective for NE over DA uptake inhibition.</div><div class="NLM_p">Isotopic <sup>86</sup>Rb<sup>+</sup> efflux assays were used to determine effects of <b>2a</b> and analogues on function of diverse human nAChR subtypes naturally or heterologously expressed by human cell lines. These assays repeatedly have been shown to be specific only for nAChR function in the cells used. In the case of SH-SY5Y cells, function of only α3β4*-nAChR is measured because α7-nAChRs that also are expressed by these cells activate and inactivate too quickly to detectably contribute to ion flux. Neither <b>2a</b> nor any of the analogues tested possess intrinsic activity as agonists at α1*-, α3β4*-, α4β2-, or α4β4-nAChR. <sup>86</sup>Rb<sup>+</sup> efflux in the presence of these ligands alone at concentrations from ∼5 nM to 100 μM (data not shown here) was indistinguishable from responses in cells exposed only to efflux buffer.</div><div class="NLM_p"><sup>86</sup>Rb<sup>+</sup> efflux assays also were used to assess whether <b>2a</b> or its analogues had activity as antagonists at human nAChR. With few exceptions (noted in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), <b>2a</b> and each of its analogues exhibited concentration-dependent inhibition of ion flux responses elicited by EC<sub>80</sub>−EC<sub>90</sub> concentrations of carbamylcholine for α1*-, α3β4*-, α4β2-, and α4β4-nAChR. Representative concentration response curves for <b>2a</b> itself, for compounds having substituted phenyl groups (<b>2c</b>, <b>2h</b>, <b>2l</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), or for compounds having amine or alkyl charges (<b>2y</b>, <b>2o</b>, <b>2x</b>, <b>2w</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) illustrate some of the features of these ligands (see also Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">Compound <b>2a</b> has IC<sub>50</sub> values of 1.8, 12, 15, and 7.9 μM for α3β4*-, α4β2-, α4β4-, and α1*-nAChRs, respectively, and thus is 4- to 8-fold selective for the α3β4* relative to the other nAChRs. All of the analogues except <b>2z</b> (approximately equipotent at α3β4*- and α4β4-nAChR) block function of α3β4*-nAChR at concentrations lower than those needed to inhibit function of the other nAChR subtypes. That is, all of the analogues are selective in their antagonism for α3β4*-nAChR. Compounds <b>2l</b>, <b>2o</b>, <b>2p</b>, and <b>2x</b> have slightly higher potencies than <b>2a</b>, the α4β2 nAChR (IC<sub>50</sub> = 7.7−9.8 μm). The 4-fold selectivity of <b>2a</b> for the α3β4*-nAChR over other subtypes is increased to >7-fold for the 3-bromo, 3-methyl, and 3-methoxyphenyl analogues <b>2c</b>, <b>2d</b>, and <b>2e</b>, respectively, and to >10-fold for the 3,4-difluorophenyl and <i>N</i>-methyl analogues <b>2j</b> and <b>2y</b>, respectively.</div><div class="NLM_p">In addition to the improvements in selectivity for α3β4*-nAChR over other subtypes, the 3-chloro, 4-methyl substituted phenyl analogue <b>2l</b> (IC<sub>50</sub> = 0.65 μM) has ∼3-fold higher inhibitory potency at α3β4*-nAChR relative to <b>2a</b>. Both mono- and dichloro-substituted phenyl compounds <b>2o</b>, <b>2p</b>, <b>2w</b>, and <b>2x</b> (IC<sub>50</sub> = 0.51−0.70 μM), having extended alkyl side chains, have ∼3-fold higher potency at α3β4*-nAChR relative to <b>2a</b> with the 3,4-dichlorophenyl ethyl and propyl compounds (<b>2w</b> and <b>2x</b>), respectively, being >10-fold more potent than the unextended 3,4-dichlorophenyl analogue (<b>2k</b>; IC<sub>50</sub> = 6.8 μM). These compounds also are remarkable because they also had higher inhibitory potency at and selectivity for DA uptake inhibition and higher potency for NE uptake inhibition than <b>2a</b>, so they all represent analogues with higher affinity than <b>2a</b> for three of its molecular targets.</div><div class="NLM_p">Compound <b>2a</b> blocks nicotine-induced antinociception in the tail-flick and hot-plate tests with AD<sub>50</sub> values of 1.2 and 15 mg/kg, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). It also blocks nicotine-induced locomotor activity and hypothermia with AD<sub>50</sub> values of 4.9 and 9.2 mg/kg, respectively. Seventeen of the 33 analogues had AD<sub>50</sub> values of 0.014−0.5 mg/kg in the tail-flick test, showing higher inhibitory potency than <b>2a</b>. Analogues <b>2r</b>, <b>2m</b>, and <b>2n</b> with AD<sub>50</sub> values of 0.014, 0.015, and 0.028 mg/kg were 86, 80, and 43 times more potent than <b>2a</b> in blocking nicotine-induced antinociception in the tail-flick test. Surprisingly, none of these analogues has higher potency than <b>2a</b> for DA, NE, and SERT uptake inhibition or any nAChR subtype. Analogues <b>2d</b>, <b>2j</b>, <b>2w</b>, and <b>2ff</b> with AD values of 0.05 mg/kg were the next most potent in the tail-flick assay, being 24-fold more potent than <b>2a</b>. Analogues <b>2c</b>, <b>2h</b>, <b>2i</b>, and <b>2x</b> (AD<sub>50</sub> = 0.09−0.15 mg/kg) have ∼10-fold better inhibitory potency than <b>2a</b> against nicotine-mediated analgesia in the tail-flick assay. Thus, <b>2x</b> is an analogue that has increased potency relative to <b>2a</b> as an inhibitor of DA and NE uptake, and at α3β4*-nAChR, analogues <b>2h</b> and <b>2c</b> have potencies comparable to those of <b>2a</b> across those targets. The 3,4-dichlorophenyl analogues <b>2k</b>, <b>2w</b>, and <b>2x</b> are ∼4-, ∼10-, and ∼77-fold more potent than their 3-chlorophenyl substituted equivalents <b>2a</b>, <b>2o</b>, and <b>2p</b>, respectively. However, the tail-flick assay results are not particularly illuminating about the molecular targets contributing to analogue effects, perhaps because effects at higher levels might override the presumed spinal level of nicotine-mediated antinociception.</div><div class="NLM_p">In the hot-plate assay, <b>2d</b> and <b>2l</b> (potent and selective at α3β4*-nAChR) and <b>2y</b> (selective for NE uptake inhibition and α3β4*-nAChR) have about 2-fold more potency than <b>2a</b>, and <b>2n</b> (inactive at transporters and less potent than <b>2a</b> at α3β4*-nAChR) has about 3-fold more potency. These findings suggest that several mechanisms might impact supraspinal mechanisms of nicotine-mediated antinociception.</div><div class="NLM_p">Of all the analogues, only <b>2d</b> has potency like <b>2a</b> in blocking nicotine’s effects on locomotion, and only <b>2d</b> and <b>2l</b> rival the ability of <b>2a</b> to inhibit nicotine’s effects on body temperature. Similar to <b>2a</b>, substituted phenyl analogues <b>2c</b>, <b>2d</b>, and <b>2l</b> (roughly sharing the in vitro fingerprint of <b>2a</b>) had potency in all four behavioral tests as nicotine antagonists. Compound <b>2x</b>, a potent DA and NE uptake inhibitor and α3β4*-nAChR antagonist, had potency in three of four of the in vivo tests.</div><div class="NLM_p last">Compounds <b>2p</b>, <b>2w</b>, and <b>2x</b>, having the highest potencies as DA uptake inhibitors, differ nearly 200-fold in potency in the tail-flick assay, and only <b>2x</b> shows activity in the hot-plate or locomotor tests. These analogues also are among the most potent at NE uptake inhibition.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several <b>2a</b> analogues were synthesized and tested for their ability to inhibit monoamine uptake and to antagonize function of four different nAChR subtypes. The analogues were also evaluated for their ability to block nicotine-induced antinociception, locomotor activity, and hypothermia.</div><div class="NLM_p">We succeeded in creating and characterizing analogues with significantly lower IC<sub>50</sub> values relative to <b>2a</b> for inhibition of both DA or NE uptake inhibition (<b>2o</b>, <b>2p</b>, <b>2w</b>, <b>2x</b>, and <b>2aa</b>).</div><div class="NLM_p">The current efforts also succeeded in generating nine agents with higher (<b>2l</b>, <b>2o</b>, <b>2p</b>, <b>2w</b>, <b>2x</b>) or slightly higher (<b>2c</b>, <b>2d</b>, <b>2h</b>, <b>2y</b>) antagonist potency relative to <b>2a</b> at α3β4*-nAChR. Of these, <b>2c</b>, <b>2d</b>, <b>2l</b>, and especially <b>2y</b> also have improved selectivity for α3β4*-nAChR over other nAChR subtypes relative to <b>2a</b>. In addition, analogues <b>2e</b> and <b>2j</b> show improved selectivity for α3β4*-nAChR although without having lower IC<sub>50</sub> values than <b>2a</b>.</div><div class="NLM_p">Compounds were also developed that had altered target selectivity between nAChR and transporters. For example, <b>2e</b> had improved selectivity for α3β4*-nAChR over DA and NE uptake inhibition, <b>2y</b> improved selectivity for α3β4*-nAChR over DA uptake inhibition, and <b>2p</b>, <b>2w</b>, and <b>2x</b> improved selectivity for DA and NE uptake inhibition over α3β4*-nAChR antagonism relative to <b>2a</b>.</div><div class="NLM_p">Thus, several new compounds have been developed that have higher potency and/or selectivity at specific neurotransmitter transporters or α3β4*-nAChR than <b>2a</b>, thereby providing leads for further target-directed drug development. These compounds also afford, in principle, opportunities to dissect roles of specific molecular targets in nicotine-mediated behavioral effects. Structure−activity relationships are complex and difficult to generalize because phenyl substitutions and amine/alkyl changes seem to interact in terms of altering potencies at and selectivities for specific targets in vitro. However, compounds with alkyl chain extensions in monochlorophenyl (like <b>2a</b>) or dichlorophenyl configurations (<b>2o</b>, <b>2p</b>, <b>2w</b>, and <b>2x</b>) had higher affinity than <b>2a</b> for all three targets, DAT, NET, and α3β4*-nAChR, implicated in <b>2a</b> action. The selectivity increase for <b>2a</b> analogues in blocking α3β4* nAChRs subtypes is very relevant, since these subtypes are highly expressed in the medial habenula and its primary target, the interpeduncular nucleus. Recent data suggest an important role for the habenulo-interpeduncular system and the nicotinic receptor subunits expressed therein in nicotine withdrawal.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Seventeen of the analogues had higher potency than <b>2a</b> as antagonists of nicotine-induced antinociception in the tail-flick test, having AD<sub>50</sub> values that ranged from ∼2- to ∼86-fold lower than that for <b>2a</b>. However, five analogues (<b>2d</b>, <b>2i</b>, <b>2l</b>, <b>2n</b>, and <b>2y</b>) were only slightly (∼2-fold) better than <b>2a</b> as antagonists of nicotine-induced antinociception in the hot plate assay, just one analogue (<b>2d</b>) rivaled or bettered <b>2a</b> as an antagonist of nicotine’s effects on locomotion, and only <b>2d</b>, <b>2i</b>, <b>2l</b>, and <b>2aa</b> rivaled or bettered the antagonistic potency of <b>2a</b> toward nicotine-induced hypothermia. Analogues <b>2m</b>, <b>2n</b>, and <b>2r</b> have the lowest AD<sub>50</sub> values in the tail-flick assay, and yet only <b>2n</b> in the hot-plate assay shows any other form of nicotine behavioral antagonism. Every ligand except <b>2p</b> that had higher potency than <b>2a</b> at α3β4*-nAChR also showed an improvement over <b>2a</b> in antagonistic potency in the tail-flick assay as did three of the ligands (<b>2o</b>, <b>2w</b>, and <b>2x</b> but not <b>2aa</b> and <b>2p</b>) that had higher potency than <b>2a</b> as antagonists for DA and NE uptake inhibition. Thus, increased potency at α3β4*-nAChR correlates with but is not necessary for improvement in ligand antagonist potency in the tail-flick assay. Moreover, when improvement in activity for DA and NE uptake inhibition is dissociated from improvement in activity at α3β4*-nAChR (i.e., for <b>2aa</b>), there is no improvement in behavioral antagonism in the tail-flick assay. Perhaps compounds like <b>2g</b>, <b>2i</b>, <b>2k</b>, <b>2j</b>, <b>2ff</b>, <b>3</b>, <b>4</b>, or even <b>2m</b>, <b>2n</b>, and <b>2r</b> that are not as active as <b>2a</b> in vitro are metabolized in vivo to forms that are active behaviorally and might also have higher affinity for DA and NE uptake inhibition and/or α3β4*-nAChR antagonism, but drug exposure times in vivo are short.</div><div class="NLM_p">In summary, several <b>2a</b> analogues were synthesized and tested for their ability to inhibit monoamine uptake and to antagonize the effects of α3β4*, α4β2, α4β4, and α1β1 nAChRs. The analogues were also evaluated for their ability to block nicotine-induced antinociception, locomotor activity, and hypothermia. Analogues <b>2o</b>, <b>2p</b>, and <b>2x</b> had significantly better IC<sub>50</sub> values for DA uptake inhibition relative to <b>2a</b>. Analogue <b>2x</b> also had a significantly better IC<sub>50</sub> value for NE uptake inhibition relative to <b>2a</b>. Analogues <b>2l</b>, <b>2o</b>, <b>2p</b>, <b>2s</b>, <b>2w</b>, and <b>2x</b> had IC<sub>50</sub> values of 2.6 to 3.6 times better than <b>2a</b> for the antagonism of the α3β4* nAChR. Seventeen of the <b>2a</b> analogues had better AD<sub>50</sub> values for blocking nicotine-induced antinociception in the tail-flick test, with analogues <b>2m</b>, <b>2n</b>, and <b>2r</b> having the lowest AD<sub>50</sub> values. Analogue <b>2x</b> with IC<sub>50</sub> values of 31 and 180 nM for DA and NE uptake inhibition compared to 658 and 1850 nM for <b>2a</b> and an IC<sub>50</sub> of 0.62 and 9.8 μM for antagonism of the α3β4* and α4β2 nAChRs, respectively, compared to 1.8 and 12 μM for <b>2a</b> had the best overall in vitro profile. This compound also had an AD<sub>50</sub> of 0.13 mg/kg in the tail-flick test compared to an AD<sub>50</sub> of 1.2 mg/kg for <b>2a</b>.</div><div class="NLM_p last">Overall, the findings support the idea that multiple molecular targets can play roles in mediating nicotine’s behavioral effects and that these new <b>2a</b> analogues have potential not only as pharmacological tools to study targets and mechanisms involved but also as new pharmacotherapies with potentially higher efficacy as aids to smoking cessation.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div class="NLM_p last">Nuclear magnetic resonance (<sup>1</sup>H NMR and <sup>13</sup>C NMR) spectra were recorded on a 300 MHz (Bruker AVANCE 300) spectrometer. Chemical shift data for the proton resonances were reported in parts per million (δ) relative to internal (CH<sub>3</sub>)<sub>4</sub>Si (δ 0.0). Optical rotations were measured on an AutoPol III polarimeter, purchased from Rudolf Research. Elemental analyses were performed by Atlantic Microlab, Norcross, GA. Purity of compounds (>95%) was established by elemental analysis. Analytical thin-layer chromatography (TLC) was carried out on plates precoated with silica gel GHLF (250 μM thickness). TLC visualization was accomplished with a UV lamp or in an iodine chamber. All moisture-sensitive reactions were performed under a positive pressure of nitrogen maintained by a direct line from a nitrogen source. Anhydrous solvents were purchased from Aldrich Chemical Co.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 2-(<i>N</i>-<i>tert</i>-Butylamino)-3′-methoxypropiophenone (<b>2e</b>) Fumarate</h3><div class="NLM_p last">To a stirred solution of 2-bromo-3′-methoxypropiophenone <b>7d</b> (400 mg, 1.5 mmol) in 3 mL of CH<sub>3</sub>CN was added 0.315 mL (3.0 mmol) of <i>tert</i>-butyamine. The mixture was stirred for 10 h at room temperature. The reaction solution was diluted with EtOAc, washed with aqueous NaHCO<sub>3</sub>, water, and brine, and then dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated, and the residue was purified by column chromatography on silica gel using MeOH−CH<sub>2</sub>Cl<sub>2</sub> (1:50 to 1:10 w/ 1% NH<sub>4</sub>OH) as the eluent to afford 138 mg (39%) of <b>2e</b>. The <b>2e</b> was immediately dissolved in Et<sub>2</sub>O, 1.0 equiv of fumaric acid (dissolved in minimal amount of MeOH) was added dropwise, and the mixture was stirred overnight. The solid was collected by filtration, washed with Et<sub>2</sub>O, and vacuum-dried to yield 150 mg (28%) of <b>2e</b> fumarate as a white solid: mp 152−153 °C. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.75 (d, <i>J</i> = 8.4 Hz, 1H), 7.63 (s, 1H), 7.54 (t, <i>J</i> = 8.1 Hz, 1H), 7.32 (dd, <i>J</i> = 8.0, 2.5 Hz, 1H), 6.68 (s, 2H), 5.20 (q, <i>J</i> = 7.1 Hz, 1H), 4.88 (s, 3H), 1.57 (d, <i>J</i> = 7.1 Hz, 3H), 1.35 (s, 9H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 196.8, 170.8, 161.5, 135.7, 134.5, 131.2, 122.0, 114.2, 59.0, 55.7, 54.3, 26.2, 18.5. LCMS (ESI) <i>m</i>/<i>z</i> 236.5 (M + 1)<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>25</sub>NO<sub>6</sub>) C, H, N.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 2-(<i>N</i>-<i>tert</i>-Butylamino)-3′-nitropropiophenone (<b>2f</b>) Fumarate</h3><div class="NLM_p last">To a stirred solution of 2-bromo-3′-nitropropiophenone <b>7e</b> (300 mg, 1.16 mmol) in 3 mL of CH<sub>3</sub>CN was added <i>tert</i>-butyamine (0.170 g, 3.0 mmol). The mixture was stirred for 6 h at 40 °C. The solution was filtered to remove the white precipitate. The reaction solution was diluted with EtOAc, washed with aqueous NaHCO<sub>3</sub>, water, and brine, and then dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated, and the residue was purified by column chromatography on silica gel using MeOH−CH<sub>2</sub>Cl<sub>2</sub> (1:50 to 1:10 w/ 1% NH<sub>4</sub>OH) as the eluent to afford 211 mg (73%) of <b>2f</b>. The <b>2f</b> was immediately dissolved in Et<sub>2</sub>O, 1.0 equiv of fumaric acid (dissolved in minimal amount of MeOH) was added dropwise, and the mixture was stirred overnight. The solid was collected by filtration, washed with Et<sub>2</sub>O, and vacuum-dried to give 270 mg (64% from <b>2f</b>) of <b>2f</b> fumarate as a white solid: mp 166−167 °C. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.94 (s, 1H), 8.59 (dd, 2H), 7.90 (t, 1H), 6.68 (s, 2H), 5.30 (q, 1H), 1.61 (d, 3H), 1.37 (s, 9H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 198.5, 172.8, 152.1, 137.9, 137.5, 133.9, 131.9, 126.5, 60.9, 56.8, 29.5, 28.7, 20.6. LCMS (ESI) <i>m</i>/<i>z</i> 252.3 (M + 1)<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>22</sub>N<sub>2</sub>O<sub>7</sub>) C, H, N.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 2-(<i>N</i>-Cyclopentylamino)-3′-fluoropropiophenone (<b>2q</b>) Hydrochloride</h3><div class="NLM_p last">To a CH<sub>3</sub>CN solution (3 mL) of 2-bromo-3′-fluoropropiophenone <b>7a</b> (290 mg, 1.26 mmol) was added cyclopentylamine (125 μL, 1.26 mmol), and the mixture was allowed to react for 3 h at room temperature. The precipitate was filtered off. The filtrate was concentrated, and the residue was purified by column chromatography on silica gel using cyclohexane−EtOAc (2:1 to 1:0 with 1% NH<sub>4</sub>OH) as the eluent to give <b>2q</b> as a light-yellow oil. The <b>2q</b> was dissolved in 50 mL of Et<sub>2</sub>O, a solution of hydrochloric acid in Et<sub>2</sub>O was added dropwise, and the mixture was stirred overnight. The precipitate was filtered, washed with Et<sub>2</sub>O, and dried under vacuum to give 50 mg (15%) of <b>2q</b>·HCl as a white solid: mp 185−186 °C. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.95 (d, 1H), 7.85 (d, 1H), 7.64 (m, 1H), 7.51 (m, 1H), 5.16 (m, 1H), 3.64 (m, 1H), 2.15 (m, 2H), 1.61−1.85 (m, 6H), 1.60 (d, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 196.4, 166.5, 163.2, 136.8, 136.7, 133.0, 126.6, 123.5, 123.2, 117.0, 116.7, 59.2, 58.9, 31.2, 25.2, 17.0. LCMS (ESI) <i>m</i>/<i>z</i> 236.4 (M + 1)<sup>+</sup>. Anal. (C<sub>14</sub>H<sub>19</sub>ClFNO) C, H, N.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 2-(<i>N</i>-Cyclopentylamino)-3′-bromopropiophenone (<b>2s</b>) Fumarate</h3><div class="NLM_p last">To a CH<sub>3</sub>CN solution (5 mL) of 2-bromo-3′-bromopropiophenone <b>7b</b> (480 mg, 1.65 mmol) was added cyclopentylamine (330 μL, 3.31 mmol), and the mixture was allowed to react for 6 h at 40 °C. After the mixture was cooled to room temperature, the precipitate was removed by filtration. The filtrate was concentrated, and the residue was purified by column chromatography on silica gel using cyclohexane−EtOAc (2:1 to 1:0 with 1% NH<sub>4</sub>OH) as the eluent to give 182 mg (37%) of <b>2s</b> as light-yellow oil. The <b>2s</b> was dissolved in 50 mL of Et<sub>2</sub>O, a MeOH solution (1 mL) of fumaric acid (71 mg) was added dropwise, and the mixture was stirred overnight. The precipitate was collected, washed with Et<sub>2</sub>O, and dried under vacuum to give 240 mg (35%) of <b>2s</b> fumarate as a white solid: mp 152−153 °C. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.25 (s, 1H), 8.07 (d, 1H), 7.89 (d, 1H), 7.54 (t, 1H), 6.68 (s, 2H), 5.13 (q, 1H), 3.30 (m, 1H), 2.13 (m, 2H), 1.83 (m, 2H), 1.68 (m, 4H), 1.56 (d, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 196.8, 171.6, 139.2, 136.7, 136.6, 133.1, 132.6, 129.2, 124.8, 59.2, 59.2, 32.5, 31.3, 25.2, 17.2, 14.8. LCMS (ESI) <i>m</i>/<i>z</i> 296.2 (M + 1)<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>22</sub>BrNO<sub>5</sub>) C, H, N.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-(<i>N</i>-Cyclopentylamino)-3′-methylpropiophenone (<b>2t</b>) Fumarate</h3><div class="NLM_p last">To a CH<sub>3</sub>CN solution (4 mL) of 2-bromo-3′-methylpropiophenone <b>7c</b> (400 mg, 1.76 mmol) was added cyclopentylamine (175 μL, 1.76 mmol), and the mixture was allowed to react for 6 h at 40 °C. After the mixture was cooled to room temperature, the precipitate was filtered off. The filtrate was concentrated, and the residue was purified by column chromatography on silica gel using cyclohexane−EtOAc (2:1 to 1:0 with 1% NH<sub>4</sub>OH) as the eluent to give 226 mg (56%) of <b>2t</b> as light-yellow oil. The free base was dissolved in 50 mL of Et<sub>2</sub>O, MeOH solution (1 mL) of fumaric acid (1 equiv) was added dropwise, and the mixture was stirred overnight. The precipitate was collected, washed with Et<sub>2</sub>O, and dried under vacuum to give 260 mg (43%) of <b>2t</b> fumarate as a white solid: mp 171−172 °C. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.90 (m, 2H), 7.56 (d, <i>J</i> = 7.5 Hz, 1H), 7.48 (t, <i>J</i> = 7.6 Hz, 1H), 6.68 (s, 2H), 5.14 (q, <i>J</i> = 7.1 Hz, 1H), 3.59 (m, 1H), 2.45 (s, 3H), 2.13 (m, 2H), 1.90−1.65 (m, 6H), 1.58 (d, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 201.0, 175.1, 144.4, 140.5, 139.9, 138.1, 134.0, 130.9, 62.6, 61.9, 34.5, 28.6, 25.0, 20.7, 10.8. LCMS (ESI) <i>m</i>/<i>z</i> 232.8 (M + 1)<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>25</sub>NO<sub>5</sub>) C, H, N.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-(<i>N</i>-Cyclopentylamino)-3′-methoxypropiophenone (<b>2u</b>) Fumarate</h3><div class="NLM_p last">To a CH<sub>3</sub>CN solution (6 mL) of 2-bromo-3′-methoxypropiophenone <b>7d</b> (600 mg, 2.47 mmol) was added cyclopentylamine (245 μL, 2.47 mmol), and the mixture was allowed to react for 6 h at 40 °C. After the mixture was cooled to room temperature, the precipitate was filtered off. The filtrate was concentrated, and the residue was purified by column chromatography on silica gel using cyclohexane−EtOAc (2:1 to 1:0 with 1% NH<sub>4</sub>OH) as the eluent to give <b>2u</b> as a light-yellow oil. The <b>2u</b> was dissolved in 50 mL of Et<sub>2</sub>O, and a MeOH solution (1 mL) of fumaric acid (1 equiv) was added dropwise and stirred overnight. The precipitate was collected, washed with Et<sub>2</sub>O, and dried under vacuum to give 290 mg (33%) of <b>2u</b> fumarate as an off-white solid: mp 144−145 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.66 (d, <i>J</i> = 7.7 Hz, 1H), 7.50 (m, 2H), 7.27 (dd, <i>J</i> = 8.2, 2.4 Hz, 1H), 6.53 (s, 2H), 4.72 (m, 1H), 3.84 (s, 3H), 3.18 (m, 1H), 1.77 (m, 2H), 1.64 (m, 2H), 1.48 (m, 4H), 1.29 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 196.5, 170.7, 161.3, 135.6, 135.1, 131.0, 121.8, 121.5, 113.9, 58.3, 57.7, 55.5, 30.3, 24.3, 16.4. LCMS (ESI) <i>m</i>/<i>z</i> 248.3 (M + 1)<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>25</sub>NO<sub>6</sub>) C, H, N.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-(<i>N</i>-Cyclopentylamino)-3′-nitropropiophenone (<b>2v</b>) Hydrochloride</h3><div class="NLM_p last">To a CH<sub>3</sub>CN solution (3 mL) of 2-bromo-3′-nitropropiophenone <b>7e</b> (300 mg, 1.16 mmol) was added cyclopentylamine (230 μL, 2.32 mmol), and the mixture was allowed to react for 6 h at room temperature. The precipitate was filtered off. The filtrate was concentrated, and the residue was purified by column chromatography on silica gel using cyclohexane−EtOAc (2:1 to 1:0 with 1% NH<sub>4</sub>OH) as the eluent to give <b>2v</b> as a light-yellow oil. The <b>2v</b> was dissolved in 50 mL of Et<sub>2</sub>O, a solution of hydrochloric acid in Et<sub>2</sub>O was added dropwise, and the mixture was stirred overnight. The precipitate was collected, washed with Et<sub>2</sub>O, and dried under vacuum to give 50 mg (15%) of <b>2v</b>·HCl as a white solid: mp 149−150 °C. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.88 (s, 1H), 8.60 (s, 1H), 8.51 (s, 1H), 7.89 (s, 1H), 5.28 (s, 1H), 3.68 (s, 1H), 2.19 (s, 2H), 1.64−1.87 (m, 9H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 195.6, 150.4, 135.9, 135.6, 132.2, 130.1, 124.7, 59.0, 58.8, 31.0, 25.0, 16.7. Anal. (C<sub>17</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>3</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-(<i>N</i>-Pyrrolidinyl)-3′-fluoropropiophenone (<b>2aa</b>) Hydrochloride</h3><div class="NLM_p last">To a CH<sub>3</sub>CN solution (3 mL) of 2-bromo-3′-fluoropropiophenone <b>7a</b> (300 mg, 1.30 mmol) was added pyrrolidine (108 μL, 1.30 mmol), and the mixture was allowed to react for 3 h at room temperature. The precipitate was filtered off. The filtrate was concentrated, and the residue was purified by column chromatography on silica gel using cyclohexane−EtOAc (2:1 to 1:0 with 1% NH<sub>4</sub>OH) as the eluent to give the <b>2aa</b> as a light-yellow oil. The <b>2aa</b> was dissolved in Et<sub>2</sub>O, a solution of hydrochloric acid in Et<sub>2</sub>O was added dropwise, and the mixture was stirred overnight. The precipitate was collected, washed with Et<sub>2</sub>O, and dried under vacuum to give 180 mg (54%) of <b>2aa</b>·HCl as a white solid: mp 184−185 °C. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.91 (d, 1H), 7.81 (d, 1H), 7.64 (m, 1H), 7.52 (m, 1H), 5.32 (m, 1H), 3.73 (m, 2H), 3.07 (m, 2H), 2.09−2.16 (m, 4H), 1.63 (d, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 196.3, 166.2, 162.9, 136.5, 132.7, 132.6, 126.2, 123.3, 123.1, 116.7, 116.4, 66.9, 55.8, 53.4, 24.4, 16.8. LCMS (ESI) <i>m</i>/<i>z</i> 222.6 (M + 1)<sup>+</sup>. Anal. (C<sub>13</sub>H<sub>17</sub>ClFNO) C, H, N.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-(<i>N</i>-Pyrrolidinyl)-3′-bromopropiophenone (<b>2bb</b>) Fumarate</h3><div class="NLM_p last">To a CH<sub>3</sub>CN/H<sub>2</sub>O solution (4 mL/2 mL) of 2-bromo-3′-bromopropiophenone <b>7b</b> (700 mg, 2.4 mmol) was added pyrrolidine (200 μL, 2.4 mmol), and the mixture was allowed to react for 4 h at room temperature. The reaction solution was diluted with EtOAc, washed with aqueous NaHCO<sub>3</sub>, water, and brine, and then dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated, and the residue was purified by column chromatography on silica gel using cyclohexane−EtOAc (2:1 to 1:0 with 1% NH<sub>4</sub>OH) as the eluent to give 452 mg (67%) of <b>2bb</b> as a light-yellow oil. The <b>2bb</b> was dissolved in 50 mL of Et<sub>2</sub>O, a MeOH solution (1 mL) of fumaric acid (1 equiv) was added dropwise, and the mixture was stirred overnight. The precipitate was collected, washed with Et<sub>2</sub>O, and dried under vacuum to give <b>2bb</b> fumarate as a white solid: mp 134−135 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.25 (s, 1H), 8.05 (d, 1H), 7.67 (d, 1H), 7.33 (t, 1H), 3.91 (q, 1H), 2.61 (m, 4H), 1.80 (m, 4H), 1.37 (d, 9H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 199.7, 137.8, 135.8, 131.8, 130.1, 127.3, 122.8, 65.0, 51.1, 23.6, 15.8. LCMS (ESI) <i>m</i>/<i>z</i> 284.7 (M + 1)<sup>+</sup>. Anal. (C<sub>17</sub>H<sub>20</sub>BrNO<sub>5</sub>) C, H, N.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-(<i>N</i>-Pyrrolidinyl)-3′-methylpropiophenone (<b>2cc</b>) Fumarate</h3><div class="NLM_p last">To a CH<sub>3</sub>CN−H<sub>2</sub>O solution (4 mL-2 mL) of 2-bromo-3′-methylpropiophenone <b>7c</b> (400 mg, 1.76 mmol) was added pyrrolidine (150 μL, 1.76 mmol), and the mixture was allowed to react for 4 h at room temperature. The reaction solution was diluted with EtOAc, washed with aqueous NaHCO<sub>3</sub>, water, and brine, and then dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated, and the residue was purified by column chromatography on silica gel using cyclohexane−EtOAc (2:1 to 1:0 with 1% NH<sub>4</sub>OH) as the eluent to give <b>2cc</b> as a light-yellow oil. The <b>2cc</b> was dissolved in Et<sub>2</sub>O, a MeOH solution (1 mL) of fumaric acid (1 equiv) was added dropwise, and the mixture was stirred overnight. The precipitate was collected, washed with Et<sub>2</sub>O, and dried under vacuum to give 320 mg (55%) of <b>2cc</b> fumarate as a white solid: mp 131−132 °C. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.86 (m, 2H), 7.57 (d, <i>J</i> = 7.6 Hz, 1H), 7.48 (t, <i>J</i> = 7.6 Hz, 1H), 6.69 (s, 2H), 5.23 (q, <i>J</i> = 7.1 Hz, 1H), 3.55−3.33 (m, 4H), 2.45 (s, 3H), 2.12 (m, 4H), 1.60 (d, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 201.2, 175.0, 144.4, 140.6, 139.9, 138.2, 134.0, 130.9, 70.3, 58.0, 28.0, 25.0, 20.6. LCMS (ESI) <i>m</i>/<i>z</i> 218.1 (M + 1)<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>23</sub>NO<sub>5</sub>) C, H, N.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-(<i>N</i>-Pyrrolidinyl)-3′-methoxypropiophenone (<b>2dd</b>) Fumarate</h3><div class="NLM_p last">To a CH<sub>3</sub>CN−H<sub>2</sub>O solution (4 mL/2 mL) of 2-bromo-3′-methyoxypropiophenone <b>7d</b> (600 mg, 2.47 mmol) was added pyrrolidine (200 μL, 2.4 mmol), and the mixture was allowed to react for 4 h at room temperature. The reaction solution was diluted with EtOAc, washed with aqueous NaHCO<sub>3</sub>, water, and brine, and then dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated, and the residue was purified by column chromatography on silica gel using cyclohexane−-EtOAc (2:1 to 1:0 with 1% NH<sub>4</sub>OH) as the eluent to give 300 mg (52%) of <b>2dd</b> as a light-yellow oil. The <b>2dd</b> was dissolved in 50 mL of Et<sub>2</sub>O, a MeOH solution (1 mL) of fumaric acid (1 equiv) was added dropwise, and the mixture was stirred overnight. The precipitate was collected, washed with Et<sub>2</sub>O, and dried under vacuum to give 340 mg (39%) of <b>2dd</b> fumarate as a white solid: mp 121−122 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.67 (d, <i>J</i> = 7.7 Hz, 1H), 7.56 (s, 1H), 7.47 (t, <i>J</i> = 8.1 Hz, 1H), 7.24 (dd, <i>J</i> = 8.2, 2.6 Hz, 1H), 6.58 (s, 2H), 4.46 (m, 1H), 3.82 (s, 3H), 2.76 (s, 4H), 1.74 (s, 4H), 1.29 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 197.7, 165.0, 157.8, 135.0, 132.7, 128.3, 119.4, 117.8, 111.6, 61.2, 53.7, 48.6, 21.6, 12.8. LCMS (ESI) <i>m</i>/<i>z</i> 234.3 (M + 1)<sup>+</sup>. Anal. (C<sub>18</sub>H<sub>23</sub>NO<sub>6</sub>) C, H, N.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-(<i>N</i>-Pyrrolidinyl)-3′-nitropropiophenone (<b>2ee</b>) Hydrochloride</h3><div class="NLM_p last">To a CH<sub>3</sub>CN−H<sub>2</sub>O solution (4 mL/2 mL) of <b>7e</b> (310 mg, 1.2 mmol) was added pyrrolidine (100 μL, 1.2 mmol), and the mixture was allowed to react for 2 h at room temperature. The reaction solution was diluted with EtOAc, washed with aqueous NaHCO<sub>3</sub>, water, and brine, and then dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated, and the residue was purified by column chromatography on silica gel using cyclohexane−EtOAc (2:1 to 1:0 with 1% NH<sub>4</sub>OH) as the eluent to give 120 mg (40%) of <b>2ee</b> as a light-yellow oil. The <b>2ee</b> was dissolved in 50 mL of Et<sub>2</sub>O, a solution of hydrochloric acid in ether was added dropwise, and the mixture was stirred overnight. The precipitate was collected, washed with Et<sub>2</sub>O, and dried under vacuum to give 60 mg (18%) of <b>2ee</b>·HCl as an off-white solid: mp 35−36 °C. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.86 (s, 1H), 8.59 (s, 1H), 8.50 (s, 1H), 7.91 (s, 1H), 5.50 (s, 1H), 3.80 (s, 2H), 3.40 (m, 2H), 2.14 (m, 4H), 1.70 (s, 3H). <sup>13</sup>C NMR (CD<sub>3</sub>OD) δ 196.2, 150.7, 136.8, 136.1, 132.9, 130.6, 125.3, 67.9, 56.8, 54.6, 25.3, 25.2, 17.7. LCMS (ESI) <i>m</i>/<i>z</i> 249.2 (M + 1)<sup>+</sup>. Anal. (C<sub>13</sub>H<sub>17</sub>ClN<sub>2</sub>O<sub>3</sub>·H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure for 2-Bromo-3-Substituted Propiophenones <b>7a</b>−<b>e</b></h3><div class="NLM_p last">To a solution of the appropriate propiophenone <b>6a</b>−<b>e</b> (25 mmol) in acetic acid (45 mL), bromine (25 mmol) was added dropwise. After the mixture was stirred overnight, the acetic acid was removed under vacuum, and the resulting residue was dissolved in EtOAc, washed with saturated NaHCO<sub>3</sub> solution, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to give the bromoketones <b>7a</b>−<b>e</b>. The unpurified <b>7a</b>−<b>e</b> were used to prepare the <b>2a</b> analogues without further purification.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Cell Lines and Culture</h3><div class="NLM_p last">HEK-293 cells stably expressing human DAT, NET, or SERT were maintained as previously described.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Use was made of several human cell lines that naturally or heterologously express specific, functional, human nAChR subtypes.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Cells of the TE671/RD line naturally expresses muscle-type nAChR (α1β1γδ- or α1*-nAChR), and SH-SY5Y neuroblastoma cells naturally expresses autonomic α3β4*-nAChRs (containing α3, β4, probably α5, and sometimes β2 subunits). Different clones of SH-EP1 epithelial cell lines have been engineered to heterologously express either α4β2-nAChR, which is thought to be the most abundant, high affinity nicotine-binding nAChR in mammalian brain, or α4β4-nAChR, another possible brain nAChR subtype (SH-EP1-hα4β2 or α4β4 cells, respectively).<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> These cells were maintained as low passage number (1−26 from our frozen stocks) cultures to ensure stable expression of native or heterologously expressed nAChR as previously described.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Cells were passaged once weekly by splitting just-confluent cultures 1/300 (TE671/RD), 1/5 (SH-SY5Y), or 1/20 (transfected SH-EP1) in serum-supplemented medium to maintain log-phase growth.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Transporter Assays</h3><div class="NLM_p last">The abilities of <b>2a</b> and its analogues to inhibit uptake of [<sup>3</sup>H]dopamine ([<sup>3</sup>H]DA), [<sup>3</sup>H]serotonin ([<sup>3</sup>H]5-HT), or [<sup>3</sup>H]norepinephrine ([<sup>3</sup>H]NE) by the respective human transporters were evaluated using the appropriate HEK-293 cell line as previously reported.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> nAChR Functional Assays</h3><div class="NLM_p">Cells were harvested at confluence from 100 mm plates by mild trypsinization (Irvine Scientific, Santa Ana, CA) and trituration or (for SH-SY5Y cells) by trituration alone before being suspended in complete medium and evenly seeded at a density of 1.25−2 confluent 100 mm plates per 24-well plate (Falcon; ∼100−125 μg of total cell protein per well in a 500 μL volume). After cells had adhered (generally overnight but no sooner than 4 h later), the medium was removed and replaced with 250 μL per well of complete medium supplemented with ∼350000 cpm of <sup>86</sup>Rb<sup>+</sup> (PerkinElmer Life and Analytical Sciences, Boston, MA) and counted at 40% efficiency using Cerenkov counting (TriCarb 1900 liquid scintillation analyzer, 59% efficiency; PerkinElmer Life Sciences). After at least 4 h and typically overnight, <sup>86</sup>Rb<sup>+</sup> efflux was measured using the “flip-plate” technique.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Briefly, after aspiration of the bulk of <sup>86</sup>Rb<sup>+</sup> loading medium from each well of the “cell plate”, each well containing cells was rinsed 3× with 2 mL of fresh <sup>86</sup>Rb<sup>+</sup> efflux buffer (130 mM NaCl, 5.4 mM KCl, 2 mM CaCl<sub>2</sub>, 5 mM glucose, 50 mM HEPES, pH 7.4) to remove extracellular <sup>86</sup>Rb<sup>+</sup>. Following removal of residual rinse buffer by aspiration, the flip-plate technique was used again to simultaneously introduce 1.5 mL of fresh efflux buffer containing drugs of choice at indicated final concentrations from a 24-well “efflux/drug plate” into the wells of the cell plate. After a 5 min incubation, the solution was “flipped” back into the efflux/drug plate, and any remaining buffer in the cell plate was removed by aspiration. Cells remaining in the cell plate were lysed and suspended by addition of 1.5 mL of 0.1 M NaOH, 0.1% sodium dodecyl sulfate to each well. Suspensions in each well were then subjected to Cerenkov counting (Wallac Micobeta Trilux 1450; 25% efficiency) after placement of inserts (Wallac 1450−109) into each well to minimize cross-talk between wells.</div><div class="NLM_p">For quality control and normalization purposes, the sum of <sup>86</sup>Rb<sup>+</sup> in cell plates and efflux/drug plates was defined to confirm material balance (i.e., that the sum of <sup>86</sup>Rb<sup>+</sup> released into the efflux/drug plates and <sup>86</sup>Rb<sup>+</sup> remaining in the cell plate was the same for each well). This ensured that <sup>86</sup>Rb<sup>+</sup> efflux was the same whether measured in absolute terms or as a percentage of loaded <sup>86</sup>Rb<sup>+</sup>. Similarly, the sum of <sup>86</sup>Rb<sup>+</sup> in cell plates and efflux/drug plates also determined the efficiency of <sup>86</sup>Rb<sup>+</sup> loading (the percentage of applied <sup>86</sup>Rb<sup>+</sup> actually loaded into cells).</div><div class="NLM_p">Control, total <sup>86</sup>Rb<sup>+</sup> efflux was assessed in the presence of only a fully efficacious concentration of carbamylcholine (1 mM for SH-EP1-hα4β2, SH-EP1-hα4β4 cells or TE671/RD cells; 3 mM for SH-SY5Y cells). Control, nonspecific <sup>86</sup>Rb<sup>+</sup> efflux was measured either in the presence of the fully efficacious concentration of carbamylcholine plus 100 μM mecamylamine, which gave full block of agonist-induced and spontaneous nAChR-mediated ion flux, or in the presence of efflux buffer alone. Either determination of nonspecific efflux was equivalent. Specific efflux was then taken as the difference in control samples between total and nonspecific <sup>86</sup>Rb<sup>+</sup> efflux. Any intrinsic agonist activity of test drugs was ascertained using samples containing test drug only at different concentrations and was normalized, after subtraction of nonspecific efflux, to specific efflux in test drug-free, control samples. Antagonism of carbamylcholine-evoked <sup>86</sup>Rb<sup>+</sup> efflux was assessed in samples containing the full agonist at a concentration where it stimulates 80−90% of maximal function (i.e., its EC<sub>80</sub>−EC<sub>90</sub> value) when exposed alone to a given nAChR subtype (i.e, 460 μM for TE671/RD cells, 2 mM for SH-SY5Y cells, 200 μM for SH-EP1-hα4β2 or -α4β4 cells) and test drugs at the concentrations shown. After subtraction of nonspecific efflux, results were normalized to specific ion flux in control samples. For studies of mechanism of antagonism, concentration−response curves were obtained using samples containing the full agonist, carbamylcholine, at the indicated concentrations alone or in the presence of a concentration of the test ligand close to its IC<sub>50</sub> value for inhibition of nAChR function. In other studies, cells were pre-exposed to analogues for 1 h (over the last hour of <sup>86</sup>Rb<sup>+</sup> loading) or 1 day (with <sup>86</sup>Rb<sup>+</sup> loading occurring during the final 4 h of drug pretreatment) before effects on nAChR function were assessed after analogue was removed (during extracellular <sup>86</sup>Rb<sup>+</sup> removal) or in the continued presence of drug.</div><div class="NLM_p last">Ion flux assay results were fit using Prism (GraphPad) to the Hill equation, <i>F</i> = <i>F</i><sub>max</sub>/(1 + (<i>X</i>/<i>Z</i>)<sup><i>n</i></sup>), where <i>F</i> is the test sample specific ion flux as a percentage of control, <i>F</i><sub>max</sub> is specific ion flux in the absence of test drug (i.e., for control samples), <i>X</i> is the test ligand concentration, <i>Z</i> is the EC<sub>50</sub> (<i>n</i> > 0 for agonists) or IC<sub>50</sub> (<i>n</i> < 0 for antagonists), and <i>n</i> is the Hill coefficient. All concentration−ion flux response curves were simple and fit well, allowing maximum and minimum ion flux values to be determined by curve fitting, but in cases where antagonists had weak functional potency, minimum ion flux was set at 0% of control. Note that because agonist concentrations used for test ligand antagonism assessments were EC<sub>80</sub>−EC<sub>90</sub> values, not all of the data, even at the lowest concentrations of test antagonist, approach 100% of specific efflux, as separately determined in sister samples exposed to fully efficacious concentrations of agonist.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Behavior</h3><div class="NLM_p last">All animal experiments were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals and Institutional Animal Care and Use Committee guidelines.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Animals</h3><div class="NLM_p last">Male Institute of Cancer Research (ICR) mice (weighing 20−25 g) obtained from Harlan (Indianapolis, IN) were used throughout the study. Animals were housed in an Association for Assessment and Accreditation of Laboratory Animal Care approved facility, were placed in groups of six, and had free access to food and water. Studies were approved by the Institutional Animal Care and Use Committee of Virginia Commonwealth University.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Tail-Flick Test</h3><div class="NLM_p last">Antinociception for pain mediated at the spinal level was assessed by the tail-flick method of D’Amour and Smith.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In brief, mice were lightly restrained while a radiant heat source was shone onto the upper portion of the tail. To minimize tissue damage, a maximum latency of 10 s was imposed. Latency to remove the tail from the heat source was recorded for each animal. A control response (2−4 s) was determined for each mouse before treatment, and a test latency was determined after drug administration (nicotine as an analgesic 5 min after subcutaneous administration at 2.5 mg/kg; nicotine administration 15 min after exposure to saline of <b>2a</b> analogue to assess the latter drug’s ability to block nicotine-mediated antinociception). Antinociceptive response was calculated as the percentage of maximum possible effect (%MPE), where %MPE = [(test control)/(10 control)] × 100.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Hot-Plate Test</h3><div class="NLM_p last">Mice were placed into a 10 cm wide glass cylinder on a hot plate (Thermojust Apparatus) maintained at 55 °C for assessment of pain responses mediated at supraspinal levels. To minimize tissue damage, a maximum exposure to the hot plate of 40 s was imposed. Measures of control latencies (time until the animal jumped or licked its paws; typically 8−12 s) were done twice for stimuli applied at least 10 min apart for each mouse. Antinociceptive responses after test drug administrations were determined and calculated as the %MPE, where %MPE = [(test latency in s − control latency in s)/(40 s − controllatency in s) × 100]. Groups of 8−12 animals were used for each drug condition. Antagonism studies were carried in mice pretreated with either saline or <b>2a</b> metabolites 15 min before nicotine. The animals were then tested 5 min after administration of a subcutaneous dose of 2.5 mg/kg nicotine.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Locomotor Activity</h3><div class="NLM_p last">Mice were placed into individual Omnitech photocell activity cages (28 cm × 16.5 cm; Omnitech Electronics, Columbus, OH) 5 min after subcutaneous administration of either 0.9% saline or nicotine (1.5 mg/kg). Interruptions of the photocell beams (two banks of eight cells each) were then recorded for the next 10 min. Data were expressed as the number of photocell interruptions. Antagonism studies were carried out by pretreating the mice with either saline or <b>2a</b> metabolites 15 min before nicotine.</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Body Temperature</h3><div class="NLM_p last">Rectal temperature was measured by a thermistor probe (inserted 24 mm) and digital thermometer (YSI Inc., Yellow Springs, OH). Readings were taken just before and 30 min after subcutaneous injection of either saline or 2.5 mg/kg nicotine. The difference in rectal temperature before and after treatment was calculated for each mouse. The ambient temperature of the laboratory varied from 21 to 24 °C from day to day. Antagonism studies were carried out by pretreating the mice with either saline or <b>2a</b> metabolites 15 min before nicotine. The animals were then tested 30 min after administration of a subcutaneous dose of 2.5 mg/kg nicotine.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/jm9017465">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30348" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30348" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Results from elemental analysis. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9017465/suppl_file/jm9017465_si_001.pdf">jm9017465_si_001.pdf (26.72 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm9017465" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. Ivy Carroll</span> - <span class="hlFld-Affiliation affiliation">Center for Organic and Medicinal Chemistry, Research Triangle Institute, Research Triangle Park, North Carolina 27709-2194</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d7b1beb497a5a3bef9b8a5b0"><span class="__cf_email__" data-cfemail="d5b3bcb695a7a1bcfbbaa7b2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce E. Blough</span> - <span class="hlFld-Affiliation affiliation">Center for Organic and Medicinal Chemistry, Research Triangle Institute, Research Triangle Park, North Carolina 27709-2194</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">S. Wayne Mascarella</span> - <span class="hlFld-Affiliation affiliation">Center for Organic and Medicinal Chemistry, Research Triangle Institute, Research Triangle Park, North Carolina 27709-2194</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hernán A. Navarro</span> - <span class="hlFld-Affiliation affiliation">Center for Organic and Medicinal Chemistry, Research Triangle Institute, Research Triangle Park, North Carolina 27709-2194</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Brek Eaton</span> - <span class="hlFld-Affiliation affiliation">Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald J. Lukas</span> - <span class="hlFld-Affiliation affiliation">Division of Neurobiology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, Arizona 85013</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">M. Imad Damaj</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and Toxicology, Medical Campus, Virginia Commonwealth University, Richmond, Virginia 23219</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72203" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72203" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by National Institutes of Health National Cooperative Drug Discovery Group Grant U19 DA019377. Other effort was supported by grants (to R.J.L) from the National Institutes of Health (Grant DA015389) and the Barrow Neurological Foundation.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span> <span class="citation_source-book">WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package</span>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>p 15.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO+Report+on+the+Global+Tobacco+Epidemic%2C+2008%3A+The+MPOWER+Package%3B+World+Health+Organization%3A+Geneva%2C+2008%3B+p+15."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DWHO%2520Report%2520on%2520the%2520Global%2520Tobacco%2520Epidemic%252C%25202008%253A%2520The%2520MPOWER%2520Package%26pub%3DWorld%2520Health%2520Organization%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Centers for Disease Control and Prevention</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Cigarette smoking among adults: United States, 2007</span>.  <span class="citation_source-journal">Morbidity Mortality Wkly. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span>− <span class="NLM_lpage">1161</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=1157-1161&author=Centers+for+Disease+Control+and+Prevention&title=Cigarette+smoking+among+adults%3A+United+States%2C+2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DCigarette%2520smoking%2520among%2520adults%253A%2520United%2520States%252C%25202007%26jtitle%3DMorbidity%2520Mortality%2520Wkly.%2520Rep.%26date%3D2007%26volume%3D56%26spage%3D1157%26epage%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Benowitz, N. L.</span><span> </span><span class="NLM_article-title">Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1038%2Fclpt.2008.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=18305452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsFCksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2008&pages=531-541&author=N.+L.+Benowitz&title=Clinical+pharmacology+of+nicotine%3A+implications+for+understanding%2C+preventing%2C+and+treating+tobacco+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Pharmacology of Nicotine: Implications for Understanding, Preventing, and Treating Tobacco Addiction</span></div><div class="casAuthors">Benowitz, N. L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">531-541</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Understanding the basic and clin. pharmacol. of nicotine provides a basis for improved prevention and treatment of tobacco addiction.  Nicotine acts on nicotinic cholinergic receptors in the brain to release dopamine and other neurotransmitters that sustain addiction.  Neuroadaptation and tolerance involve changes in both nicotinic receptors and neural plasticity.  Nicotine addiction can occur in the context of phys. dependence characterized by self-medication to modulate neg. affect and/or to relieve withdrawal symptoms, as well as, in light or occasional smokers, primarily for pos. reinforcement in specific situations.  Nicotine is metabolized primarily by CYP2A6.  Its clearance exhibits considerable individual variability that is detd. by genetic, racial, and hormonal (sex) factors.  Genetically slow metab. of nicotine appears to be assocd. with a lower level of dependence.  Nicotine dependence is highly heritable and appears to be influenced by genes coding for some nicotine receptor subtypes, some neurotransmitter genes, and genes involved in neural connectivity.  Novel pharmacotherapies for nicotine dependence include partial agonists for nicotinic receptors and nicotine vaccines.  Pharmacogenetic studies suggest various candidate genes and a nicotine metab. phenotype that influence outcome.  Human pharmacol. studies of nicotine and smoking behavior also provide a basis for assessing the benefits and risks of long-term nicotine use for harm redn. and for a potential cigarette regulatory strategy that includes reducing nicotine content of cigarettes to nonaddictive levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbBNl-p5vZebVg90H21EOLACvtfcHk0li7U6ck8ocTkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsFCksrk%253D&md5=645fabce1b3ab788ac387d03a5fa67b8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2008.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2008.3%26sid%3Dliteratum%253Aachs%26aulast%3DBenowitz%26aufirst%3DN.%2BL.%26atitle%3DClinical%2520pharmacology%2520of%2520nicotine%253A%2520implications%2520for%2520understanding%252C%2520preventing%252C%2520and%2520treating%2520tobacco%2520addiction%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D83%26spage%3D531%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lerman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeSage, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Malley, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benowitz, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigall, W. A.</span><span> </span><span class="NLM_article-title">Translational research in medication development for nicotine dependence</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=746-762&author=C.+Lermanauthor=M.+G.+LeSageauthor=K.+A.+Perkinsauthor=S.+S.+O%27Malleyauthor=S.+J.+Siegelauthor=N.+L.+Benowitzauthor=W.+A.+Corrigall&title=Translational+research+in+medication+development+for+nicotine+dependence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLerman%26aufirst%3DC.%26aulast%3DLeSage%26aufirst%3DM.%2BG.%26aulast%3DPerkins%26aufirst%3DK.%2BA.%26aulast%3DO%2527Malley%26aufirst%3DS.%2BS.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26aulast%3DBenowitz%26aufirst%3DN.%2BL.%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26atitle%3DTranslational%2520research%2520in%2520medication%2520development%2520for%2520nicotine%2520dependence%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D746%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Heterogeneity and complexity of native brain nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1102-1111&author=C.+Gottiauthor=M.+Morettiauthor=A.+Gaimarriauthor=A.+Zanardiauthor=F.+Clementiauthor=M.+Zoli&title=Heterogeneity+and+complexity+of+native+brain+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DZanardi%26aufirst%3DA.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DHeterogeneity%2520and%2520complexity%2520of%2520native%2520brain%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1102%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Rahman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Hernandez, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.2174%2F187152708786927831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=19128201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFansQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=422-441&author=S.+Rahmanauthor=G.+Y.+Lopez-Hernandezauthor=W.+A.+Corrigallauthor=R.+L.+Papke&title=Neuronal+nicotinic+receptors+as+brain+targets+for+pharmacotherapy+of+drug+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction</span></div><div class="casAuthors">Rahman, Shafiqur; Lopez-Hernandez, Gretchen Y.; Corrigall, William A.; Papke, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-441</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotine addiction and other forms of drug addiction continue to be significant public health problems in the United States and the rest of the world.  Accumulated evidence indicates that brain nicotinic acetylcholine receptors (nAChRs) are a heterogenous family of ion channels expressed in the various parts of the brain.  A growing body of preclin. studies suggests that brain nAChRs are crit. targets for the development of pharmacotherapies for nicotine and other drug addictions.  In this review, we will discuss the nAChR subtypes, their function in response to endogenous brain transmitters, and how their functions are regulated in the presence of nicotine.  Furthermore, we will discuss the role of nAChRs in mediating nicotine-induced addictive behavior in animal models.  Addnl., we will provide an overview of the effects of nicotine and nicotinic compds. on the mesolimbic dopamine system, part of the reinforcement/reward circuitry of the brain, as an example of the neurochem. basis of nicotine addiction and other drug addictions.  An appreciation of the complexity of nicotinic receptors and their regulation will be necessary for the development of nicotinic receptor modulators as potential pharmacotherapy for drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuQExQTuj1E7Vg90H21EOLACvtfcHk0liKlDGtPWoCYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFansQ%253D%253D&md5=1e358be78d8fd3b9da199e25dbb950a5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F187152708786927831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152708786927831%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DLopez-Hernandez%26aufirst%3DG.%2BY.%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26atitle%3DNeuronal%2520nicotinic%2520receptors%2520as%2520brain%2520targets%2520for%2520pharmacotherapy%2520of%2520drug%2520addiction%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2008%26volume%3D7%26spage%3D422%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Adams, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutter, T. J.</span><span> </span><span class="NLM_article-title">Calcium permeability and modulation of nicotinic acetylcholine receptor-channels in rat parasympathetic neurons</span> <span class="citation_source-journal">J. Physiol. (Paris)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1992&pages=67-76&author=D.+J.+Adamsauthor=T.+J.+Nutter&title=Calcium+permeability+and+modulation+of+nicotinic+acetylcholine+receptor-channels+in+rat+parasympathetic+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DNutter%26aufirst%3DT.%2BJ.%26atitle%3DCalcium%2520permeability%2520and%2520modulation%2520of%2520nicotinic%2520acetylcholine%2520receptor-channels%2520in%2520rat%2520parasympathetic%2520neurons%26jtitle%3DJ.%2520Physiol.%2520%2528Paris%2529%26date%3D1992%26volume%3D86%26spage%3D67%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2428</span><span class="NLM_x">–</span> <span class="NLM_lpage">2439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1111%2Fj.1460-9568.1996.tb01206.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=8950106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A280%3ADyaK2s7gslemuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=2428-2439&author=N.+Le+Novereauthor=M.+Zoliauthor=J.+P.+Changeux&title=Neuronal+nicotinic+receptor+alpha+6+subunit+mRNA+is+selectively+concentrated+in+catecholaminergic+nuclei+of+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain</span></div><div class="casAuthors">Le Novere N; Zoli M; Changeux J P</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2428-39</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Although the neuronal nicotinic receptor alpha 6 subunit was cloned several years ago, its functional significance remains to be investigated.  Here we describe an in situ hybridization study of the mRNA for this subunit in the adult rat central nervous system using oligonucleotide probes.  Specific alpha 6 mRNA labelling was restricted to a few nuclei throughout the brain; it was particularly high in several catecholaminergic nuclei [the locus coeruleus (A6), the ventral tegmental area (A10) and the substantia nigra (A9)] at levels significantly higher than those found for any other known nicotinic receptor subunit mRNA.  Labelling for alpha 6 mRNA was also detected at lower levels in the reticular thalamic nucleus, the supramammillary nucleus and the mesencephalic V nucleus.  Some cells of the medial habenula (medioventral part) and of the interpeduncular nucleus (central and lateral parts) were also labelled.  The distribution of alpha 6 mRNA was compared with the distribution of the other known nicotinic acetylcholine receptor subunit mRNAs.  In several nuclei, the expression of alpha 6 was complementary to those of other alpha subunits.  Moreover, some of the cell groups (such as the substantia nigra, the ventral tegmental area and the locus coeruleus) previously thought to contain mainly alpha 3 mRNA in fact were found to contain high levels of alpha 6 mRNA.  Finally, we found extensive colocalization of alpha 6 and beta 3, indicating the possible existence of nicotinic receptor hetero-oligomers containing both subunits.  The present results show that alpha 6 is the major nicotinic acetylcholine receptor alpha subunit expressed in dopaminergic cell groups of the mesencephalon and noradrenergic cells of the locus coeruleus.  This suggests the involvement of the alpha 6 subunit in some of the major functions of central nicotinic circuits, including the modulation of locomotor behaviour and reward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGTspW95ieGmK_SFaaT9INfW6udTcc2eZ0cIplTioDGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7gslemuw%253D%253D&md5=1703784567106fda7afda74e1ca6e554</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.1996.tb01206.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.1996.tb01206.x%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DNeuronal%2520nicotinic%2520receptor%2520alpha%25206%2520subunit%2520mRNA%2520is%2520selectively%2520concentrated%2520in%2520catecholaminergic%2520nuclei%2520of%2520the%2520rat%2520brain%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1996%26volume%3D8%26spage%3D2428%26epage%3D2439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Goldner, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineley, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, J. W.</span><span> </span><span class="NLM_article-title">Immunohistochemical localization of the nicotinic acetylcholine receptor subunit alpha6 to dopaminergic neurons in the substantia nigra and ventral tegmental area</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2739</span><span class="NLM_x">–</span> <span class="NLM_lpage">2742</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=2739-2742&author=F.+M.+Goldnerauthor=K.+T.+Dineleyauthor=J.+W.+Patrick&title=Immunohistochemical+localization+of+the+nicotinic+acetylcholine+receptor+subunit+alpha6+to+dopaminergic+neurons+in+the+substantia+nigra+and+ventral+tegmental+area"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldner%26aufirst%3DF.%2BM.%26aulast%3DDineley%26aufirst%3DK.%2BT.%26aulast%3DPatrick%26aufirst%3DJ.%2BW.%26atitle%3DImmunohistochemical%2520localization%2520of%2520the%2520nicotinic%2520acetylcholine%2520receptor%2520subunit%2520alpha6%2520to%2520dopaminergic%2520neurons%2520in%2520the%2520substantia%2520nigra%2520and%2520ventral%2520tegmental%2520area%26jtitle%3DNeuroReport%26date%3D1997%26volume%3D8%26spage%3D2739%26epage%3D2742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Exley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, S. J.</span><span> </span><span class="NLM_article-title">Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2158</span><span class="NLM_x">–</span> <span class="NLM_lpage">2166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=2158-2166&author=R.+Exleyauthor=M.+A.+Clementsauthor=H.+Hartungauthor=J.+M.+McIntoshauthor=S.+J.+Cragg&title=Alpha6-containing+nicotinic+acetylcholine+receptors+dominate+the+nicotine+control+of+dopamine+neurotransmission+in+nucleus+accumbens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DExley%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%2BA.%26aulast%3DHartung%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DCragg%26aufirst%3DS.%2BJ.%26atitle%3DAlpha6-containing%2520nicotinic%2520acetylcholine%2520receptors%2520dominate%2520the%2520nicotine%2520control%2520of%2520dopamine%2520neurotransmission%2520in%2520nucleus%2520accumbens%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D2158%26epage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Corrigall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. B.</span><span> </span><span class="NLM_article-title">The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1992&pages=285-289&author=W.+A.+Corrigallauthor=K.+B.+Franklinauthor=K.+M.+Coenauthor=P.+B.+Clarke&title=The+mesolimbic+dopaminergic+system+is+implicated+in+the+reinforcing+effects+of+nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26aulast%3DFranklin%26aufirst%3DK.%2BB.%26aulast%3DCoen%26aufirst%3DK.%2BM.%26aulast%3DClarke%26aufirst%3DP.%2BB.%26atitle%3DThe%2520mesolimbic%2520dopaminergic%2520system%2520is%2520implicated%2520in%2520the%2520reinforcing%2520effects%2520of%2520nicotine%26jtitle%3DPsychopharmacology%26date%3D1992%26volume%3D107%26spage%3D285%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Brody, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olmstead, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farahi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkern, M. A.</span><span> </span><span class="NLM_article-title">Smoking-induced ventral striatum dopamine release</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1176%2Fappi.ajp.161.7.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=15229053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A280%3ADC%252BD2czis1yqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=1211-1218&author=A.+L.+Brodyauthor=R.+E.+Olmsteadauthor=E.+D.+Londonauthor=J.+Farahiauthor=J.+H.+Meyerauthor=P.+Grossmanauthor=G.+S.+Leeauthor=J.+Huangauthor=E.+L.+Hahnauthor=M.+A.+Mandelkern&title=Smoking-induced+ventral+striatum+dopamine+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Smoking-induced ventral striatum dopamine release</span></div><div class="casAuthors">Brody Arthur L; Olmstead Richard E; London Edythe D; Farahi Judah; Meyer Jeffrey H; Grossman Paul; Lee Grace S; Huang Joe; Hahn Emily L; Mandelkern Mark A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1211-8</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Substantial evidence from animal models demonstrates that dopamine release in the ventral striatum underlies the reinforcing properties of nicotine.  The authors used [(11)C]raclopride bolus-plus-continuous-infusion positron emission tomography (PET) to determine smoking-induced ventral striatum dopamine release in humans.  METHOD:  Twenty nicotine-dependent smokers (who smoked > or =15 cigarettes/day) underwent a [(11)C]raclopride bolus-plus-continuous-infusion PET session.  During the session, subjects had a 10-minute break outside the PET apparatus during which 10 subjects smoked a cigarette and 10 did not smoke (as a control condition).  RESULTS:  The group that smoked had greater reductions in [(11)C]raclopride binding potential in ventral striatum regions of interest than the group that did not smoke, particularly in the left ventral caudate/nucleus accumbens and left ventral putamen (range for smoking group=-25.9% to -36.6% reduction).  Significant correlations were found between change from before to after the smoking break in craving ratings and change from before to after the break in binding potential for these two regions.  CONCLUSIONS:  Nicotine-dependent subjects who smoked during a break in PET scanning had greater reductions in [(11)C]raclopride binding potential (an indirect measure of dopamine release) than nicotine-dependent subjects who did not smoke.  The magnitude of binding potential changes was comparable to that found in studies that used similar methods to examine the effects of other addictive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRk4_DvvsbbrpggzHGM8X5CfW6udTcc2eY5mLWZ1mCNBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czis1yqtg%253D%253D&md5=745fbf6bd4538acec7ac76bbca229ce9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.7.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.7.1211%26sid%3Dliteratum%253Aachs%26aulast%3DBrody%26aufirst%3DA.%2BL.%26aulast%3DOlmstead%26aufirst%3DR.%2BE.%26aulast%3DLondon%26aufirst%3DE.%2BD.%26aulast%3DFarahi%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DGrossman%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DG.%2BS.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DE.%2BL.%26aulast%3DMandelkern%26aufirst%3DM.%2BA.%26atitle%3DSmoking-induced%2520ventral%2520striatum%2520dopamine%2520release%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D1211%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Fant, R. V.; Buchhalter, A. R.; Buchman, A. C.; Henningfield, J. E.</span><span> </span><span class="NLM_article-title">Pharmacotherapy for Tobacco Dependence</span>. In  <span class="citation_source-book">Nicotine Psychopharmacology. Handbook of Experimental Pharmacology</span>; <span class="NLM_contrib-group">Henningfield, J. E.; London, E. D.; Pogun, S.</span>, Eds.; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">Berlin</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">192</span>, p  <span class="NLM_fpage">487</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1007%2F978-3-540-69248-5_17" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=487&author=R.+V.+Fant&author=A.+R.+Buchhalter&author=A.+C.+Buchman&author=J.+E.+Henningfieldauthor=J.+E.+Henningfield&author=E.+D.+London&author=S.+Pogun&title=Nicotine+Psychopharmacology.+Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-69248-5_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-540-69248-5_17%26sid%3Dliteratum%253Aachs%26aulast%3DFant%26aufirst%3DR.%2BV.%26atitle%3DPharmacotherapy%2520for%2520Tobacco%2520Dependence%26btitle%3DNicotine%2520Psychopharmacology.%2520Handbook%2520of%2520Experimental%2520Pharmacology%26aulast%3DHenningfield%26aufirst%3DJ.%2BE.%26pub%3DSpringer-Verlag%26date%3D2009%26volume%3D192%26spage%3D487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Gonzales, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennard, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oncken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azoulay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span> </span><span class="NLM_article-title">Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=47-55&author=D.+Gonzalesauthor=S.+I.+Rennardauthor=M.+Nidesauthor=C.+Onckenauthor=S.+Azoulayauthor=C.+B.+Billingauthor=E.+J.+Watskyauthor=J.+Gongauthor=K.+E.+Williamsauthor=K.+R.+Reeves&title=Varenicline%2C+an+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist%2C+vs+sustained-release+bupropion+and+placebo+for+smoking+cessation%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzales%26aufirst%3DD.%26aulast%3DRennard%26aufirst%3DS.%2BI.%26aulast%3DNides%26aufirst%3DM.%26aulast%3DOncken%26aufirst%3DC.%26aulast%3DAzoulay%26aufirst%3DS.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DWatsky%26aufirst%3DE.%2BJ.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26atitle%3DVarenicline%252C%2520an%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520vs%2520sustained-release%2520bupropion%2520and%2520placebo%2520for%2520smoking%2520cessation%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fryer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=9862757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADyaK1MXisVyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=1999&pages=88-92&author=J.+D.+Fryerauthor=R.+J.+Lukas&title=Noncompetitive+functional+inhibition+at+diverse%2C+human+nicotinic+acetylcholine+receptor+subtypes+by+bupropion%2C+phencyclidine%2C+and+ibogaine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine</span></div><div class="casAuthors">Fryer, John D.; Lukas, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-92</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChR) are diverse members of the neurotransmitter-gated ion channel superfamily and play crit. roles in chem. signaling throughout the nervous system.  The present study establishes the acute functional effects of bupropion, phencyclidine, and ibogaine on two human nAChR subtypes.  Function of muscle-type nAChR (α1βγδ) in TE671/RD cells or of ganglionic nAChR (α3β4α5±β2) in SH-SY5Y neuroblastoma cells was measured with 86Rb+ efflux assays.  Functional blockade of human muscle-type and ganglionic nAChR is produced by each of the drugs in the low to intermediate micromolar range.  Functional blockade is insurmountable by increasing agonist concns. in TE671/RD and SH-SY5Y cells for each of these drugs, suggesting non-competitive inhibition of nAChR function.  Based on these findings, we hypothesize that nAChR are targets of diverse substances of abuse and agents used in antiaddiction/smoking cessation strategies.  We also hypothesize that nAChR play heretofore underappreciated roles in depression and as targets for clin. useful antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVpy_mL2ERbLVg90H21EOLACvtfcHk0li6FblN_jXdhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVyksg%253D%253D&md5=aab872eddec4e95e355beccf952600e7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DJ.%2BD.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DNoncompetitive%2520functional%2520inhibition%2520at%2520diverse%252C%2520human%2520nicotinic%2520acetylcholine%2520receptor%2520subtypes%2520by%2520bupropion%252C%2520phencyclidine%252C%2520and%2520ibogaine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D288%26spage%3D88%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Slemmer, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span> </span><span class="NLM_article-title">Bupropion is a nicotinic antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=10991997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1ynsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=321-327&author=J.+E.+Slemmerauthor=B.+R.+Martinauthor=M.+I.+Damaj&title=Bupropion+is+a+nicotinic+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bupropion is a nicotinic antagonist</span></div><div class="casAuthors">Slemmer, Jennifer E.; Martin, Billy R.; Damaj, M. Imad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">321-327</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuronal nicotinic receptors are ligand-gated ion channels of the central and peripheral central nervous system that regulate synaptic activity from both pre- and postsynaptic sites.  The present study establishes the acute interaction of bupropion, an antidepressant agent that is also effective in nicotine dependence, with nicotine and nicotinic receptors using different in vivo and in vitro tests.  Bupropion was found to block nicotine's antinociception (in two tests), motor effects, hypothermia, and convulsive effects with different potencies in the present investigation, suggesting that bupropion possesses some selectivity for neuronal nicotinic receptors underlying these various nicotinic effects.  In addn., bupropion blocks nicotine activation of α3β2, α4β2, and α7 neuronal acetylcholine nicotinic receptors (nAChRs) with some degree of selectivity.  It was ∼50 and 12 times more effective in blocking α3β2 and α4β2 than α7.  This functional blockade was noncompetitive, because it was insurmountable by increasing concn. of ACh in the nAChRs subtypes tested.  Furthermore, bupropion at high concn. failed to displace brain [3H]nicotine binding sites, a site largely composed of α4β2 subunit combination.  Given the observation that bupropion inhibition of α3β2 and α4β2 receptors exhibits voltage-independence properties, bupropion may not be acting as an open channel blocker.  These effects may explain in part bupropion's efficacy in nicotine dependence.  Our present findings suggest that functional blockade of neuronal nAChRs are useful in nicotine dependence treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqESPQh1LO9LVg90H21EOLACvtfcHk0lgYFM74MCC0pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1ynsrg%253D&md5=65966b022e015f86dadaedbb1c97dbaf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSlemmer%26aufirst%3DJ.%2BE.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26atitle%3DBupropion%2520is%2520a%2520nicotinic%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D321%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Harbeson, S. L.</span><span> </span><span class="NLM_article-title">Propiophenone Derivatives</span>. WIPO Patent WO/2009/105218,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+L.+Harbeson&title=Propiophenone+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26atitle%3DPropiophenone%2520Derivatives%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hadizadeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebrahimzadeh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosseinzadeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motamed-Shariaty, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekhradnia, A. R.</span><span> </span><span class="NLM_article-title">Antidepressant and antioxidant activities of some 2-benzoxazolinone derivatives as bupropion analogues</span> <span class="citation_source-journal">Pharmacologyonline</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=331-335&author=F.+Hadizadehauthor=M.+A.+Ebrahimzadehauthor=H.+Hosseinzadehauthor=V.+Motamed-Shariatyauthor=S.+Salamiauthor=A.+R.+Bekhradnia&title=Antidepressant+and+antioxidant+activities+of+some+2-benzoxazolinone+derivatives+as+bupropion+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHadizadeh%26aufirst%3DF.%26aulast%3DEbrahimzadeh%26aufirst%3DM.%2BA.%26aulast%3DHosseinzadeh%26aufirst%3DH.%26aulast%3DMotamed-Shariaty%26aufirst%3DV.%26aulast%3DSalami%26aufirst%3DS.%26aulast%3DBekhradnia%26aufirst%3DA.%2BR.%26atitle%3DAntidepressant%2520and%2520antioxidant%2520activities%2520of%2520some%25202-benzoxazolinone%2520derivatives%2520as%2520bupropion%2520analogues%26jtitle%3DPharmacologyonline%26date%3D2009%26volume%3D1%26spage%3D331%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Foley, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzi, N. V.</span><span> </span><span class="NLM_article-title">Novel aminopropiophenones as potential antidepressants</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=252-260&author=K.+F.+Foleyauthor=N.+V.+Cozzi&title=Novel+aminopropiophenones+as+potential+antidepressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoley%26aufirst%3DK.%2BF.%26aulast%3DCozzi%26aufirst%3DN.%2BV.%26atitle%3DNovel%2520aminopropiophenones%2520as%2520potential%2520antidepressants%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2003%26volume%3D60%26spage%3D252%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Miller, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumithran, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwoskin, L. P.</span><span> </span><span class="NLM_article-title">Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1124%2Fjpet.102.033852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=12183670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsF2htrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=1113-1122&author=D.+K.+Millerauthor=S.+P.+Sumithranauthor=L.+P.+Dwoskin&title=Bupropion+inhibits+nicotine-evoked+%5B%283%29H%5Doverflow+from+rat+striatal+slices+preloaded+with+%5B%283%29H%5Ddopamine+and+from+rat+hippocampal+slices+preloaded+with+%5B%283%29H%5Dnorepinephrine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bupropion inhibits nicotine-evoked [3H]overflow from rat striatal slices preloaded with [3H]dopamine and from rat hippocampal slices preloaded with [3H]norepinephrine</span></div><div class="casAuthors">Miller, Dennis K.; Sumithran, Sangeetha P.; Dwoskin, Linda P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1113-1122</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Bupropion, an efficacious antidepressant and smoking cessation agent, inhibits dopamine and norepinephrine transporters (DAT and NET, resp.).  Recently, bupropion has been reported to noncompetitively inhibit α3β2, α3β4, and α4β2 nicotinic acetylcholine receptors (nAChRs) expressed in Xenopus oocytes or established cell lines.  The present study evaluated bupropion-induced inhibition of native α3β2* and α3β4* nAChRs using functional neurotransmitter release assays, nicotine-evoked [3H]overflow from superfused rat striatal slices preloaded with [3H]dopamine ([3H]DA), and nicotine-evoked [3H]overflow from hippocampal slices preloaded with [3H]norepinephrine ([3H]NE).  The mechanism of inhibition was evaluated using Schild anal.  To eliminate the interaction of bupropion with DAT or NET, nomifensine or desipramine, resp., was included in the superfusion buffer.  A high bupropion concn. (100 μM) elicited intrinsic activity in the [3H]DA release assay.  However, none of the concns. (1 nM-100 μM) examd. evoked [3H]NE overflow and, thus, were without intrinsic activity in this assay.  Moreover, bupropion inhibited both nicotine-evoked [3H]DA overflow (IC50 = 1.27 μM) and nicotine-evoked [3H]NE overflow (IC50 = 323 nM) at bupropion concns. well below those eliciting intrinsic activity.  Results from Schild analyses suggest that bupropion competitively inhibits nicotine-evoked [3H]DA overflow, whereas evidence for receptor reserve was obtained upon assessment of bupropion inhibition of nicotine-evoked [3H]NE overflow.  Thus, bupropion acts as an antagonist at α3β2* and α3β4* nAChRs in rat striatum and hippocampus, resp., across the same concn. range that inhibits DAT and NET function.  The combination of nAChR and transporter inhibition produced by bupropion may contribute to its clin. efficacy as a smoking cessation agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLRTYoa89ckbVg90H21EOLACvtfcHk0lgtQA6St17X7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsF2htrg%253D&md5=726aede0d8aae7e092d8de0b55889233</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.033852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.033852%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BK.%26aulast%3DSumithran%26aufirst%3DS.%2BP.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DBupropion%2520inhibits%2520nicotine-evoked%2520%255B%25283%2529H%255Doverflow%2520from%2520rat%2520striatal%2520slices%2520preloaded%2520with%2520%255B%25283%2529H%255Ddopamine%2520and%2520from%2520rat%2520hippocampal%2520slices%2520preloaded%2520with%2520%255B%25283%2529H%255Dnorepinephrine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D1113%26epage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mooney, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofuoglu, M.</span><span> </span><span class="NLM_article-title">Bupropion for the treatment of nicotine withdrawal and craving</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1586%2F14737175.6.7.965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=16831112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1Crtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=965-981&author=M.+E.+Mooneyauthor=M.+Sofuoglu&title=Bupropion+for+the+treatment+of+nicotine+withdrawal+and+craving"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bupropion for the treatment of nicotine withdrawal and craving</span></div><div class="casAuthors">Mooney, Marc E.; Sofuoglu, Mehmet</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">965-981</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past decade, bupropion has become a major pharmacotherapy for smoking cessation in the Western world.  Unlike other smoking cessation pharmacotherapies, bupropion is a non-nicotine treatment.  Compared with a placebo control, bupropion approx. doubles smoking quit rates.  Most smoking cessation pharmacotherapies are thought to work, in part, by reducing nicotine withdrawal and craving.  This article reviews preclin., human lab. and clin. trial studies of the effect of bupropion on nicotine withdrawal and craving.  Preclin. studies demonstrate that in rats undergoing nicotine withdrawal, bupropion can dose-dependently lower changes in brain-reward threshold and somatic signs of nicotine withdrawal.  Human lab. studies have demonstrated that bupropion can alleviate some nicotine withdrawal symptoms, including depressed mood, irritability, difficulty concg. and increased appetite.  Moreover, bupropion has shown some efficacy in alleviating craving to smoke.  Clin. trials of bupropion have offered mixed support of its ability to reduce nicotine withdrawal, wt. gain during treatment and craving.  Strong mediational evidence of bupropion's action through relief of withdrawal and craving in smoking cessation is growing.  Greater understanding of the psychol. mechanisms of bupropion action will likely be obtained through advances in the conceptualization and measurement of withdrawal and craving.  Improvements in the efficacy of bupropion may be achieved through pharmacogenetic studies, with particular emphasis on its metabolites.  Ultimately, the efficacy of bupropion may be augmented by combination with other agents that target withdrawal and craving through complementary neurobiol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyt6mIQDaAsbVg90H21EOLACvtfcHk0lgtQA6St17X7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1Crtbk%253D&md5=dee397eb1988216650f6086b3fd8ba6a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1586%2F14737175.6.7.965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.6.7.965%26sid%3Dliteratum%253Aachs%26aulast%3DMooney%26aufirst%3DM.%2BE.%26aulast%3DSofuoglu%26aufirst%3DM.%26atitle%3DBupropion%2520for%2520the%2520treatment%2520of%2520nicotine%2520withdrawal%2520and%2520craving%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2006%26volume%3D6%26spage%3D965%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Paterson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balfour, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1111%2Fj.1460-9568.2007.05546.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=17561823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A280%3ADC%252BD2szpsVGjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=3099-3108&author=N.+E.+Patersonauthor=D.+J.+Balfourauthor=A.+Markou&title=Chronic+bupropion+attenuated+the+anhedonic+component+of+nicotine+withdrawal+in+rats+via+inhibition+of+dopamine+reuptake+in+the+nucleus+accumbens+shell"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell</span></div><div class="casAuthors">Paterson Neil E; Balfour David J; Markou Athina</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3099-108</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Bupropion, a dopamine reuptake inhibitor, is an effective therapy for smoking cessation, but the behavioral and neurochemical mechanisms mediating its antismoking properties are relatively unknown.  To explore the hypothesis that bupropion ameliorates nicotine withdrawal partly by a dopamine-dependent mechanism, we investigated the effects of chronic bupropion on potassium-stimulated dopamine overflow in the nucleus accumbens shell in nicotine-withdrawing rats.  We also assessed the effects of chronic bupropion on behavioral aspects of nicotine withdrawal measured by elevations in brain reward thresholds and somatic signs of withdrawal.  Rats were treated with nicotine or saline for 7 days and then coadministration of bupropion or saline was initiated.  After 14 days of coadministration of bupropion/saline and nicotine/saline, nicotine/saline administration was terminated, whereas bupropion/saline administration continued.  These conditions mimic bupropion administration in human smokers.  Cessation of nicotine administration in non-bupropion-treated rats elevated reward thresholds reflecting a reward deficit, increased somatic signs and diminished potassium-evoked dopamine overflow in the nucleus accumbens shell.  Chronic bupropion lowered reward thresholds and increased potassium-evoked dopamine release regardless of previous nicotine exposure, possibly by inhibition of dopamine reuptake, and thus attenuated the anhedonic and neurochemical effects of nicotine withdrawal.  Chronic bupropion blocked withdrawal-associated increased somatic signs.  Finally, acute experimenter-administered nicotine enhanced brain reward function equally in all groups, indicating that bupropion does not alter the reward-facilitating effects of experimenter-administered nicotine.  In conclusion, the bupropion-induced increase in extracellular dopamine in the nucleus accumbens shell may ameliorate the anhedonia associated with nicotine withdrawal, which in turn may facilitate smoking cessation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRj_y60Fl2GEhJ5E29YNGvQfW6udTcc2eZBsNRkkJZWSbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szpsVGjuw%253D%253D&md5=0d2b249de74b42b77400805a08af810e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2007.05546.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2007.05546.x%26sid%3Dliteratum%253Aachs%26aulast%3DPaterson%26aufirst%3DN.%2BE.%26aulast%3DBalfour%26aufirst%3DD.%2BJ.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DChronic%2520bupropion%2520attenuated%2520the%2520anhedonic%2520component%2520of%2520nicotine%2520withdrawal%2520in%2520rats%2520via%2520inhibition%2520of%2520dopamine%2520reuptake%2520in%2520the%2520nucleus%2520accumbens%2520shell%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2007%26volume%3D25%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Reuben, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. B.</span><span> </span><span class="NLM_article-title">Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1016%2FS0014-2999%2800%2900004-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=10770996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFGqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2000&pages=39-49&author=M.+Reubenauthor=S.+Boyeauthor=P.+B.+Clarke&title=Nicotinic+receptors+modulating+somatodendritic+and+terminal+dopamine+release+differ+pharmacologically"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically</span></div><div class="casAuthors">Reuben, M.; Boye, S.; Clarke, P. B. S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">39-49</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Ascending dopaminergic and noradrenergic neurons possess somatodendritic and terminal nicotinic cholinoceptors in the rat.  Each neuronal population expresses mRNA for several types of nicotinic cholinoceptor subunits, including α6 and β3.  In superfused rat striatal synaptosomes, epibatidine evoked release of [3H]dopamine with similar efficacy to ACh, whereas nicotine and cytisine were weaker (70% and 58%, resp.).  The four agonists were equi-efficacious in evoking [3H]noradrenaline release from hippocampal synaptosomes.  Nicotine-evoked synaptosomal release was tetrodotoxin-insensitive.  Somatodendritic nicotinic cholinoceptors on dopaminergic neurons were studied using a dendrosomal [3H]dopamine release assay and also in locomotor activity tests.  In both assays, nicotine appeared more efficacious than epibatidine.  Furthermore, with repeated nicotine exposure, the acute locomotor stimulant response to nicotine increased, whereas the epibatidine response became undetectable.  In conclusion, somatodendritic nicotinic cholinoceptors located on dopaminergic neurons appear to differ pharmacol. from those on striatal dopaminergic terminals and hippocampal noradrenergic terminals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Cl7pAViYhbVg90H21EOLACvtfcHk0lgWxvXVj4jpUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFGqu78%253D&md5=eea11e0f24b4ed31e558233905958185</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900004-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900004-2%26sid%3Dliteratum%253Aachs%26aulast%3DReuben%26aufirst%3DM.%26aulast%3DBoye%26aufirst%3DS.%26aulast%3DClarke%26aufirst%3DP.%2BB.%26atitle%3DNicotinic%2520receptors%2520modulating%2520somatodendritic%2520and%2520terminal%2520dopamine%2520release%2520differ%2520pharmacologically%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D393%26spage%3D39%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Makhay, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Donnell, J. M.</span><span> </span><span class="NLM_article-title">Effects of antidepressants in rats trained to discriminate the beta-2 adrenergic agonist clenbuterol</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1999&pages=319-324&author=M.+M.+Makhayauthor=J.+M.+O%27Donnell&title=Effects+of+antidepressants+in+rats+trained+to+discriminate+the+beta-2+adrenergic+agonist+clenbuterol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMakhay%26aufirst%3DM.%2BM.%26aulast%3DO%2527Donnell%26aufirst%3DJ.%2BM.%26atitle%3DEffects%2520of%2520antidepressants%2520in%2520rats%2520trained%2520to%2520discriminate%2520the%2520beta-2%2520adrenergic%2520agonist%2520clenbuterol%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1999%26volume%3D63%26spage%3D319%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holleman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolckenhauer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landavazo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatch, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, M. J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6768</span><span class="NLM_x">–</span> <span class="NLM_lpage">6781</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901189z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6768-6781&author=F.+I.+Carrollauthor=B.+Bloughauthor=P.+Abrahamauthor=A.+C.+Millsauthor=J.+A.+Hollemanauthor=S.+A.+Wolckenhauerauthor=A.+M.+Deckerauthor=A.+Landavazoauthor=K.+T.+McElroyauthor=H.+A.+Navarroauthor=M.+B.+Gatchauthor=M.+J.+Foster&title=Synthesis+and+biological+evaluation+of+bupropion+analogues+as+potential+pharmacotherapies+for+cocaine+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction</span></div><div class="casAuthors">Carroll, F. Ivy; Blough, Bruce E.; Abraham, Philip; Mills, Andrew C.; Holleman, J. Ashley; Wolckenhauer, Scott A.; Decker, Ann M.; Landavazo, Antonio; McElroy, K. Timothy; Navarro, Hernan A.; Gatch, Michael B.; Forster, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6768-6781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of bupropion (I) analogs was synthesized, and their in vitro and in vivo pharmacol. properties evaluated with the goal of developing an analog that had better properties for treating addictions.  Their in vitro pharmacol. properties were examd. by [3H]dopamine ([3H]DA), [3H]serotonin ([3H]5HT), and [3H]norepinephrine ([3H]NE) uptake inhibition studies, and by binding studies at the dopamine, serotonin, and norepinephrine transporters using [125I]RTI-55 in cloned transporters.  Several analogs showed increased [3H]DA uptake inhibition with reduced or little change in [3H]5HT and [3H]NE uptake inhibition relative to bupropion.  Thirty-five analogs were evaluated in a 1 h locomotor activity observation test and 32 in an 8 h locomotor activity observation test and compared to the locomotor activity of cocaine.  Twenty-four analogs were evaluated for generalization to cocaine drug discrimination after i.p. administration, and twelve analogs were tested in a time course cocaine discrimination study using oral administration.  2-(N-Cyclopropylamino)-3-chloropropiophenone (II) had the most favorable in vitro efficacy and in vivo pharmacol. profile for an indirect dopamine agonist pharmacotherapy for treating cocaine, methamphetamine, nicotine, and other drugs of abuse addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpISymClen03bVg90H21EOLACvtfcHk0ljy792UK-7SBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLnL&md5=b3511748a08e7abf7510ceddb12bbedc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm901189z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901189z%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DBlough%26aufirst%3DB.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DMills%26aufirst%3DA.%2BC.%26aulast%3DHolleman%26aufirst%3DJ.%2BA.%26aulast%3DWolckenhauer%26aufirst%3DS.%2BA.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DLandavazo%26aufirst%3DA.%26aulast%3DMcElroy%26aufirst%3DK.%2BT.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DGatch%26aufirst%3DM.%2BB.%26aulast%3DFoster%26aufirst%3DM.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520bupropion%2520analogues%2520as%2520potential%2520pharmacotherapies%2520for%2520cocaine%2520addiction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6768%26epage%3D6781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Eshleman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumbay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martens, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span> </span><span class="NLM_article-title">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=10215666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=877-885&author=A.+J.+Eshlemanauthor=M.+Carmolliauthor=M.+Cumbayauthor=C.+R.+Martensauthor=K.+A.+Neveauthor=A.+Janowsky&title=Characteristics+of+drug+interactions+with+recombinant+biogenic+amine+transporters+expressed+in+the+same+cell+type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span></div><div class="casAuthors">Eshleman, Amy J.; Carmolli, Marya; Cumbay, Medhane; Martens, Carey R.; Neve, Kim A.; Janowsky, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">877-885</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of drugs on the uptake of [3H]neurotransmitter by and the binding of [125I]3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester ([125I]RTI-55) to the recombinant human dopamine (hDAT), serotonin (hSERT), or norepinephrine (hNET) transporters stably expressed in human embryonic kidney 293 cells were studied.  RTI-55 had similar affinity for the hDAT and hSERT and lower affinity for hNET (Kd = 1.83, 0.98, and 12.1 nM, resp.).  Kinetic anal. of [125I]RTI-55 binding indicated that the dissocn. rate (k-1) was significantly lower for hSERT and the assocn. rate (k+1) was significantly lower for hNET compared with the hDAT.  The potency of drugs at blocking [3H]neurotransmitter uptake was highly correlated with potency at blocking radioligand binding for hDAT and hSERT.  Substrates were more potent at the inhibition of [3H]neurotransmitter uptake than radioligand binding.  The potency of drugs was highly correlated between displacement of [3H]nisoxetine (Kd = 6.0 nM) and [125I]RTI-55 from the hNET, suggesting that these radioligands recognize similar sites on the transporter protein.  The correlation obsd. between inhibitory potency for uptake and binding of either ligand at the hNET was lower than correlations between uptake and binding for hDAT and hSERT.  The present results indicate that the cocaine analog [125I]RTI-55 has unique binding properties at each of the transporters and that the use of recombinant transporters expressed by a single cell type can provide a powerful screening tool for drugs interacting with biogenic amine transporters, such as possible cocaine antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn_1UJqie3bVg90H21EOLACvtfcHk0ljy792UK-7SBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D&md5=c808b4d81da86e57460406d2163c5e65</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DCarmolli%26aufirst%3DM.%26aulast%3DCumbay%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DC.%2BR.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DCharacteristics%2520of%2520drug%2520interactions%2520with%2520recombinant%2520biogenic%2520amine%2520transporters%2520expressed%2520in%2520the%2520same%2520cell%2520type%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D877%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirza, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=675-682&author=M.+I.+Damajauthor=F.+I.+Carrollauthor=J.+B.+Eatonauthor=H.+A.+Navarroauthor=B.+E.+Bloughauthor=S.+Mirzaauthor=R.+J.+Lukasauthor=B.+R.+Martin&title=Enantioselective+effects+of+hydroxy+metabolites+of+bupropion+on+behavior+and+on+function+of+monoamine+transporters+and+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DMirza%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DEnantioselective%2520effects%2520of%2520hydroxy%2520metabolites%2520of%2520bupropion%2520on%2520behavior%2520and%2520on%2520function%2520of%2520monoamine%2520transporters%2520and%2520nicotinic%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D675%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Salas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Biasi, M.</span><span> </span><span class="NLM_article-title">Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">3014</span><span class="NLM_x">–</span> <span class="NLM_lpage">3018</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1523%2FJNEUROSCI.4934-08.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=19279237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVamsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=3014-3018&author=R.+Salasauthor=R.+Sturmauthor=J.+Boulterauthor=M.+De+Biasi&title=Nicotinic+receptors+in+the+habenulo-interpeduncular+system+are+necessary+for+nicotine+withdrawal+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice</span></div><div class="casAuthors">Salas, Ramiro; Sturm, Renea; Boulter, Jim; De Biasi, Mariella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3014-3018</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In humans, tobacco withdrawal produces symptoms that contribute to the difficulty assocd. with smoking cessation.  Nicotine withdrawal symptoms can also be obsd. in rodents.  A major standing question is which nicotinic receptor subtypes and which areas of the brain are necessary for nicotine withdrawal to occur.  Using knock-out mice, we previously showed that the β4, but not the β2 subunit of nicotinic acetylcholine receptors, is necessary for the somatic manifestations of nicotine withdrawal.  Since the β4 subunit is highly expressed in the medial habenula, we focused our studies on the medial habenula and its primary target, the interpeduncular nucleus.  In particular, we studied nicotine withdrawal in mice lacking the α2 or the α5 nicotinic receptor subunits, which are highly expressed in the interpeduncular nucleus.  We pptd. withdrawal by systemically injecting the nicotinic antagonist mecamylamine in mice chronically treated with nicotine.  Both the α2 and the α5 null mutations abolished the somatic manifestations of nicotine withdrawal.  In addn., in wild-type mice chronically treated with nicotine, mecamylamine pptd. withdrawal when microinjected into the habenula or the interpeduncular nucleus, but not into the cortex, ventral tegmental area or hippocampus.  Our results demonstrate a major role for the habenulo-interpeduncular system and the nicotinic receptor subunits expressed therein, in nicotine withdrawal symptoms.  Our data suggest that the efforts to develop new smoking cessation therapies should conc. on these areas and receptor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYJtFJmqRLLVg90H21EOLACvtfcHk0lgZ-q6rHFDzIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVamsbs%253D&md5=cc06018ed9a980e6ad1fd8304cbb7538</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4934-08.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4934-08.2009%26sid%3Dliteratum%253Aachs%26aulast%3DSalas%26aufirst%3DR.%26aulast%3DSturm%26aufirst%3DR.%26aulast%3DBoulter%26aufirst%3DJ.%26aulast%3DDe%2BBiasi%26aufirst%3DM.%26atitle%3DNicotinic%2520receptors%2520in%2520the%2520habenulo-interpeduncular%2520system%2520are%2520necessary%2520for%2520nicotine%2520withdrawal%2520in%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D3014%26epage%3D3018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lukas, R. J.; Fryer, J. D.; Eaton, J. B.; Gentry, C. L.</span><span> </span><span class="NLM_article-title">Some Methods for Studies of Nicotinic Acetylcholine Receptor Pharmacology</span>. In  <span class="citation_source-book">Nicotinic Receptors and the Nervous System</span>; <span class="NLM_contrib-group">Levin, E. D.</span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">3</span>− <span class="NLM_lpage">27</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=3-27&author=R.+J.+Lukas&author=J.+D.+Fryer&author=J.+B.+Eaton&author=C.+L.+Gentryauthor=E.+D.+Levin&title=Nicotinic+Receptors+and+the+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DSome%2520Methods%2520for%2520Studies%2520of%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Pharmacology%26btitle%3DNicotinic%2520Receptors%2520and%2520the%2520Nervous%2520System%26aulast%3DLevin%26aufirst%3DE.%2BD.%26pub%3DCRC%2520Press%26date%3D2002%26spage%3D3%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhlman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinlein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=1283-1294&author=J.+B.+Eatonauthor=J.+H.+Pengauthor=K.+M.+Schroederauthor=A.+A.+Georgeauthor=J.+D.+Fryerauthor=C.+Krishnanauthor=L.+Buhlmanauthor=Y.+P.+Kuoauthor=O.+Steinleinauthor=R.+J.+Lukas&title=Characterization+of+human+alpha+4+beta+2-nicotinic+acetylcholine+receptors+stably+and+heterologously+expressed+in+native+nicotinic+receptor-null+SH-EP1+human+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DPeng%26aufirst%3DJ.%2BH.%26aulast%3DSchroeder%26aufirst%3DK.%2BM.%26aulast%3DGeorge%26aufirst%3DA.%2BA.%26aulast%3DFryer%26aufirst%3DJ.%2BD.%26aulast%3DKrishnan%26aufirst%3DC.%26aulast%3DBuhlman%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DY.%2BP.%26aulast%3DSteinlein%26aufirst%3DO.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DCharacterization%2520of%2520human%2520alpha%25204%2520beta%25202-nicotinic%2520acetylcholine%2520receptors%2520stably%2520and%2520heterologously%2520expressed%2520in%2520native%2520nicotinic%2520receptor-null%2520SH-EP1%2520human%2520epithelial%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D1283%26epage%3D1294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Gentry, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=11714893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVCktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=1038-1048&author=C.+L.+Gentryauthor=R.+J.+Lukas&title=Local+anesthetics+noncompetitively+inhibit+function+of+four+distinct+nicotinic+acetylcholine+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes</span></div><div class="casAuthors">Gentry, Cynthia L.; Lukas, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1038-1048</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Local anesthetics (LAs) are considered to act primarily by inhibiting voltage-gated Na+ channels.  However, LAs also are pharmacol. active at other ion channels including nicotinic acetylcholine receptors (nAChR).  NAChR exist as a family of diverse subtypes, each of which has a unique pharmacol. profile.  The current studies established effects of LAs on function of four human nAChR subtypes: naturally expressed muscle-type (α1*-nAChR) or autonomic (α3β4*-nAChR) nAChR, or heterologously expressed nAChR contg. α4 with either β2- or β4-subunits (α4β2- or α4β4-nAChR).  Of the LAs tested, those with structures contg. two sepd. arom. rings (e.g., proadifen and adiphenine) had the greatest inhibition potency (IC50 values between 0.34 and 6.3 μM) but lowest selectivity (∼4-fold) across the four nAChR subtypes examd.  From the fused, two-ring (isoquinoline backbone) class of LAs, dimethisoquin had comparatively moderate inhibition potency (IC50 values between 2.4 and 61 μM) and ∼30-fold selectivity across nAChR subtypes.  Lidocaine, a commonly used LA from the single ring category of LAs, blocked nAChR function with IC50 values of between 52 and 250 μM and had only ∼5-fold selectivity across nAChR subtypes.  Its quaternary tri-Et ammonium analog, QX-314, had greater inhibition potency, but the tri-Me ammonium deriv., QX-222, was the least potent LA at all but the α4β2-nAChR subtype.  With only a few exceptions, LA effects were consistent with noncompetitive inhibition of nAChR function and occurred at therapeutic doses.  These studies suggest structural determinants for LA action at diverse nAChR subtypes and that nAChR likely are clin. relevant targets of LAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgwUhNlMnNWrVg90H21EOLACvtfcHk0lhaX6-MUTMbiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVCktL0%253D&md5=93812a342040356130830e57ac370bb8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGentry%26aufirst%3DC.%2BL.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DLocal%2520anesthetics%2520noncompetitively%2520inhibit%2520function%2520of%2520four%2520distinct%2520nicotinic%2520acetylcholine%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D1038%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">D'Amour, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span> </span><span class="NLM_article-title">A method for determining loss of pain sensation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1941</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1941&pages=74-79&author=F.+E.+D%27Amourauthor=D.+L.+Smith&title=A+method+for+determining+loss+of+pain+sensation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%2527Amour%26aufirst%3DF.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26atitle%3DA%2520method%2520for%2520determining%2520loss%2520of%2520pain%2520sensation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1941%26volume%3D72%26spage%3D74%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 34 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Donna Walther, Abdelrahman R. Shalabi, Michael H. Baumann, <span class="NLM_string-name hlFld-ContribAuthor">Richard A. Glennon</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic Structure–Activity Studies on Selected 2-, 3-, and 4-Monosubstituted Synthetic Methcathinone Analogs as Monoamine Transporter Releasing Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 740-745. <a href="https://doi.org/10.1021/acschemneuro.8b00524" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00524</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00524%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSystematic%252BStructure%2525E2%252580%252593Activity%252BStudies%252Bon%252BSelected%252B2-%25252C%252B3-%25252C%252Band%252B4-Monosubstituted%252BSynthetic%252BMethcathinone%252BAnalogs%252Bas%252BMonoamine%252BTransporter%252BReleasing%252BAgents%26aulast%3DWalther%26aufirst%3DDonna%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D01102018%26date%3D24102018%26date%3D07112018%26date%3D24102018%26volume%3D10%26issue%3D1%26spage%3D740%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">François  Crestey</span>, <span class="hlFld-ContribAuthor ">Anders A.  Jensen</span>, <span class="hlFld-ContribAuthor ">Christian  Soerensen</span>, <span class="hlFld-ContribAuthor ">Charlotte Busk  Magnus</span>, <span class="hlFld-ContribAuthor ">Jesper T.  Andreasen</span>, <span class="hlFld-ContribAuthor ">Günther H. J.  Peters</span>, and <span class="hlFld-ContribAuthor ">Jesper L.  Kristensen</span>  . </span><span class="cited-content_cbyCitation_article-title">Dual Nicotinic Acetylcholine Receptor α4β2 Antagonists/α7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (4)
                                     , 1719-1729. <a href="https://doi.org/10.1021/acs.jmedchem.7b01895" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01895</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01895%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BNicotinic%252BAcetylcholine%252BReceptor%252B%2525CE%2525B14%2525CE%2525B22%252BAntagonists%25252F%2525CE%2525B17%252BAgonists%25253A%252BSynthesis%25252C%252BDocking%252BStudies%25252C%252Band%252BPharmacological%252BEvaluation%252Bof%252BTetrahydroisoquinolines%252Band%252BTetrahydroisoquinolinium%252BSalts%26aulast%3DCrestey%26aufirst%3DFran%25C3%25A7ois%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D29122017%26date%3D07022018%26date%3D22022018%26date%3D31012018%26volume%3D61%26issue%3D4%26spage%3D1719%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A Bakarr  Kanu</span>, <span class="hlFld-ContribAuthor ">Simon D.  Brandt</span>, <span class="hlFld-ContribAuthor ">Mike D.  Williams</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhang</span>, and <span class="hlFld-ContribAuthor ">Herbert H.  Hill</span>  . </span><span class="cited-content_cbyCitation_article-title">Analysis of Psychoactive Cathinones and Tryptamines by Electrospray Ionization Atmospheric Pressure Ion Mobility Time-of-Flight Mass Spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2013,</strong> <em>85 </em>
                                    (18)
                                     , 8535-8542. <a href="https://doi.org/10.1021/ac401951a" title="DOI URL">https://doi.org/10.1021/ac401951a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ac401951a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fac401951a%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DAnalysis%252Bof%252BPsychoactive%252BCathinones%252Band%252BTryptamines%252Bby%252BElectrospray%252BIonization%252BAtmospheric%252BPressure%252BIon%252BMobility%252BTime-of-Flight%252BMass%252BSpectrometry%26aulast%3DKanu%26aufirst%3DA%2BBakarr%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D16112012%26date%3D22072013%26date%3D20082013%26date%3D17092013%26date%3D22072013%26volume%3D85%26issue%3D18%26spage%3D8535%26epage%3D8542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akash  Pandhare</span>, <span class="hlFld-ContribAuthor ">Ayman K.  Hamouda</span>, <span class="hlFld-ContribAuthor ">Brandon  Staggs</span>, <span class="hlFld-ContribAuthor ">Shaili  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Phaneendra K.  Duddempudi</span>, <span class="hlFld-ContribAuthor ">John R.  Lever</span>, <span class="hlFld-ContribAuthor ">David J.  Lapinsky</span>, <span class="hlFld-ContribAuthor ">Michaela  Jansen</span>, <span class="hlFld-ContribAuthor ">Jonathan B.  Cohen</span>, and <span class="hlFld-ContribAuthor ">Michael P.  Blanton</span>  . </span><span class="cited-content_cbyCitation_article-title">Bupropion Binds to Two Sites in the Torpedo Nicotinic Acetylcholine Receptor Transmembrane Domain: A Photoaffinity Labeling Study with the Bupropion Analogue [125I]-SADU-3-72. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2012,</strong> <em>51 </em>
                                    (12)
                                     , 2425-2435. <a href="https://doi.org/10.1021/bi300101r" title="DOI URL">https://doi.org/10.1021/bi300101r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi300101r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi300101r%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DBupropion%252BBinds%252Bto%252BTwo%252BSites%252Bin%252Bthe%252BTorpedo%252BNicotinic%252BAcetylcholine%252BReceptor%252BTransmembrane%252BDomain%25253A%252BA%252BPhotoaffinity%252BLabeling%252BStudy%252Bwith%252Bthe%252BBupropion%252BAnalogue%252B%25255B125I%25255D-SADU-3-72%26aulast%3DPandhare%26aufirst%3DAkash%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D23012012%26date%3D02032012%26date%3D15032012%26date%3D27032012%26date%3D06032012%26volume%3D51%26issue%3D12%26spage%3D2425%26epage%3D2435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Ivy  Carroll</span>, <span class="hlFld-ContribAuthor ">Ana Z.  Muresan</span>, <span class="hlFld-ContribAuthor ">Bruce E.  Blough</span>, <span class="hlFld-ContribAuthor ">Hernán A.  Navarro</span>, <span class="hlFld-ContribAuthor ">S. Wayne  Mascarella</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Huang</span>, <span class="hlFld-ContribAuthor ">M. Imad  Damaj</span>, and <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-(Substituted Phenyl)-3,5,5-trimethylmorpholine Analogues and Their Effects on Monoamine Uptake, Nicotinic Acetylcholine Receptor Function, and Behavioral Effects of Nicotine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (5)
                                     , 1441-1448. <a href="https://doi.org/10.1021/jm1014555" title="DOI URL">https://doi.org/10.1021/jm1014555</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1014555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1014555%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-%252528Substituted%252BPhenyl%252529-3%25252C5%25252C5-trimethylmorpholine%252BAnalogues%252Band%252BTheir%252BEffects%252Bon%252BMonoamine%252BUptake%25252C%252BNicotinic%252BAcetylcholine%252BReceptor%252BFunction%25252C%252Band%252BBehavioral%252BEffects%252Bof%252BNicotine%26aulast%3DCarroll%26aufirst%3DF.%2BIvy%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D11112010%26date%3D14022011%26date%3D10032011%26volume%3D54%26issue%3D5%26spage%3D1441%26epage%3D1448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Ivy  Carroll</span>, <span class="hlFld-ContribAuthor ">Bruce E.  Blough</span>, <span class="hlFld-ContribAuthor ">S. Wayne  Mascarella</span>, <span class="hlFld-ContribAuthor ">Hernán A.  Navarro</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Ronald, J.  Lukas</span>, and <span class="hlFld-ContribAuthor ">M. Imad  Damaj</span>  . </span><span class="cited-content_cbyCitation_article-title">Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2β-substituted Tropanes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (23)
                                     , 8345-8353. <a href="https://doi.org/10.1021/jm100994w" title="DOI URL">https://doi.org/10.1021/jm100994w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100994w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100994w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNicotinic%252BAcetylcholine%252BReceptor%252BEfficacy%252Band%252BPharmacological%252BProperties%252Bof%252B3-%252528Substituted%252Bphenyl%252529-2%2525CE%2525B2-substituted%252BTropanes%26aulast%3DCarroll%26aufirst%3DF.%2BIvy%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D02082010%26date%3D08112010%26date%3D09122010%26volume%3D53%26issue%3D23%26spage%3D8345%26epage%3D8353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianhua  Liu</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Barbara  Caldarone</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemistry and Pharmacological Characterization of Novel Nitrogen Analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(Azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-Nicotinic Acetylcholine Receptor-Selective Partial Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (19)
                                     , 6973-6985. <a href="https://doi.org/10.1021/jm100765u" title="DOI URL">https://doi.org/10.1021/jm100765u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100765u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100765u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemistry%252Band%252BPharmacological%252BCharacterization%252Bof%252BNovel%252BNitrogen%252BAnalogues%252Bof%252BAMOP-H-OH%252B%252528Sazetidine-A%25252C%252B6-%25255B5-%252528Azetidin-2-ylmethoxy%252529pyridin-3-yl%25255Dhex-5-yn-1-ol%252529%252Bas%252B%2525CE%2525B14%2525CE%2525B22-Nicotinic%252BAcetylcholine%252BReceptor-Selective%252BPartial%252BAgonists%26aulast%3DLiu%26aufirst%3DJianhua%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D19052010%26date%3D07092010%26date%3D14102010%26volume%3D53%26issue%3D19%26spage%3D6973%26epage%3D6985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>, <span class="hlFld-ContribAuthor ">Ana Z.  Muresan</span>, <span class="hlFld-ContribAuthor ">M. Imad  Damaj</span>, <span class="hlFld-ContribAuthor ">Bruce E.  Blough</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Huang</span>, <span class="hlFld-ContribAuthor ">Hernán A.  Navarro</span>, <span class="hlFld-ContribAuthor ">S. Wayne  Mascarella</span>, <span class="hlFld-ContribAuthor ">J. Brek  Eaton</span>, <span class="hlFld-ContribAuthor ">Syndia K.  Marxer-Miller</span> and <span class="hlFld-ContribAuthor ">F. Ivy  Carroll</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of in Vitro and in Vivo Profiles of Hydroxybupropion Analogues: Aids to Smoking Cessation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (12)
                                     , 4731-4748. <a href="https://doi.org/10.1021/jm1003232" title="DOI URL">https://doi.org/10.1021/jm1003232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1003232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1003232%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252Bin%252BVitro%252Band%252Bin%252BVivo%252BProfiles%252Bof%252BHydroxybupropion%252BAnalogues%25253A%252BAids%252Bto%252BSmoking%252BCessation%26aulast%3DLukas%26aufirst%3DRonald%2BJ.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D10032010%26date%3D28052010%26date%3D24062010%26volume%3D53%26issue%3D12%26spage%3D4731%26epage%3D4748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaime J.  Castrellon</span>, <span class="hlFld-ContribAuthor ">James  Meade</span>, <span class="hlFld-ContribAuthor ">Lucy  Greenwald</span>, <span class="hlFld-ContribAuthor ">Katlyn  Hurst</span>, <span class="hlFld-ContribAuthor ">Gregory R.  Samanez-Larkin</span>. </span><span class="cited-content_cbyCitation_article-title">Dopaminergic modulation of reward discounting in healthy rats: a systematic review and meta-analysis. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2021,</strong> <em>238 </em>
                                    (3)
                                     , 711-723. <a href="https://doi.org/10.1007/s00213-020-05723-5" title="DOI URL">https://doi.org/10.1007/s00213-020-05723-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-020-05723-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-020-05723-5%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DDopaminergic%252Bmodulation%252Bof%252Breward%252Bdiscounting%252Bin%252Bhealthy%252Brats%25253A%252Ba%252Bsystematic%252Breview%252Band%252Bmeta-analysis%26aulast%3DCastrellon%26aufirst%3DJaime%2BJ.%26date%3D2021%26date%3D2020%26volume%3D238%26issue%3D3%26spage%3D711%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruce E.  Blough</span>, <span class="hlFld-ContribAuthor ">Ann M.  Decker</span>, <span class="hlFld-ContribAuthor ">Antonio  Landavazo</span>, <span class="hlFld-ContribAuthor ">Ojas A.  Namjoshi</span>, <span class="hlFld-ContribAuthor ">John S.  Partilla</span>, <span class="hlFld-ContribAuthor ">Michael H.  Baumann</span>, <span class="hlFld-ContribAuthor ">Richard B.  Rothman</span>. </span><span class="cited-content_cbyCitation_article-title">The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2019,</strong> <em>236 </em>
                                    (3)
                                     , 915-924. <a href="https://doi.org/10.1007/s00213-018-5063-9" title="DOI URL">https://doi.org/10.1007/s00213-018-5063-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-018-5063-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-018-5063-9%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DThe%252Bdopamine%25252C%252Bserotonin%252Band%252Bnorepinephrine%252Breleasing%252Bactivities%252Bof%252Ba%252Bseries%252Bof%252Bmethcathinone%252Banalogs%252Bin%252Bmale%252Brat%252Bbrain%252Bsynaptosomes%26aulast%3DBlough%26aufirst%3DBruce%2BE.%26date%3D2019%26date%3D2018%26volume%3D236%26issue%3D3%26spage%3D915%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Domenico  Albanese</span>, <span class="hlFld-ContribAuthor ">Nicoletta  Gaggero</span>. </span><span class="cited-content_cbyCitation_article-title">An Overview the N-Heterocyclic Carbene-Catalyzed Aza-Benzoin Condensation Reaction. </span><span class="cited-content_cbyCitation_journal-name">Catalysts</span><span> <strong>2018,</strong> <em>8 </em>
                                    (5)
                                     , 181. <a href="https://doi.org/10.3390/catal8050181" title="DOI URL">https://doi.org/10.3390/catal8050181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/catal8050181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcatal8050181%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysts%26atitle%3DAn%252BOverview%252Bthe%252BN-Heterocyclic%252BCarbene-Catalyzed%252BAza-Benzoin%252BCondensation%252BReaction%26aulast%3DAlbanese%26aufirst%3DDomenico%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D5%26spage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaili  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Ole V.  Mortensen</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Monoamine Transporters. </span><span class="cited-content_cbyCitation_journal-name">Current Protocols in Pharmacology</span><span> <strong>2017,</strong> <em>79 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/cpph.32" title="DOI URL">https://doi.org/10.1002/cpph.32</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpph.32&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpph.32%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Protocols%2520in%2520Pharmacology%26atitle%3DOverview%252Bof%252BMonoamine%252BTransporters%26aulast%3DAggarwal%26aufirst%3DShaili%26date%3D2017%26date%3D2018%26volume%3D79%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc  Grifell</span>, <span class="hlFld-ContribAuthor ">Mireia  Ventura</span>, <span class="hlFld-ContribAuthor ">Xoán  Carbón</span>, <span class="hlFld-ContribAuthor ">Pol  Quintana</span>, <span class="hlFld-ContribAuthor ">Liliana  Galindo</span>, <span class="hlFld-ContribAuthor ">Álvaro  Palma</span>, <span class="hlFld-ContribAuthor ">Ivan  Fornis</span>, <span class="hlFld-ContribAuthor ">Cristina  Gil</span>, <span class="hlFld-ContribAuthor ">Magi  Farre</span>, <span class="hlFld-ContribAuthor ">Marta  Torrens</span>. </span><span class="cited-content_cbyCitation_article-title">Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone). </span><span class="cited-content_cbyCitation_journal-name">Human Psychopharmacology: Clinical and Experimental</span><span> <strong>2017,</strong> <em>32 </em>
                                    (3)
                                     , e2621. <a href="https://doi.org/10.1002/hup.2621" title="DOI URL">https://doi.org/10.1002/hup.2621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hup.2621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhup.2621%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Psychopharmacology%253A%2520Clinical%2520and%2520Experimental%26atitle%3DPatterns%252Bof%252Buse%252Band%252Btoxicity%252Bof%252Bnew%252Bpara-halogenated%252Bsubstituted%252Bcathinones%25253A%252B4-CMC%252B%252528clephedrone%252529%25252C%252B4-CEC%252B%2525284-chloroethcatinone%252529%252Band%252B4-BMC%252B%252528brephedrone%252529%26aulast%3DGrifell%26aufirst%3DMarc%26date%3D2017%26date%3D2017%26volume%3D32%26issue%3D3%26spage%3De2621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Porcu</span>, <span class="hlFld-ContribAuthor ">M.P.  Castelli</span>. </span><span class="cited-content_cbyCitation_article-title">Cannabis and the Use of Amphetamine-Like Substances. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, e101-e110. <a href="https://doi.org/10.1016/B978-0-12-800756-3.00066-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-800756-3.00066-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800756-3.00066-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800756-3.00066-1%26sid%3Dliteratum%253Aachs%26atitle%3DCannabis%252Band%252Bthe%252BUse%252Bof%252BAmphetamine-Like%252BSubstances%26aulast%3DPorcu%26aufirst%3DA.%26date%3D2017%26spage%3De101%26epage%3De110%26pub%3DElsevier%26atitle%3DHandbook%252Bof%252BCannabis%252Band%252BRelated%252BPathologies%26date%3D2017%26volume%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Zdrazil</span>, <span class="hlFld-ContribAuthor ">Eva  Hellsberg</span>, <span class="hlFld-ContribAuthor ">Michael  Viereck</span>, <span class="hlFld-ContribAuthor ">Gerhard F.  Ecker</span>. </span><span class="cited-content_cbyCitation_article-title">From linked open data to molecular interaction: studying selectivity trends for ligands of the human serotonin and dopamine transporter. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (9)
                                     , 1819-1831. <a href="https://doi.org/10.1039/C6MD00207B" title="DOI URL">https://doi.org/10.1039/C6MD00207B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00207B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00207B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DFrom%252Blinked%252Bopen%252Bdata%252Bto%252Bmolecular%252Binteraction%25253A%252Bstudying%252Bselectivity%252Btrends%252Bfor%252Bligands%252Bof%252Bthe%252Bhuman%252Bserotonin%252Band%252Bdopamine%252Btransporter%26aulast%3DZdrazil%26aufirst%3DBarbara%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D9%26spage%3D1819%26epage%3D1831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. I.  Golovko</span>, <span class="hlFld-ContribAuthor ">E. Yu.  Bonitenko</span>, <span class="hlFld-ContribAuthor ">M. B.  Ivanov</span>, <span class="hlFld-ContribAuthor ">V. A.  Barinov</span>, <span class="hlFld-ContribAuthor ">E. P.  Zatsepin</span>. </span><span class="cited-content_cbyCitation_article-title">The neurochemical bases of the pharmacological activity of ligands of monoamine-transport systems. </span><span class="cited-content_cbyCitation_journal-name">Neurochemical Journal</span><span> <strong>2016,</strong> <em>10 </em>
                                    (3)
                                     , 173-183. <a href="https://doi.org/10.1134/S1819712416030065" title="DOI URL">https://doi.org/10.1134/S1819712416030065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1819712416030065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1819712416030065%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemical%2520Journal%26atitle%3DThe%252Bneurochemical%252Bbases%252Bof%252Bthe%252Bpharmacological%252Bactivity%252Bof%252Bligands%252Bof%252Bmonoamine-transport%252Bsystems%26aulast%3DGolovko%26aufirst%3DA.%2BI.%26date%3D2016%26date%3D2016%26volume%3D10%26issue%3D3%26spage%3D173%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. R.  Masters</span>, <span class="hlFld-ContribAuthor ">B. T.  Gufford</span>, <span class="hlFld-ContribAuthor ">J. B. L.  Lu</span>, <span class="hlFld-ContribAuthor ">I. F.  Metzger</span>, <span class="hlFld-ContribAuthor ">D. R.  Jones</span>, <span class="hlFld-ContribAuthor ">Z.  Desta</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2016,</strong> <em>358 </em>
                                    (2)
                                     , 230-238. <a href="https://doi.org/10.1124/jpet.116.232876" title="DOI URL">https://doi.org/10.1124/jpet.116.232876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.116.232876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.116.232876%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DChiral%252BPlasma%252BPharmacokinetics%252Band%252BUrinary%252BExcretion%252Bof%252BBupropion%252Band%252BMetabolites%252Bin%252BHealthy%252BVolunteers%26aulast%3DMasters%26aufirst%3DA.%2BR.%26date%3D2016%26date%3D2016%26volume%3D358%26issue%3D2%26spage%3D230%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruben  Vardanyan</span>, <span class="hlFld-ContribAuthor ">Victor  Hruby</span>. </span><span class="cited-content_cbyCitation_article-title">Antidepressants. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 111-143. <a href="https://doi.org/10.1016/B978-0-12-411492-0.00007-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-411492-0.00007-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-411492-0.00007-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-411492-0.00007-9%26sid%3Dliteratum%253Aachs%26atitle%3DAntidepressants%26aulast%3DVardanyan%26aufirst%3DRuben%26date%3D2016%26spage%3D111%26epage%3D143%26pub%3DElsevier%26atitle%3DSynthesis%252Bof%252BBest-Seller%252BDrugs%26date%3D2016%26volume%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Saad  Yousuf</span>, <span class="hlFld-ContribAuthor ">Bradley J.  Kerr</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Regulatory Transporters in Neuropathic Pain. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 245-271. <a href="https://doi.org/10.1016/bs.apha.2015.12.003" title="DOI URL">https://doi.org/10.1016/bs.apha.2015.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apha.2015.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apha.2015.12.003%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Bof%252BRegulatory%252BTransporters%252Bin%252BNeuropathic%252BPain%26aulast%3DYousuf%26aufirst%3DMuhammad%2BSaad%26date%3D2016%26spage%3D245%26epage%3D271%26pub%3DElsevier%26atitle%3DPharmacological%252BMechanisms%252Band%252Bthe%252BModulation%252Bof%252BPain%26date%3D2016%26volume%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Lei  Tian</span>, <span class="hlFld-ContribAuthor ">Chi  Zhang</span>, <span class="hlFld-ContribAuthor ">Liqin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of deuterium-labeled hydroxybupropion. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2015,</strong> <em>58 </em>
                                    (10)
                                     , 411-413. <a href="https://doi.org/10.1002/jlcr.3314" title="DOI URL">https://doi.org/10.1002/jlcr.3314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3314%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DSynthesis%252Bof%252Bdeuterium-labeled%252Bhydroxybupropion%26aulast%3DLi%26aufirst%3DJian%26date%3D2015%26date%3D2015%26volume%3D58%26issue%3D10%26spage%3D411%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John D.  Power</span>, <span class="hlFld-ContribAuthor ">Pierce  Kavanagh</span>, <span class="hlFld-ContribAuthor ">John  O'Brien</span>, <span class="hlFld-ContribAuthor ">Michael  Barry</span>, <span class="hlFld-ContribAuthor ">Brendan  Twamley</span>, <span class="hlFld-ContribAuthor ">Brian  Talbot</span>, <span class="hlFld-ContribAuthor ">Geraldine  Dowling</span>, <span class="hlFld-ContribAuthor ">Simon D.  Brandt</span>. </span><span class="cited-content_cbyCitation_article-title">Test purchase, identification and synthesis of 2‐amino‐1‐(4‐bromo‐2, 5‐dimethoxyphenyl)ethan‐1‐one (bk‐2C‐B). </span><span class="cited-content_cbyCitation_journal-name">Drug Testing and Analysis</span><span> <strong>2015,</strong> <em>7 </em>
                                    (6)
                                     , 512-518. <a href="https://doi.org/10.1002/dta.1699" title="DOI URL">https://doi.org/10.1002/dta.1699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/dta.1699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fdta.1699%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Testing%2520and%2520Analysis%26atitle%3DTest%252Bpurchase%25252C%252Bidentification%252Band%252Bsynthesis%252Bof%252B2%2525E2%252580%252590amino%2525E2%252580%2525901%2525E2%252580%252590%2525284%2525E2%252580%252590bromo%2525E2%252580%2525902%25252C%252B5%2525E2%252580%252590dimethoxyphenyl%252529ethan%2525E2%252580%2525901%2525E2%252580%252590one%252B%252528bk%2525E2%252580%2525902C%2525E2%252580%252590B%252529%26aulast%3DPower%26aufirst%3DJohn%2BD.%26date%3D2015%26date%3D2014%26volume%3D7%26issue%3D6%26spage%3D512%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">References. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 290-333. <a href="https://doi.org/10.1002/9781118943670.refs" title="DOI URL">https://doi.org/10.1002/9781118943670.refs</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118943670.refs&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118943670.refs%26sid%3Dliteratum%253Aachs%26atitle%3DReferences%26date%3D2014%26date%3D2014%26spage%3D290%26epage%3D333%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DDrug%252BDiscovery%252Bfor%252Bthe%252BTreatment%252Bof%252BAddiction%26aulast%3DFulton%26aufirst%3DBrian%2BS.%26date%3D2014%26volume%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  O'Byrne</span>, <span class="hlFld-ContribAuthor ">Robert  williams</span>, <span class="hlFld-ContribAuthor ">John  walsh</span>, <span class="hlFld-ContribAuthor ">John  Gilmer</span>. </span><span class="cited-content_cbyCitation_article-title">Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2014,</strong> <em>7 </em>
                                    (6)
                                     , 676-694. <a href="https://doi.org/10.3390/ph7060676" title="DOI URL">https://doi.org/10.3390/ph7060676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph7060676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph7060676%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DPart%252BTwo%25253A%252BEvaluation%252Bof%252BN-methylbupropion%252Bas%252Ba%252BPotential%252BBupropion%252BProdrug%26aulast%3DO%2527Byrne%26aufirst%3DPaul%26date%3D2014%26date%3D2014%26volume%3D7%26issue%3D6%26spage%3D676%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Ivy  Carroll</span>, <span class="hlFld-ContribAuthor ">Bruce E.  Blough</span>, <span class="hlFld-ContribAuthor ">S. Wayne  Mascarella</span>, <span class="hlFld-ContribAuthor ">Hernán A.  Navarro</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Lukas</span>, <span class="hlFld-ContribAuthor ">M. Imad  Damaj</span>. </span><span class="cited-content_cbyCitation_article-title">Bupropion and Bupropion Analogs as Treatments for CNS Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 177-216. <a href="https://doi.org/10.1016/B978-0-12-420118-7.00005-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-420118-7.00005-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-420118-7.00005-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-420118-7.00005-6%26sid%3Dliteratum%253Aachs%26atitle%3DBupropion%252Band%252BBupropion%252BAnalogs%252Bas%252BTreatments%252Bfor%252BCNS%252BDisorders%26aulast%3DCarroll%26aufirst%3DF.%2BIvy%26date%3D2014%26spage%3D177%26epage%3D216%26pub%3DElsevier%26atitle%3DEmerging%252BTargets%252B%252526%252BTherapeutics%252Bin%252Bthe%252BTreatment%252Bof%252BPsychostimulant%252BAbuse%26date%3D2014%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asuka  Kaizaki</span>, <span class="hlFld-ContribAuthor ">Sachiko  Tanaka</span>, <span class="hlFld-ContribAuthor ">Satoshi  Numazawa</span>. </span><span class="cited-content_cbyCitation_article-title">New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Toxicological Sciences</span><span> <strong>2014,</strong> <em>39 </em>
                                    (1)
                                     , 1-6. <a href="https://doi.org/10.2131/jts.39.1" title="DOI URL">https://doi.org/10.2131/jts.39.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2131/jts.39.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2131%2Fjts.39.1%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Toxicological%2520Sciences%26atitle%3DNew%252Brecreational%252Bdrug%252B1-phenyl-2-%2525281-pyrrolidinyl%252529-1-pentanone%252B%252528alpha-PVP%252529%252Bactivates%252Bcentral%252Bnervous%252Bsystem%252Bvia%252Bdopaminergic%252Bneuron%26aulast%3DKaizaki%26aufirst%3DAsuka%26date%3D2014%26volume%3D39%26issue%3D1%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajan  Radhakrishnan</span>, <span class="hlFld-ContribAuthor ">Abel  Santamaría</span>, <span class="hlFld-ContribAuthor ">Liliana  Escobar</span>, <span class="hlFld-ContribAuthor ">Hugo Rubén  Arias</span>. </span><span class="cited-content_cbyCitation_article-title">The β4 nicotinic receptor subunit modulates the chronic antidepressant effect mediated by bupropion. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience Letters</span><span> <strong>2013,</strong> <em>555 </em>, 68-72. <a href="https://doi.org/10.1016/j.neulet.2013.08.009" title="DOI URL">https://doi.org/10.1016/j.neulet.2013.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neulet.2013.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neulet.2013.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520Letters%26atitle%3DThe%252B%2525CE%2525B24%252Bnicotinic%252Breceptor%252Bsubunit%252Bmodulates%252Bthe%252Bchronic%252Bantidepressant%252Beffect%252Bmediated%252Bby%252Bbupropion%26aulast%3DRadhakrishnan%26aufirst%3DRajan%26date%3D2013%26volume%3D555%26spage%3D68%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas V.  Cozzi</span>, <span class="hlFld-ContribAuthor ">Simon D.  Brandt</span>, <span class="hlFld-ContribAuthor ">Paul F.  Daley</span>, <span class="hlFld-ContribAuthor ">John S.  Partilla</span>, <span class="hlFld-ContribAuthor ">Richard B.  Rothman</span>, <span class="hlFld-ContribAuthor ">Andreas  Tulzer</span>, <span class="hlFld-ContribAuthor ">Harald H.  Sitte</span>, <span class="hlFld-ContribAuthor ">Michael H.  Baumann</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2013,</strong> <em>699 </em>
                                    (1-3)
                                     , 180-187. <a href="https://doi.org/10.1016/j.ejphar.2012.11.008" title="DOI URL">https://doi.org/10.1016/j.ejphar.2012.11.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2012.11.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DPharmacological%252Bexamination%252Bof%252Btrifluoromethyl%252Bring-substituted%252Bmethcathinone%252Banalogs%26aulast%3DCozzi%26aufirst%3DNicholas%2BV.%26date%3D2013%26volume%3D699%26issue%3D1-3%26spage%3D180%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hugo R.  Arias</span>, <span class="hlFld-ContribAuthor ">Dominik  Feuerbach</span>, <span class="hlFld-ContribAuthor ">Katarzyna M.  Targowska-Duda</span>, <span class="hlFld-ContribAuthor ">Shaili  Aggarwal</span>, <span class="hlFld-ContribAuthor ">David J.  Lapinsky</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Jozwiak</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and functional interaction of (±)-2-(N-tert-butylamino)-3′-iodo-4′-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors. </span><span class="cited-content_cbyCitation_journal-name">Neurochemistry International</span><span> <strong>2012,</strong> <em>61 </em>
                                    (8)
                                     , 1433-1441. <a href="https://doi.org/10.1016/j.neuint.2012.10.011" title="DOI URL">https://doi.org/10.1016/j.neuint.2012.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuint.2012.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuint.2012.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemistry%2520International%26atitle%3DStructural%252Band%252Bfunctional%252Binteraction%252Bof%252B%252528%2525C2%2525B1%252529-2-%252528N-tert-butylamino%252529-3%2525E2%252580%2525B2-iodo-4%2525E2%252580%2525B2-azidopropiophenone%25252C%252Ba%252Bphotoreactive%252Bbupropion%252Bderivative%25252C%252Bwith%252Bnicotinic%252Bacetylcholine%252Breceptors%26aulast%3DArias%26aufirst%3DHugo%2BR.%26date%3D2012%26volume%3D61%26issue%3D8%26spage%3D1433%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon D.  Brandt</span>, <span class="hlFld-ContribAuthor ">Paul F.  Daley</span>, <span class="hlFld-ContribAuthor ">Nicholas V.  Cozzi</span>. </span><span class="cited-content_cbyCitation_article-title">Analytical characterization of three trifluoromethyl-substituted methcathinone isomers. </span><span class="cited-content_cbyCitation_journal-name">Drug Testing and Analysis</span><span> <strong>2012,</strong> <em>4 </em>
                                    (6)
                                     , 525-529. <a href="https://doi.org/10.1002/dta.382" title="DOI URL">https://doi.org/10.1002/dta.382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/dta.382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fdta.382%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Testing%2520and%2520Analysis%26atitle%3DAnalytical%252Bcharacterization%252Bof%252Bthree%252Btrifluoromethyl-substituted%252Bmethcathinone%252Bisomers%26aulast%3DBrandt%26aufirst%3DSimon%2BD.%26date%3D2012%26date%3D2012%26volume%3D4%26issue%3D6%26spage%3D525%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael H  Baumann</span>, <span class="hlFld-ContribAuthor ">Mario A  Ayestas</span>, <span class="hlFld-ContribAuthor ">John S  Partilla</span>, <span class="hlFld-ContribAuthor ">Jacqueline R  Sink</span>, <span class="hlFld-ContribAuthor ">Alexander T  Shulgin</span>, <span class="hlFld-ContribAuthor ">Paul F  Daley</span>, <span class="hlFld-ContribAuthor ">Simon D  Brandt</span>, <span class="hlFld-ContribAuthor ">Richard B  Rothman</span>, <span class="hlFld-ContribAuthor ">Arnold E  Ruoho</span>, <span class="hlFld-ContribAuthor ">Nicholas V  Cozzi</span>. </span><span class="cited-content_cbyCitation_article-title">The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2012,</strong> <em>37 </em>
                                    (5)
                                     , 1192-1203. <a href="https://doi.org/10.1038/npp.2011.304" title="DOI URL">https://doi.org/10.1038/npp.2011.304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/npp.2011.304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnpp.2011.304%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DThe%252BDesigner%252BMethcathinone%252BAnalogs%25252C%252BMephedrone%252Band%252BMethylone%25252C%252Bare%252BSubstrates%252Bfor%252BMonoamine%252BTransporters%252Bin%252BBrain%252BTissue%26aulast%3DBaumann%26aufirst%3DMichael%2BH%26date%3D2012%26date%3D2011%26volume%3D37%26issue%3D5%26spage%3D1192%26epage%3D1203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Lapinsky</span>, <span class="hlFld-ContribAuthor ">Shaili  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Tammy L.  Nolan</span>, <span class="hlFld-ContribAuthor ">Christopher K.  Surratt</span>, <span class="hlFld-ContribAuthor ">John R.  Lever</span>, <span class="hlFld-ContribAuthor ">Rejwi  Acharya</span>, <span class="hlFld-ContribAuthor ">Roxanne A.  Vaughan</span>, <span class="hlFld-ContribAuthor ">Akash  Pandhare</span>, <span class="hlFld-ContribAuthor ">Michael P.  Blanton</span>. </span><span class="cited-content_cbyCitation_article-title">(±)-2-(N-tert-Butylamino)-3′-[125I]-iodo-4′-azidopropiophenone: A dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 523-526. <a href="https://doi.org/10.1016/j.bmcl.2011.10.086" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.10.086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.10.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.10.086%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%252528%2525C2%2525B1%252529-2-%252528N-tert-Butylamino%252529-3%2525E2%252580%2525B2-%25255B125I%25255D-iodo-4%2525E2%252580%2525B2-azidopropiophenone%25253A%252BA%252Bdopamine%252Btransporter%252Band%252Bnicotinic%252Bacetylcholine%252Breceptor%252Bphotoaffinity%252Bligand%252Bbased%252Bon%252Bbupropion%252B%252528Wellbutrin%25252C%252BZyban%252529%26aulast%3DLapinsky%26aufirst%3DDavid%2BJ.%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D523%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon D.  Brandt</span>, <span class="hlFld-ContribAuthor ">Sally  Freeman</span>, <span class="hlFld-ContribAuthor ">Harry R.  Sumnall</span>, <span class="hlFld-ContribAuthor ">Fiona  Measham</span>, <span class="hlFld-ContribAuthor ">Jon  Cole</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones. </span><span class="cited-content_cbyCitation_journal-name">Drug Testing and Analysis</span><span> <strong>2011,</strong> <em>3 </em>
                                    (9)
                                     , 569-575. <a href="https://doi.org/10.1002/dta.204" title="DOI URL">https://doi.org/10.1002/dta.204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/dta.204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fdta.204%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Testing%2520and%2520Analysis%26atitle%3DAnalysis%252Bof%252BNRG%252B%2525E2%252580%252598legal%252Bhighs%2525E2%252580%252599%252Bin%252Bthe%252BUK%25253A%252Bidentification%252Band%252Bformation%252Bof%252Bnovel%252Bcathinones%26aulast%3DBrandt%26aufirst%3DSimon%2BD.%26date%3D2011%26date%3D2010%26volume%3D3%26issue%3D9%26spage%3D569%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John P.  Kelly</span>. </span><span class="cited-content_cbyCitation_article-title">Cathinone derivatives: A review of their chemistry, pharmacology and toxicology. </span><span class="cited-content_cbyCitation_journal-name">Drug Testing and Analysis</span><span> <strong>2011,</strong> <em>3 </em>
                                    (7-8)
                                     , 439-453. <a href="https://doi.org/10.1002/dta.313" title="DOI URL">https://doi.org/10.1002/dta.313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/dta.313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fdta.313%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Testing%2520and%2520Analysis%26atitle%3DCathinone%252Bderivatives%25253A%252BA%252Breview%252Bof%252Btheir%252Bchemistry%25252C%252Bpharmacology%252Band%252Btoxicology%26aulast%3DKelly%26aufirst%3DJohn%2BP.%26date%3D2011%26date%3D2011%26volume%3D3%26issue%3D7-8%26spage%3D439%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon D.  Brandt</span>, <span class="hlFld-ContribAuthor ">Robert C. R.  Wootton</span>, <span class="hlFld-ContribAuthor ">Giorgia  De Paoli</span>, <span class="hlFld-ContribAuthor ">Sally  Freeman</span>. </span><span class="cited-content_cbyCitation_article-title">The naphyrone story: The Alpha or Beta-naphthyl Isomer?. </span><span class="cited-content_cbyCitation_journal-name">Drug Testing and Analysis</span><span> <strong>2010,</strong> <em>2 </em>
                                    (10)
                                     , 496-502. <a href="https://doi.org/10.1002/dta.185" title="DOI URL">https://doi.org/10.1002/dta.185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/dta.185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fdta.185%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Testing%2520and%2520Analysis%26atitle%3DThe%252Bnaphyrone%252Bstory%25253A%252BThe%252BAlpha%252Bor%252BBeta-naphthyl%252BIsomer%25253F%26aulast%3DBrandt%26aufirst%3DSimon%2BD.%26date%3D2010%26date%3D2010%26volume%3D2%26issue%3D10%26spage%3D496%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/medium/jm-2009-017465_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9017465&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/medium/jm-2009-017465_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0005.jpeg" id="rightTab-_i2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9017465&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/medium/jm-2009-017465_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <i><sup>a</sup></i></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9017465&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/medium/jm-2009-017465_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Specific <sup>86</sup>Rb<sup>+</sup> efflux (ordinate, percentage of control) was determined for functional, human muscle-type α1β1γδ-nAChR (△), ganglionic α3β4*-nAChR (▼), α4β2-nAChR (○), or α4β4-nAChR (▲) naturally or heterologously expressed in human cell lines in the presence of a receptor subtype-specific, EC<sub>80</sub>−EC<sub>90</sub> concentration of the full agonist, carbamylcholine, either alone or in the presence of the indicated concentrations (abscissa, log molar) of <b>2a</b> or its analogues having phenyl substitutions (compounds <b>2c</b>, <b>2l</b>, and <b>2h</b>) as indicated. Mean micromolar IC<sub>50</sub> values and SEM as a multiplication/division factor of the mean micromolar IC<sub>50</sub> value are provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9017465&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/medium/jm-2009-017465_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Specific <sup>86</sup>Rb<sup>+</sup> efflux (ordinate, percentage of control) was determined for functional, human muscle-type α1β1γδ-nAChR (Δ), ganglionic α3β4*-nAChR (▼), α4β2-nAChR (○), or α4β4-nAChR (▲) naturally or heterologously expressed in human cell lines in the presence of a receptor subtype-specific, EC<sub>80</sub>−EC<sub>90</sub> concentration of the full agonist, carbamylcholine, either alone or in the presence of the indicated concentrations (abscissa, log molar) of <b>2a</b> analogues having alkyl or phenyl plus alkyl substitutions (compounds <b>2y</b>, <b>2o</b>, <b>2w</b>, and <b>2x</b>) as indicated. Mean micromolar IC<sub>50</sub> values and SEM as a multiplication/division factor of the mean micromolar IC<sub>50</sub> value are provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm9017465/production/images/large/jm-2009-017465_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9017465&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62132" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62132" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span> <span class="citation_source-book">WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package</span>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>p 15.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=WHO+Report+on+the+Global+Tobacco+Epidemic%2C+2008%3A+The+MPOWER+Package%3B+World+Health+Organization%3A+Geneva%2C+2008%3B+p+15."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DWHO%2520Report%2520on%2520the%2520Global%2520Tobacco%2520Epidemic%252C%25202008%253A%2520The%2520MPOWER%2520Package%26pub%3DWorld%2520Health%2520Organization%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Centers for Disease Control and Prevention</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Cigarette smoking among adults: United States, 2007</span>.  <span class="citation_source-journal">Morbidity Mortality Wkly. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span>− <span class="NLM_lpage">1161</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=1157-1161&author=Centers+for+Disease+Control+and+Prevention&title=Cigarette+smoking+among+adults%3A+United+States%2C+2007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DCigarette%2520smoking%2520among%2520adults%253A%2520United%2520States%252C%25202007%26jtitle%3DMorbidity%2520Mortality%2520Wkly.%2520Rep.%26date%3D2007%26volume%3D56%26spage%3D1157%26epage%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Benowitz, N. L.</span><span> </span><span class="NLM_article-title">Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1038%2Fclpt.2008.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=18305452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsFCksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2008&pages=531-541&author=N.+L.+Benowitz&title=Clinical+pharmacology+of+nicotine%3A+implications+for+understanding%2C+preventing%2C+and+treating+tobacco+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Pharmacology of Nicotine: Implications for Understanding, Preventing, and Treating Tobacco Addiction</span></div><div class="casAuthors">Benowitz, N. L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">531-541</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Understanding the basic and clin. pharmacol. of nicotine provides a basis for improved prevention and treatment of tobacco addiction.  Nicotine acts on nicotinic cholinergic receptors in the brain to release dopamine and other neurotransmitters that sustain addiction.  Neuroadaptation and tolerance involve changes in both nicotinic receptors and neural plasticity.  Nicotine addiction can occur in the context of phys. dependence characterized by self-medication to modulate neg. affect and/or to relieve withdrawal symptoms, as well as, in light or occasional smokers, primarily for pos. reinforcement in specific situations.  Nicotine is metabolized primarily by CYP2A6.  Its clearance exhibits considerable individual variability that is detd. by genetic, racial, and hormonal (sex) factors.  Genetically slow metab. of nicotine appears to be assocd. with a lower level of dependence.  Nicotine dependence is highly heritable and appears to be influenced by genes coding for some nicotine receptor subtypes, some neurotransmitter genes, and genes involved in neural connectivity.  Novel pharmacotherapies for nicotine dependence include partial agonists for nicotinic receptors and nicotine vaccines.  Pharmacogenetic studies suggest various candidate genes and a nicotine metab. phenotype that influence outcome.  Human pharmacol. studies of nicotine and smoking behavior also provide a basis for assessing the benefits and risks of long-term nicotine use for harm redn. and for a potential cigarette regulatory strategy that includes reducing nicotine content of cigarettes to nonaddictive levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbBNl-p5vZebVg90H21EOLACvtfcHk0liVUOYkJvK-qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsFCksrk%253D&md5=645fabce1b3ab788ac387d03a5fa67b8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2008.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2008.3%26sid%3Dliteratum%253Aachs%26aulast%3DBenowitz%26aufirst%3DN.%2BL.%26atitle%3DClinical%2520pharmacology%2520of%2520nicotine%253A%2520implications%2520for%2520understanding%252C%2520preventing%252C%2520and%2520treating%2520tobacco%2520addiction%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D83%26spage%3D531%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lerman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeSage, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Malley, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benowitz, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigall, W. A.</span><span> </span><span class="NLM_article-title">Translational research in medication development for nicotine dependence</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=746-762&author=C.+Lermanauthor=M.+G.+LeSageauthor=K.+A.+Perkinsauthor=S.+S.+O%27Malleyauthor=S.+J.+Siegelauthor=N.+L.+Benowitzauthor=W.+A.+Corrigall&title=Translational+research+in+medication+development+for+nicotine+dependence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLerman%26aufirst%3DC.%26aulast%3DLeSage%26aufirst%3DM.%2BG.%26aulast%3DPerkins%26aufirst%3DK.%2BA.%26aulast%3DO%2527Malley%26aufirst%3DS.%2BS.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26aulast%3DBenowitz%26aufirst%3DN.%2BL.%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26atitle%3DTranslational%2520research%2520in%2520medication%2520development%2520for%2520nicotine%2520dependence%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D746%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Gotti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaimarri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span> </span><span class="NLM_article-title">Heterogeneity and complexity of native brain nicotinic receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=1102-1111&author=C.+Gottiauthor=M.+Morettiauthor=A.+Gaimarriauthor=A.+Zanardiauthor=F.+Clementiauthor=M.+Zoli&title=Heterogeneity+and+complexity+of+native+brain+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotti%26aufirst%3DC.%26aulast%3DMoretti%26aufirst%3DM.%26aulast%3DGaimarri%26aufirst%3DA.%26aulast%3DZanardi%26aufirst%3DA.%26aulast%3DClementi%26aufirst%3DF.%26aulast%3DZoli%26aufirst%3DM.%26atitle%3DHeterogeneity%2520and%2520complexity%2520of%2520native%2520brain%2520nicotinic%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D74%26spage%3D1102%26epage%3D1111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Rahman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Hernandez, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papke, R. L.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.2174%2F187152708786927831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=19128201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFansQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=422-441&author=S.+Rahmanauthor=G.+Y.+Lopez-Hernandezauthor=W.+A.+Corrigallauthor=R.+L.+Papke&title=Neuronal+nicotinic+receptors+as+brain+targets+for+pharmacotherapy+of+drug+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction</span></div><div class="casAuthors">Rahman, Shafiqur; Lopez-Hernandez, Gretchen Y.; Corrigall, William A.; Papke, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-441</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nicotine addiction and other forms of drug addiction continue to be significant public health problems in the United States and the rest of the world.  Accumulated evidence indicates that brain nicotinic acetylcholine receptors (nAChRs) are a heterogenous family of ion channels expressed in the various parts of the brain.  A growing body of preclin. studies suggests that brain nAChRs are crit. targets for the development of pharmacotherapies for nicotine and other drug addictions.  In this review, we will discuss the nAChR subtypes, their function in response to endogenous brain transmitters, and how their functions are regulated in the presence of nicotine.  Furthermore, we will discuss the role of nAChRs in mediating nicotine-induced addictive behavior in animal models.  Addnl., we will provide an overview of the effects of nicotine and nicotinic compds. on the mesolimbic dopamine system, part of the reinforcement/reward circuitry of the brain, as an example of the neurochem. basis of nicotine addiction and other drug addictions.  An appreciation of the complexity of nicotinic receptors and their regulation will be necessary for the development of nicotinic receptor modulators as potential pharmacotherapy for drug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuQExQTuj1E7Vg90H21EOLACvtfcHk0ljmAUZdenLwmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFansQ%253D%253D&md5=1e358be78d8fd3b9da199e25dbb950a5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F187152708786927831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152708786927831%26sid%3Dliteratum%253Aachs%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DLopez-Hernandez%26aufirst%3DG.%2BY.%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26aulast%3DPapke%26aufirst%3DR.%2BL.%26atitle%3DNeuronal%2520nicotinic%2520receptors%2520as%2520brain%2520targets%2520for%2520pharmacotherapy%2520of%2520drug%2520addiction%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2008%26volume%3D7%26spage%3D422%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Adams, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutter, T. J.</span><span> </span><span class="NLM_article-title">Calcium permeability and modulation of nicotinic acetylcholine receptor-channels in rat parasympathetic neurons</span> <span class="citation_source-journal">J. Physiol. (Paris)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1992&pages=67-76&author=D.+J.+Adamsauthor=T.+J.+Nutter&title=Calcium+permeability+and+modulation+of+nicotinic+acetylcholine+receptor-channels+in+rat+parasympathetic+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DD.%2BJ.%26aulast%3DNutter%26aufirst%3DT.%2BJ.%26atitle%3DCalcium%2520permeability%2520and%2520modulation%2520of%2520nicotinic%2520acetylcholine%2520receptor-channels%2520in%2520rat%2520parasympathetic%2520neurons%26jtitle%3DJ.%2520Physiol.%2520%2528Paris%2529%26date%3D1992%26volume%3D86%26spage%3D67%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changeux, J. P.</span><span> </span><span class="NLM_article-title">Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2428</span><span class="NLM_x">–</span> <span class="NLM_lpage">2439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1111%2Fj.1460-9568.1996.tb01206.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=8950106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A280%3ADyaK2s7gslemuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=2428-2439&author=N.+Le+Novereauthor=M.+Zoliauthor=J.+P.+Changeux&title=Neuronal+nicotinic+receptor+alpha+6+subunit+mRNA+is+selectively+concentrated+in+catecholaminergic+nuclei+of+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain</span></div><div class="casAuthors">Le Novere N; Zoli M; Changeux J P</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2428-39</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Although the neuronal nicotinic receptor alpha 6 subunit was cloned several years ago, its functional significance remains to be investigated.  Here we describe an in situ hybridization study of the mRNA for this subunit in the adult rat central nervous system using oligonucleotide probes.  Specific alpha 6 mRNA labelling was restricted to a few nuclei throughout the brain; it was particularly high in several catecholaminergic nuclei [the locus coeruleus (A6), the ventral tegmental area (A10) and the substantia nigra (A9)] at levels significantly higher than those found for any other known nicotinic receptor subunit mRNA.  Labelling for alpha 6 mRNA was also detected at lower levels in the reticular thalamic nucleus, the supramammillary nucleus and the mesencephalic V nucleus.  Some cells of the medial habenula (medioventral part) and of the interpeduncular nucleus (central and lateral parts) were also labelled.  The distribution of alpha 6 mRNA was compared with the distribution of the other known nicotinic acetylcholine receptor subunit mRNAs.  In several nuclei, the expression of alpha 6 was complementary to those of other alpha subunits.  Moreover, some of the cell groups (such as the substantia nigra, the ventral tegmental area and the locus coeruleus) previously thought to contain mainly alpha 3 mRNA in fact were found to contain high levels of alpha 6 mRNA.  Finally, we found extensive colocalization of alpha 6 and beta 3, indicating the possible existence of nicotinic receptor hetero-oligomers containing both subunits.  The present results show that alpha 6 is the major nicotinic acetylcholine receptor alpha subunit expressed in dopaminergic cell groups of the mesencephalon and noradrenergic cells of the locus coeruleus.  This suggests the involvement of the alpha 6 subunit in some of the major functions of central nicotinic circuits, including the modulation of locomotor behaviour and reward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGTspW95ieGmK_SFaaT9INfW6udTcc2eba5xjBh1vIwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7gslemuw%253D%253D&md5=1703784567106fda7afda74e1ca6e554</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.1996.tb01206.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.1996.tb01206.x%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DZoli%26aufirst%3DM.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26atitle%3DNeuronal%2520nicotinic%2520receptor%2520alpha%25206%2520subunit%2520mRNA%2520is%2520selectively%2520concentrated%2520in%2520catecholaminergic%2520nuclei%2520of%2520the%2520rat%2520brain%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1996%26volume%3D8%26spage%3D2428%26epage%3D2439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Goldner, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineley, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, J. W.</span><span> </span><span class="NLM_article-title">Immunohistochemical localization of the nicotinic acetylcholine receptor subunit alpha6 to dopaminergic neurons in the substantia nigra and ventral tegmental area</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2739</span><span class="NLM_x">–</span> <span class="NLM_lpage">2742</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=2739-2742&author=F.+M.+Goldnerauthor=K.+T.+Dineleyauthor=J.+W.+Patrick&title=Immunohistochemical+localization+of+the+nicotinic+acetylcholine+receptor+subunit+alpha6+to+dopaminergic+neurons+in+the+substantia+nigra+and+ventral+tegmental+area"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldner%26aufirst%3DF.%2BM.%26aulast%3DDineley%26aufirst%3DK.%2BT.%26aulast%3DPatrick%26aufirst%3DJ.%2BW.%26atitle%3DImmunohistochemical%2520localization%2520of%2520the%2520nicotinic%2520acetylcholine%2520receptor%2520subunit%2520alpha6%2520to%2520dopaminergic%2520neurons%2520in%2520the%2520substantia%2520nigra%2520and%2520ventral%2520tegmental%2520area%26jtitle%3DNeuroReport%26date%3D1997%26volume%3D8%26spage%3D2739%26epage%3D2742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Exley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, S. J.</span><span> </span><span class="NLM_article-title">Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2158</span><span class="NLM_x">–</span> <span class="NLM_lpage">2166</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=2158-2166&author=R.+Exleyauthor=M.+A.+Clementsauthor=H.+Hartungauthor=J.+M.+McIntoshauthor=S.+J.+Cragg&title=Alpha6-containing+nicotinic+acetylcholine+receptors+dominate+the+nicotine+control+of+dopamine+neurotransmission+in+nucleus+accumbens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DExley%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%2BA.%26aulast%3DHartung%26aufirst%3DH.%26aulast%3DMcIntosh%26aufirst%3DJ.%2BM.%26aulast%3DCragg%26aufirst%3DS.%2BJ.%26atitle%3DAlpha6-containing%2520nicotinic%2520acetylcholine%2520receptors%2520dominate%2520the%2520nicotine%2520control%2520of%2520dopamine%2520neurotransmission%2520in%2520nucleus%2520accumbens%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D2158%26epage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Corrigall, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. B.</span><span> </span><span class="NLM_article-title">The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1992&pages=285-289&author=W.+A.+Corrigallauthor=K.+B.+Franklinauthor=K.+M.+Coenauthor=P.+B.+Clarke&title=The+mesolimbic+dopaminergic+system+is+implicated+in+the+reinforcing+effects+of+nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorrigall%26aufirst%3DW.%2BA.%26aulast%3DFranklin%26aufirst%3DK.%2BB.%26aulast%3DCoen%26aufirst%3DK.%2BM.%26aulast%3DClarke%26aufirst%3DP.%2BB.%26atitle%3DThe%2520mesolimbic%2520dopaminergic%2520system%2520is%2520implicated%2520in%2520the%2520reinforcing%2520effects%2520of%2520nicotine%26jtitle%3DPsychopharmacology%26date%3D1992%26volume%3D107%26spage%3D285%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Brody, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olmstead, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farahi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkern, M. A.</span><span> </span><span class="NLM_article-title">Smoking-induced ventral striatum dopamine release</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1176%2Fappi.ajp.161.7.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=15229053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A280%3ADC%252BD2czis1yqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=1211-1218&author=A.+L.+Brodyauthor=R.+E.+Olmsteadauthor=E.+D.+Londonauthor=J.+Farahiauthor=J.+H.+Meyerauthor=P.+Grossmanauthor=G.+S.+Leeauthor=J.+Huangauthor=E.+L.+Hahnauthor=M.+A.+Mandelkern&title=Smoking-induced+ventral+striatum+dopamine+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Smoking-induced ventral striatum dopamine release</span></div><div class="casAuthors">Brody Arthur L; Olmstead Richard E; London Edythe D; Farahi Judah; Meyer Jeffrey H; Grossman Paul; Lee Grace S; Huang Joe; Hahn Emily L; Mandelkern Mark A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1211-8</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Substantial evidence from animal models demonstrates that dopamine release in the ventral striatum underlies the reinforcing properties of nicotine.  The authors used [(11)C]raclopride bolus-plus-continuous-infusion positron emission tomography (PET) to determine smoking-induced ventral striatum dopamine release in humans.  METHOD:  Twenty nicotine-dependent smokers (who smoked > or =15 cigarettes/day) underwent a [(11)C]raclopride bolus-plus-continuous-infusion PET session.  During the session, subjects had a 10-minute break outside the PET apparatus during which 10 subjects smoked a cigarette and 10 did not smoke (as a control condition).  RESULTS:  The group that smoked had greater reductions in [(11)C]raclopride binding potential in ventral striatum regions of interest than the group that did not smoke, particularly in the left ventral caudate/nucleus accumbens and left ventral putamen (range for smoking group=-25.9% to -36.6% reduction).  Significant correlations were found between change from before to after the smoking break in craving ratings and change from before to after the break in binding potential for these two regions.  CONCLUSIONS:  Nicotine-dependent subjects who smoked during a break in PET scanning had greater reductions in [(11)C]raclopride binding potential (an indirect measure of dopamine release) than nicotine-dependent subjects who did not smoke.  The magnitude of binding potential changes was comparable to that found in studies that used similar methods to examine the effects of other addictive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRk4_DvvsbbrpggzHGM8X5CfW6udTcc2eYsdduZRMaBQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czis1yqtg%253D%253D&md5=745fbf6bd4538acec7ac76bbca229ce9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.7.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.7.1211%26sid%3Dliteratum%253Aachs%26aulast%3DBrody%26aufirst%3DA.%2BL.%26aulast%3DOlmstead%26aufirst%3DR.%2BE.%26aulast%3DLondon%26aufirst%3DE.%2BD.%26aulast%3DFarahi%26aufirst%3DJ.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DGrossman%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DG.%2BS.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHahn%26aufirst%3DE.%2BL.%26aulast%3DMandelkern%26aufirst%3DM.%2BA.%26atitle%3DSmoking-induced%2520ventral%2520striatum%2520dopamine%2520release%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D1211%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Fant, R. V.; Buchhalter, A. R.; Buchman, A. C.; Henningfield, J. E.</span><span> </span><span class="NLM_article-title">Pharmacotherapy for Tobacco Dependence</span>. In  <span class="citation_source-book">Nicotine Psychopharmacology. Handbook of Experimental Pharmacology</span>; <span class="NLM_contrib-group">Henningfield, J. E.; London, E. D.; Pogun, S.</span>, Eds.; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">Berlin</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">192</span>, p  <span class="NLM_fpage">487</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1007%2F978-3-540-69248-5_17" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=487&author=R.+V.+Fant&author=A.+R.+Buchhalter&author=A.+C.+Buchman&author=J.+E.+Henningfieldauthor=J.+E.+Henningfield&author=E.+D.+London&author=S.+Pogun&title=Nicotine+Psychopharmacology.+Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-69248-5_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-540-69248-5_17%26sid%3Dliteratum%253Aachs%26aulast%3DFant%26aufirst%3DR.%2BV.%26atitle%3DPharmacotherapy%2520for%2520Tobacco%2520Dependence%26btitle%3DNicotine%2520Psychopharmacology.%2520Handbook%2520of%2520Experimental%2520Pharmacology%26aulast%3DHenningfield%26aufirst%3DJ.%2BE.%26pub%3DSpringer-Verlag%26date%3D2009%26volume%3D192%26spage%3D487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Gonzales, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennard, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nides, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oncken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azoulay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billing, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, K. R.</span><span> </span><span class="NLM_article-title">Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2006&pages=47-55&author=D.+Gonzalesauthor=S.+I.+Rennardauthor=M.+Nidesauthor=C.+Onckenauthor=S.+Azoulayauthor=C.+B.+Billingauthor=E.+J.+Watskyauthor=J.+Gongauthor=K.+E.+Williamsauthor=K.+R.+Reeves&title=Varenicline%2C+an+alpha4beta2+nicotinic+acetylcholine+receptor+partial+agonist%2C+vs+sustained-release+bupropion+and+placebo+for+smoking+cessation%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzales%26aufirst%3DD.%26aulast%3DRennard%26aufirst%3DS.%2BI.%26aulast%3DNides%26aufirst%3DM.%26aulast%3DOncken%26aufirst%3DC.%26aulast%3DAzoulay%26aufirst%3DS.%26aulast%3DBilling%26aufirst%3DC.%2BB.%26aulast%3DWatsky%26aufirst%3DE.%2BJ.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DK.%2BE.%26aulast%3DReeves%26aufirst%3DK.%2BR.%26atitle%3DVarenicline%252C%2520an%2520alpha4beta2%2520nicotinic%2520acetylcholine%2520receptor%2520partial%2520agonist%252C%2520vs%2520sustained-release%2520bupropion%2520and%2520placebo%2520for%2520smoking%2520cessation%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2006%26volume%3D296%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fryer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=9862757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADyaK1MXisVyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=1999&pages=88-92&author=J.+D.+Fryerauthor=R.+J.+Lukas&title=Noncompetitive+functional+inhibition+at+diverse%2C+human+nicotinic+acetylcholine+receptor+subtypes+by+bupropion%2C+phencyclidine%2C+and+ibogaine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine</span></div><div class="casAuthors">Fryer, John D.; Lukas, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-92</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChR) are diverse members of the neurotransmitter-gated ion channel superfamily and play crit. roles in chem. signaling throughout the nervous system.  The present study establishes the acute functional effects of bupropion, phencyclidine, and ibogaine on two human nAChR subtypes.  Function of muscle-type nAChR (α1βγδ) in TE671/RD cells or of ganglionic nAChR (α3β4α5±β2) in SH-SY5Y neuroblastoma cells was measured with 86Rb+ efflux assays.  Functional blockade of human muscle-type and ganglionic nAChR is produced by each of the drugs in the low to intermediate micromolar range.  Functional blockade is insurmountable by increasing agonist concns. in TE671/RD and SH-SY5Y cells for each of these drugs, suggesting non-competitive inhibition of nAChR function.  Based on these findings, we hypothesize that nAChR are targets of diverse substances of abuse and agents used in antiaddiction/smoking cessation strategies.  We also hypothesize that nAChR play heretofore underappreciated roles in depression and as targets for clin. useful antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVpy_mL2ERbLVg90H21EOLACvtfcHk0ljLWEo5CbSTIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVyksg%253D%253D&md5=aab872eddec4e95e355beccf952600e7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DJ.%2BD.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DNoncompetitive%2520functional%2520inhibition%2520at%2520diverse%252C%2520human%2520nicotinic%2520acetylcholine%2520receptor%2520subtypes%2520by%2520bupropion%252C%2520phencyclidine%252C%2520and%2520ibogaine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D288%26spage%3D88%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Slemmer, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damaj, M. I.</span><span> </span><span class="NLM_article-title">Bupropion is a nicotinic antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=10991997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1ynsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=321-327&author=J.+E.+Slemmerauthor=B.+R.+Martinauthor=M.+I.+Damaj&title=Bupropion+is+a+nicotinic+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bupropion is a nicotinic antagonist</span></div><div class="casAuthors">Slemmer, Jennifer E.; Martin, Billy R.; Damaj, M. Imad</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">321-327</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Neuronal nicotinic receptors are ligand-gated ion channels of the central and peripheral central nervous system that regulate synaptic activity from both pre- and postsynaptic sites.  The present study establishes the acute interaction of bupropion, an antidepressant agent that is also effective in nicotine dependence, with nicotine and nicotinic receptors using different in vivo and in vitro tests.  Bupropion was found to block nicotine's antinociception (in two tests), motor effects, hypothermia, and convulsive effects with different potencies in the present investigation, suggesting that bupropion possesses some selectivity for neuronal nicotinic receptors underlying these various nicotinic effects.  In addn., bupropion blocks nicotine activation of α3β2, α4β2, and α7 neuronal acetylcholine nicotinic receptors (nAChRs) with some degree of selectivity.  It was ∼50 and 12 times more effective in blocking α3β2 and α4β2 than α7.  This functional blockade was noncompetitive, because it was insurmountable by increasing concn. of ACh in the nAChRs subtypes tested.  Furthermore, bupropion at high concn. failed to displace brain [3H]nicotine binding sites, a site largely composed of α4β2 subunit combination.  Given the observation that bupropion inhibition of α3β2 and α4β2 receptors exhibits voltage-independence properties, bupropion may not be acting as an open channel blocker.  These effects may explain in part bupropion's efficacy in nicotine dependence.  Our present findings suggest that functional blockade of neuronal nAChRs are useful in nicotine dependence treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqESPQh1LO9LVg90H21EOLACvtfcHk0liv7wH-VCTdHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1ynsrg%253D&md5=65966b022e015f86dadaedbb1c97dbaf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSlemmer%26aufirst%3DJ.%2BE.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26atitle%3DBupropion%2520is%2520a%2520nicotinic%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D321%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Harbeson, S. L.</span><span> </span><span class="NLM_article-title">Propiophenone Derivatives</span>. WIPO Patent WO/2009/105218,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+L.+Harbeson&title=Propiophenone+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26atitle%3DPropiophenone%2520Derivatives%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hadizadeh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebrahimzadeh, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosseinzadeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motamed-Shariaty, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekhradnia, A. R.</span><span> </span><span class="NLM_article-title">Antidepressant and antioxidant activities of some 2-benzoxazolinone derivatives as bupropion analogues</span> <span class="citation_source-journal">Pharmacologyonline</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=331-335&author=F.+Hadizadehauthor=M.+A.+Ebrahimzadehauthor=H.+Hosseinzadehauthor=V.+Motamed-Shariatyauthor=S.+Salamiauthor=A.+R.+Bekhradnia&title=Antidepressant+and+antioxidant+activities+of+some+2-benzoxazolinone+derivatives+as+bupropion+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHadizadeh%26aufirst%3DF.%26aulast%3DEbrahimzadeh%26aufirst%3DM.%2BA.%26aulast%3DHosseinzadeh%26aufirst%3DH.%26aulast%3DMotamed-Shariaty%26aufirst%3DV.%26aulast%3DSalami%26aufirst%3DS.%26aulast%3DBekhradnia%26aufirst%3DA.%2BR.%26atitle%3DAntidepressant%2520and%2520antioxidant%2520activities%2520of%2520some%25202-benzoxazolinone%2520derivatives%2520as%2520bupropion%2520analogues%26jtitle%3DPharmacologyonline%26date%3D2009%26volume%3D1%26spage%3D331%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Foley, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzi, N. V.</span><span> </span><span class="NLM_article-title">Novel aminopropiophenones as potential antidepressants</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2003&pages=252-260&author=K.+F.+Foleyauthor=N.+V.+Cozzi&title=Novel+aminopropiophenones+as+potential+antidepressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoley%26aufirst%3DK.%2BF.%26aulast%3DCozzi%26aufirst%3DN.%2BV.%26atitle%3DNovel%2520aminopropiophenones%2520as%2520potential%2520antidepressants%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2003%26volume%3D60%26spage%3D252%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Miller, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumithran, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwoskin, L. P.</span><span> </span><span class="NLM_article-title">Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1124%2Fjpet.102.033852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=12183670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsF2htrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=1113-1122&author=D.+K.+Millerauthor=S.+P.+Sumithranauthor=L.+P.+Dwoskin&title=Bupropion+inhibits+nicotine-evoked+%5B%283%29H%5Doverflow+from+rat+striatal+slices+preloaded+with+%5B%283%29H%5Ddopamine+and+from+rat+hippocampal+slices+preloaded+with+%5B%283%29H%5Dnorepinephrine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bupropion inhibits nicotine-evoked [3H]overflow from rat striatal slices preloaded with [3H]dopamine and from rat hippocampal slices preloaded with [3H]norepinephrine</span></div><div class="casAuthors">Miller, Dennis K.; Sumithran, Sangeetha P.; Dwoskin, Linda P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1113-1122</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Bupropion, an efficacious antidepressant and smoking cessation agent, inhibits dopamine and norepinephrine transporters (DAT and NET, resp.).  Recently, bupropion has been reported to noncompetitively inhibit α3β2, α3β4, and α4β2 nicotinic acetylcholine receptors (nAChRs) expressed in Xenopus oocytes or established cell lines.  The present study evaluated bupropion-induced inhibition of native α3β2* and α3β4* nAChRs using functional neurotransmitter release assays, nicotine-evoked [3H]overflow from superfused rat striatal slices preloaded with [3H]dopamine ([3H]DA), and nicotine-evoked [3H]overflow from hippocampal slices preloaded with [3H]norepinephrine ([3H]NE).  The mechanism of inhibition was evaluated using Schild anal.  To eliminate the interaction of bupropion with DAT or NET, nomifensine or desipramine, resp., was included in the superfusion buffer.  A high bupropion concn. (100 μM) elicited intrinsic activity in the [3H]DA release assay.  However, none of the concns. (1 nM-100 μM) examd. evoked [3H]NE overflow and, thus, were without intrinsic activity in this assay.  Moreover, bupropion inhibited both nicotine-evoked [3H]DA overflow (IC50 = 1.27 μM) and nicotine-evoked [3H]NE overflow (IC50 = 323 nM) at bupropion concns. well below those eliciting intrinsic activity.  Results from Schild analyses suggest that bupropion competitively inhibits nicotine-evoked [3H]DA overflow, whereas evidence for receptor reserve was obtained upon assessment of bupropion inhibition of nicotine-evoked [3H]NE overflow.  Thus, bupropion acts as an antagonist at α3β2* and α3β4* nAChRs in rat striatum and hippocampus, resp., across the same concn. range that inhibits DAT and NET function.  The combination of nAChR and transporter inhibition produced by bupropion may contribute to its clin. efficacy as a smoking cessation agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLRTYoa89ckbVg90H21EOLACvtfcHk0lgaRGlAaQUqGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsF2htrg%253D&md5=726aede0d8aae7e092d8de0b55889233</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.033852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.033852%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DD.%2BK.%26aulast%3DSumithran%26aufirst%3DS.%2BP.%26aulast%3DDwoskin%26aufirst%3DL.%2BP.%26atitle%3DBupropion%2520inhibits%2520nicotine-evoked%2520%255B%25283%2529H%255Doverflow%2520from%2520rat%2520striatal%2520slices%2520preloaded%2520with%2520%255B%25283%2529H%255Ddopamine%2520and%2520from%2520rat%2520hippocampal%2520slices%2520preloaded%2520with%2520%255B%25283%2529H%255Dnorepinephrine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D1113%26epage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mooney, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofuoglu, M.</span><span> </span><span class="NLM_article-title">Bupropion for the treatment of nicotine withdrawal and craving</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1586%2F14737175.6.7.965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=16831112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1Crtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=965-981&author=M.+E.+Mooneyauthor=M.+Sofuoglu&title=Bupropion+for+the+treatment+of+nicotine+withdrawal+and+craving"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bupropion for the treatment of nicotine withdrawal and craving</span></div><div class="casAuthors">Mooney, Marc E.; Sofuoglu, Mehmet</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">965-981</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past decade, bupropion has become a major pharmacotherapy for smoking cessation in the Western world.  Unlike other smoking cessation pharmacotherapies, bupropion is a non-nicotine treatment.  Compared with a placebo control, bupropion approx. doubles smoking quit rates.  Most smoking cessation pharmacotherapies are thought to work, in part, by reducing nicotine withdrawal and craving.  This article reviews preclin., human lab. and clin. trial studies of the effect of bupropion on nicotine withdrawal and craving.  Preclin. studies demonstrate that in rats undergoing nicotine withdrawal, bupropion can dose-dependently lower changes in brain-reward threshold and somatic signs of nicotine withdrawal.  Human lab. studies have demonstrated that bupropion can alleviate some nicotine withdrawal symptoms, including depressed mood, irritability, difficulty concg. and increased appetite.  Moreover, bupropion has shown some efficacy in alleviating craving to smoke.  Clin. trials of bupropion have offered mixed support of its ability to reduce nicotine withdrawal, wt. gain during treatment and craving.  Strong mediational evidence of bupropion's action through relief of withdrawal and craving in smoking cessation is growing.  Greater understanding of the psychol. mechanisms of bupropion action will likely be obtained through advances in the conceptualization and measurement of withdrawal and craving.  Improvements in the efficacy of bupropion may be achieved through pharmacogenetic studies, with particular emphasis on its metabolites.  Ultimately, the efficacy of bupropion may be augmented by combination with other agents that target withdrawal and craving through complementary neurobiol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyt6mIQDaAsbVg90H21EOLACvtfcHk0lgaRGlAaQUqGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1Crtbk%253D&md5=dee397eb1988216650f6086b3fd8ba6a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1586%2F14737175.6.7.965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.6.7.965%26sid%3Dliteratum%253Aachs%26aulast%3DMooney%26aufirst%3DM.%2BE.%26aulast%3DSofuoglu%26aufirst%3DM.%26atitle%3DBupropion%2520for%2520the%2520treatment%2520of%2520nicotine%2520withdrawal%2520and%2520craving%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2006%26volume%3D6%26spage%3D965%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Paterson, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balfour, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1111%2Fj.1460-9568.2007.05546.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=17561823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A280%3ADC%252BD2szpsVGjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=3099-3108&author=N.+E.+Patersonauthor=D.+J.+Balfourauthor=A.+Markou&title=Chronic+bupropion+attenuated+the+anhedonic+component+of+nicotine+withdrawal+in+rats+via+inhibition+of+dopamine+reuptake+in+the+nucleus+accumbens+shell"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell</span></div><div class="casAuthors">Paterson Neil E; Balfour David J; Markou Athina</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3099-108</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Bupropion, a dopamine reuptake inhibitor, is an effective therapy for smoking cessation, but the behavioral and neurochemical mechanisms mediating its antismoking properties are relatively unknown.  To explore the hypothesis that bupropion ameliorates nicotine withdrawal partly by a dopamine-dependent mechanism, we investigated the effects of chronic bupropion on potassium-stimulated dopamine overflow in the nucleus accumbens shell in nicotine-withdrawing rats.  We also assessed the effects of chronic bupropion on behavioral aspects of nicotine withdrawal measured by elevations in brain reward thresholds and somatic signs of withdrawal.  Rats were treated with nicotine or saline for 7 days and then coadministration of bupropion or saline was initiated.  After 14 days of coadministration of bupropion/saline and nicotine/saline, nicotine/saline administration was terminated, whereas bupropion/saline administration continued.  These conditions mimic bupropion administration in human smokers.  Cessation of nicotine administration in non-bupropion-treated rats elevated reward thresholds reflecting a reward deficit, increased somatic signs and diminished potassium-evoked dopamine overflow in the nucleus accumbens shell.  Chronic bupropion lowered reward thresholds and increased potassium-evoked dopamine release regardless of previous nicotine exposure, possibly by inhibition of dopamine reuptake, and thus attenuated the anhedonic and neurochemical effects of nicotine withdrawal.  Chronic bupropion blocked withdrawal-associated increased somatic signs.  Finally, acute experimenter-administered nicotine enhanced brain reward function equally in all groups, indicating that bupropion does not alter the reward-facilitating effects of experimenter-administered nicotine.  In conclusion, the bupropion-induced increase in extracellular dopamine in the nucleus accumbens shell may ameliorate the anhedonia associated with nicotine withdrawal, which in turn may facilitate smoking cessation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRj_y60Fl2GEhJ5E29YNGvQfW6udTcc2eatDVwnGM7hHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szpsVGjuw%253D%253D&md5=0d2b249de74b42b77400805a08af810e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2007.05546.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2007.05546.x%26sid%3Dliteratum%253Aachs%26aulast%3DPaterson%26aufirst%3DN.%2BE.%26aulast%3DBalfour%26aufirst%3DD.%2BJ.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DChronic%2520bupropion%2520attenuated%2520the%2520anhedonic%2520component%2520of%2520nicotine%2520withdrawal%2520in%2520rats%2520via%2520inhibition%2520of%2520dopamine%2520reuptake%2520in%2520the%2520nucleus%2520accumbens%2520shell%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2007%26volume%3D25%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Reuben, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. B.</span><span> </span><span class="NLM_article-title">Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1016%2FS0014-2999%2800%2900004-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=10770996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFGqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2000&pages=39-49&author=M.+Reubenauthor=S.+Boyeauthor=P.+B.+Clarke&title=Nicotinic+receptors+modulating+somatodendritic+and+terminal+dopamine+release+differ+pharmacologically"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically</span></div><div class="casAuthors">Reuben, M.; Boye, S.; Clarke, P. B. S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">393</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">39-49</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Ascending dopaminergic and noradrenergic neurons possess somatodendritic and terminal nicotinic cholinoceptors in the rat.  Each neuronal population expresses mRNA for several types of nicotinic cholinoceptor subunits, including α6 and β3.  In superfused rat striatal synaptosomes, epibatidine evoked release of [3H]dopamine with similar efficacy to ACh, whereas nicotine and cytisine were weaker (70% and 58%, resp.).  The four agonists were equi-efficacious in evoking [3H]noradrenaline release from hippocampal synaptosomes.  Nicotine-evoked synaptosomal release was tetrodotoxin-insensitive.  Somatodendritic nicotinic cholinoceptors on dopaminergic neurons were studied using a dendrosomal [3H]dopamine release assay and also in locomotor activity tests.  In both assays, nicotine appeared more efficacious than epibatidine.  Furthermore, with repeated nicotine exposure, the acute locomotor stimulant response to nicotine increased, whereas the epibatidine response became undetectable.  In conclusion, somatodendritic nicotinic cholinoceptors located on dopaminergic neurons appear to differ pharmacol. from those on striatal dopaminergic terminals and hippocampal noradrenergic terminals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Cl7pAViYhbVg90H21EOLACvtfcHk0lj0NW2yDaF87w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFGqu78%253D&md5=eea11e0f24b4ed31e558233905958185</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900004-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900004-2%26sid%3Dliteratum%253Aachs%26aulast%3DReuben%26aufirst%3DM.%26aulast%3DBoye%26aufirst%3DS.%26aulast%3DClarke%26aufirst%3DP.%2BB.%26atitle%3DNicotinic%2520receptors%2520modulating%2520somatodendritic%2520and%2520terminal%2520dopamine%2520release%2520differ%2520pharmacologically%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D393%26spage%3D39%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Makhay, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Donnell, J. M.</span><span> </span><span class="NLM_article-title">Effects of antidepressants in rats trained to discriminate the beta-2 adrenergic agonist clenbuterol</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1999&pages=319-324&author=M.+M.+Makhayauthor=J.+M.+O%27Donnell&title=Effects+of+antidepressants+in+rats+trained+to+discriminate+the+beta-2+adrenergic+agonist+clenbuterol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMakhay%26aufirst%3DM.%2BM.%26aulast%3DO%2527Donnell%26aufirst%3DJ.%2BM.%26atitle%3DEffects%2520of%2520antidepressants%2520in%2520rats%2520trained%2520to%2520discriminate%2520the%2520beta-2%2520adrenergic%2520agonist%2520clenbuterol%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1999%26volume%3D63%26spage%3D319%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holleman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolckenhauer, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landavazo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatch, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, M. J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6768</span><span class="NLM_x">–</span> <span class="NLM_lpage">6781</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901189z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6768-6781&author=F.+I.+Carrollauthor=B.+Bloughauthor=P.+Abrahamauthor=A.+C.+Millsauthor=J.+A.+Hollemanauthor=S.+A.+Wolckenhauerauthor=A.+M.+Deckerauthor=A.+Landavazoauthor=K.+T.+McElroyauthor=H.+A.+Navarroauthor=M.+B.+Gatchauthor=M.+J.+Foster&title=Synthesis+and+biological+evaluation+of+bupropion+analogues+as+potential+pharmacotherapies+for+cocaine+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction</span></div><div class="casAuthors">Carroll, F. Ivy; Blough, Bruce E.; Abraham, Philip; Mills, Andrew C.; Holleman, J. Ashley; Wolckenhauer, Scott A.; Decker, Ann M.; Landavazo, Antonio; McElroy, K. Timothy; Navarro, Hernan A.; Gatch, Michael B.; Forster, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6768-6781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of bupropion (I) analogs was synthesized, and their in vitro and in vivo pharmacol. properties evaluated with the goal of developing an analog that had better properties for treating addictions.  Their in vitro pharmacol. properties were examd. by [3H]dopamine ([3H]DA), [3H]serotonin ([3H]5HT), and [3H]norepinephrine ([3H]NE) uptake inhibition studies, and by binding studies at the dopamine, serotonin, and norepinephrine transporters using [125I]RTI-55 in cloned transporters.  Several analogs showed increased [3H]DA uptake inhibition with reduced or little change in [3H]5HT and [3H]NE uptake inhibition relative to bupropion.  Thirty-five analogs were evaluated in a 1 h locomotor activity observation test and 32 in an 8 h locomotor activity observation test and compared to the locomotor activity of cocaine.  Twenty-four analogs were evaluated for generalization to cocaine drug discrimination after i.p. administration, and twelve analogs were tested in a time course cocaine discrimination study using oral administration.  2-(N-Cyclopropylamino)-3-chloropropiophenone (II) had the most favorable in vitro efficacy and in vivo pharmacol. profile for an indirect dopamine agonist pharmacotherapy for treating cocaine, methamphetamine, nicotine, and other drugs of abuse addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpISymClen03bVg90H21EOLACvtfcHk0lj0NW2yDaF87w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLnL&md5=b3511748a08e7abf7510ceddb12bbedc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm901189z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901189z%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DBlough%26aufirst%3DB.%26aulast%3DAbraham%26aufirst%3DP.%26aulast%3DMills%26aufirst%3DA.%2BC.%26aulast%3DHolleman%26aufirst%3DJ.%2BA.%26aulast%3DWolckenhauer%26aufirst%3DS.%2BA.%26aulast%3DDecker%26aufirst%3DA.%2BM.%26aulast%3DLandavazo%26aufirst%3DA.%26aulast%3DMcElroy%26aufirst%3DK.%2BT.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DGatch%26aufirst%3DM.%2BB.%26aulast%3DFoster%26aufirst%3DM.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520bupropion%2520analogues%2520as%2520potential%2520pharmacotherapies%2520for%2520cocaine%2520addiction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6768%26epage%3D6781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Eshleman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmolli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumbay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martens, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowsky, A.</span><span> </span><span class="NLM_article-title">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=10215666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=877-885&author=A.+J.+Eshlemanauthor=M.+Carmolliauthor=M.+Cumbayauthor=C.+R.+Martensauthor=K.+A.+Neveauthor=A.+Janowsky&title=Characteristics+of+drug+interactions+with+recombinant+biogenic+amine+transporters+expressed+in+the+same+cell+type"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type</span></div><div class="casAuthors">Eshleman, Amy J.; Carmolli, Marya; Cumbay, Medhane; Martens, Carey R.; Neve, Kim A.; Janowsky, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">877-885</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The effects of drugs on the uptake of [3H]neurotransmitter by and the binding of [125I]3β-(4-iodophenyl)tropane-2β-carboxylic acid Me ester ([125I]RTI-55) to the recombinant human dopamine (hDAT), serotonin (hSERT), or norepinephrine (hNET) transporters stably expressed in human embryonic kidney 293 cells were studied.  RTI-55 had similar affinity for the hDAT and hSERT and lower affinity for hNET (Kd = 1.83, 0.98, and 12.1 nM, resp.).  Kinetic anal. of [125I]RTI-55 binding indicated that the dissocn. rate (k-1) was significantly lower for hSERT and the assocn. rate (k+1) was significantly lower for hNET compared with the hDAT.  The potency of drugs at blocking [3H]neurotransmitter uptake was highly correlated with potency at blocking radioligand binding for hDAT and hSERT.  Substrates were more potent at the inhibition of [3H]neurotransmitter uptake than radioligand binding.  The potency of drugs was highly correlated between displacement of [3H]nisoxetine (Kd = 6.0 nM) and [125I]RTI-55 from the hNET, suggesting that these radioligands recognize similar sites on the transporter protein.  The correlation obsd. between inhibitory potency for uptake and binding of either ligand at the hNET was lower than correlations between uptake and binding for hDAT and hSERT.  The present results indicate that the cocaine analog [125I]RTI-55 has unique binding properties at each of the transporters and that the use of recombinant transporters expressed by a single cell type can provide a powerful screening tool for drugs interacting with biogenic amine transporters, such as possible cocaine antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn_1UJqie3bVg90H21EOLACvtfcHk0lj6aevvU4bFGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGisrg%253D&md5=c808b4d81da86e57460406d2163c5e65</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEshleman%26aufirst%3DA.%2BJ.%26aulast%3DCarmolli%26aufirst%3DM.%26aulast%3DCumbay%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DC.%2BR.%26aulast%3DNeve%26aufirst%3DK.%2BA.%26aulast%3DJanowsky%26aufirst%3DA.%26atitle%3DCharacteristics%2520of%2520drug%2520interactions%2520with%2520recombinant%2520biogenic%2520amine%2520transporters%2520expressed%2520in%2520the%2520same%2520cell%2520type%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D877%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Damaj, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirza, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=675-682&author=M.+I.+Damajauthor=F.+I.+Carrollauthor=J.+B.+Eatonauthor=H.+A.+Navarroauthor=B.+E.+Bloughauthor=S.+Mirzaauthor=R.+J.+Lukasauthor=B.+R.+Martin&title=Enantioselective+effects+of+hydroxy+metabolites+of+bupropion+on+behavior+and+on+function+of+monoamine+transporters+and+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDamaj%26aufirst%3DM.%2BI.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DBlough%26aufirst%3DB.%2BE.%26aulast%3DMirza%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DEnantioselective%2520effects%2520of%2520hydroxy%2520metabolites%2520of%2520bupropion%2520on%2520behavior%2520and%2520on%2520function%2520of%2520monoamine%2520transporters%2520and%2520nicotinic%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D675%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Salas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Biasi, M.</span><span> </span><span class="NLM_article-title">Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">3014</span><span class="NLM_x">–</span> <span class="NLM_lpage">3018</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm9017465&amp;key=10.1523%2FJNEUROSCI.4934-08.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=19279237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVamsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=3014-3018&author=R.+Salasauthor=R.+Sturmauthor=J.+Boulterauthor=M.+De+Biasi&title=Nicotinic+receptors+in+the+habenulo-interpeduncular+system+are+necessary+for+nicotine+withdrawal+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice</span></div><div class="casAuthors">Salas, Ramiro; Sturm, Renea; Boulter, Jim; De Biasi, Mariella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3014-3018</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">In humans, tobacco withdrawal produces symptoms that contribute to the difficulty assocd. with smoking cessation.  Nicotine withdrawal symptoms can also be obsd. in rodents.  A major standing question is which nicotinic receptor subtypes and which areas of the brain are necessary for nicotine withdrawal to occur.  Using knock-out mice, we previously showed that the β4, but not the β2 subunit of nicotinic acetylcholine receptors, is necessary for the somatic manifestations of nicotine withdrawal.  Since the β4 subunit is highly expressed in the medial habenula, we focused our studies on the medial habenula and its primary target, the interpeduncular nucleus.  In particular, we studied nicotine withdrawal in mice lacking the α2 or the α5 nicotinic receptor subunits, which are highly expressed in the interpeduncular nucleus.  We pptd. withdrawal by systemically injecting the nicotinic antagonist mecamylamine in mice chronically treated with nicotine.  Both the α2 and the α5 null mutations abolished the somatic manifestations of nicotine withdrawal.  In addn., in wild-type mice chronically treated with nicotine, mecamylamine pptd. withdrawal when microinjected into the habenula or the interpeduncular nucleus, but not into the cortex, ventral tegmental area or hippocampus.  Our results demonstrate a major role for the habenulo-interpeduncular system and the nicotinic receptor subunits expressed therein, in nicotine withdrawal symptoms.  Our data suggest that the efforts to develop new smoking cessation therapies should conc. on these areas and receptor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYJtFJmqRLLVg90H21EOLACvtfcHk0lgUNzLxjp8aPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVamsbs%253D&md5=cc06018ed9a980e6ad1fd8304cbb7538</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4934-08.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4934-08.2009%26sid%3Dliteratum%253Aachs%26aulast%3DSalas%26aufirst%3DR.%26aulast%3DSturm%26aufirst%3DR.%26aulast%3DBoulter%26aufirst%3DJ.%26aulast%3DDe%2BBiasi%26aufirst%3DM.%26atitle%3DNicotinic%2520receptors%2520in%2520the%2520habenulo-interpeduncular%2520system%2520are%2520necessary%2520for%2520nicotine%2520withdrawal%2520in%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D3014%26epage%3D3018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lukas, R. J.; Fryer, J. D.; Eaton, J. B.; Gentry, C. L.</span><span> </span><span class="NLM_article-title">Some Methods for Studies of Nicotinic Acetylcholine Receptor Pharmacology</span>. In  <span class="citation_source-book">Nicotinic Receptors and the Nervous System</span>; <span class="NLM_contrib-group">Levin, E. D.</span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">3</span>− <span class="NLM_lpage">27</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=3-27&author=R.+J.+Lukas&author=J.+D.+Fryer&author=J.+B.+Eaton&author=C.+L.+Gentryauthor=E.+D.+Levin&title=Nicotinic+Receptors+and+the+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DSome%2520Methods%2520for%2520Studies%2520of%2520Nicotinic%2520Acetylcholine%2520Receptor%2520Pharmacology%26btitle%3DNicotinic%2520Receptors%2520and%2520the%2520Nervous%2520System%26aulast%3DLevin%26aufirst%3DE.%2BD.%26pub%3DCRC%2520Press%26date%3D2002%26spage%3D3%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Eaton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhlman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinlein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=1283-1294&author=J.+B.+Eatonauthor=J.+H.+Pengauthor=K.+M.+Schroederauthor=A.+A.+Georgeauthor=J.+D.+Fryerauthor=C.+Krishnanauthor=L.+Buhlmanauthor=Y.+P.+Kuoauthor=O.+Steinleinauthor=R.+J.+Lukas&title=Characterization+of+human+alpha+4+beta+2-nicotinic+acetylcholine+receptors+stably+and+heterologously+expressed+in+native+nicotinic+receptor-null+SH-EP1+human+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEaton%26aufirst%3DJ.%2BB.%26aulast%3DPeng%26aufirst%3DJ.%2BH.%26aulast%3DSchroeder%26aufirst%3DK.%2BM.%26aulast%3DGeorge%26aufirst%3DA.%2BA.%26aulast%3DFryer%26aufirst%3DJ.%2BD.%26aulast%3DKrishnan%26aufirst%3DC.%26aulast%3DBuhlman%26aufirst%3DL.%26aulast%3DKuo%26aufirst%3DY.%2BP.%26aulast%3DSteinlein%26aufirst%3DO.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DCharacterization%2520of%2520human%2520alpha%25204%2520beta%25202-nicotinic%2520acetylcholine%2520receptors%2520stably%2520and%2520heterologously%2520expressed%2520in%2520native%2520nicotinic%2520receptor-null%2520SH-EP1%2520human%2520epithelial%2520cells%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D1283%26epage%3D1294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Gentry, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, R. J.</span><span> </span><span class="NLM_article-title">Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm9017465&amp;key=11714893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm9017465&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovVCktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=1038-1048&author=C.+L.+Gentryauthor=R.+J.+Lukas&title=Local+anesthetics+noncompetitively+inhibit+function+of+four+distinct+nicotinic+acetylcholine+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes</span></div><div class="casAuthors">Gentry, Cynthia L.; Lukas, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1038-1048</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Local anesthetics (LAs) are considered to act primarily by inhibiting voltage-gated Na+ channels.  However, LAs also are pharmacol. active at other ion channels including nicotinic acetylcholine receptors (nAChR).  NAChR exist as a family of diverse subtypes, each of which has a unique pharmacol. profile.  The current studies established effects of LAs on function of four human nAChR subtypes: naturally expressed muscle-type (α1*-nAChR) or autonomic (α3β4*-nAChR) nAChR, or heterologously expressed nAChR contg. α4 with either β2- or β4-subunits (α4β2- or α4β4-nAChR).  Of the LAs tested, those with structures contg. two sepd. arom. rings (e.g., proadifen and adiphenine) had the greatest inhibition potency (IC50 values between 0.34 and 6.3 μM) but lowest selectivity (∼4-fold) across the four nAChR subtypes examd.  From the fused, two-ring (isoquinoline backbone) class of LAs, dimethisoquin had comparatively moderate inhibition potency (IC50 values between 2.4 and 61 μM) and ∼30-fold selectivity across nAChR subtypes.  Lidocaine, a commonly used LA from the single ring category of LAs, blocked nAChR function with IC50 values of between 52 and 250 μM and had only ∼5-fold selectivity across nAChR subtypes.  Its quaternary tri-Et ammonium analog, QX-314, had greater inhibition potency, but the tri-Me ammonium deriv., QX-222, was the least potent LA at all but the α4β2-nAChR subtype.  With only a few exceptions, LA effects were consistent with noncompetitive inhibition of nAChR function and occurred at therapeutic doses.  These studies suggest structural determinants for LA action at diverse nAChR subtypes and that nAChR likely are clin. relevant targets of LAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgwUhNlMnNWrVg90H21EOLACvtfcHk0lgUNzLxjp8aPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovVCktL0%253D&md5=93812a342040356130830e57ac370bb8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGentry%26aufirst%3DC.%2BL.%26aulast%3DLukas%26aufirst%3DR.%2BJ.%26atitle%3DLocal%2520anesthetics%2520noncompetitively%2520inhibit%2520function%2520of%2520four%2520distinct%2520nicotinic%2520acetylcholine%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D1038%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">D'Amour, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span> </span><span class="NLM_article-title">A method for determining loss of pain sensation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1941</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1941&pages=74-79&author=F.+E.+D%27Amourauthor=D.+L.+Smith&title=A+method+for+determining+loss+of+pain+sensation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%2527Amour%26aufirst%3DF.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26atitle%3DA%2520method%2520for%2520determining%2520loss%2520of%2520pain%2520sensation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1941%26volume%3D72%26spage%3D74%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a href="/doi/suppl/10.1021/jm9017465">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88037"></div></div></div></div></div><hr /></hr><p class="last">Results from elemental analysis. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9017465/suppl_file/jm9017465_si_001.pdf">jm9017465_si_001.pdf (26.72 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm9017465&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm9017465%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-5%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm9017465" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                941KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679929825c32223c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
